,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,155,1,1,,507098,5280863,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the rad50 strain,Other,,
1,157,1,1,,507098,5280863,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mec2-1 strain,Other,,
2,161,1,1,,507098,5280863,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the sgs1 mgt1 strain,Other,,
3,165,1,1,,507098,5280863,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the cln2 rad14 strain,Other,,
4,167,1,1,,507098,5280863,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the bub3 strain,Other,,
5,175,1,1,,507098,5280863,Inactive,,,,,NCI Yeast Anticancer Drug Screen. Data for the mlh1 rad18 strain,Other,,
6,179,1,1,,507098,5280863,Inactive,,,,,NCI AIDS Antiviral Assay,Confirmatory,,
7,357,2,1,,11112381,5280863,Inconclusive,,,,,AP1 Signaling Pathway,Confirmatory,,
8,382,1,4,,10318979,5280863,Active,206729857.0,1195.0,,,"Compound Screen Assay, Human CLK1",Other,,
9,395,1,3,,10318979,5280863,Active,57165436.0,8576.0,,,"Compound Screen Assay, Human STK16",Screening,,
10,410,1,5,,11112381,5280863,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
11,410,1,5,,11112382,5280863,Active,73915100.0,1544.0,,,p450-cyp1a2,Confirmatory,,
12,411,2,1,,11112381,5280863,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
13,411,2,1,,11112382,5280863,Inactive,160794.0,,,Potency,qHTS Assay for Inhibitors of Firefly Luciferase,Confirmatory,,
14,421,1,3,,17389844,5280863,Inactive,,,,,Cell Viability - BJ,Confirmatory,,
15,426,1,2,,17389844,5280863,Inactive,,,,,Cell Viability - Jurkat,Confirmatory,,
16,427,1,1,,17389844,5280863,Inactive,,,,,Cell Viability - Hek293,Confirmatory,,
17,433,1,1,,17389844,5280863,Inactive,,,,,Cell Viability - HepG2,Confirmatory,,
18,434,1,2,,17389844,5280863,Inactive,,,,,Cell Viability - MRC5,Confirmatory,,
19,435,1,2,,17389844,5280863,Inactive,,,,,Cell Viability - SK-N-SH,Confirmatory,,
20,444,1,1,,11112381,5280863,Inconclusive,,,,,NFAT Signaling Pathway,Confirmatory,,
21,445,3,1,,11112381,5280863,Inconclusive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
22,445,3,1,,11112382,5280863,Inactive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
23,445,3,1,,17389844,5280863,Inconclusive,10092619.0,4792.0,,,IkB Signaling,Confirmatory,,
24,446,1,1,,11112381,5280863,Inconclusive,,,,,Stat Signaling Pathway,Confirmatory,,
25,447,1,1,,11112381,5280863,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
26,447,1,1,,11112382,5280863,Inconclusive,,,,,O-Glc NAc Transferase (sOGT),Confirmatory,,
27,448,1,2,,11112381,5280863,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
28,448,1,2,,11112382,5280863,Inactive,4325211.0,,,,Schistosoma Mansoni Peroxiredoxins (Prx2),Confirmatory,,
29,450,1,2,,11112381,5280863,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
30,450,1,2,,11112382,5280863,Inactive,66528677.0,2908.0,,,GR-GFP Redistribution,Confirmatory,,
31,451,1,2,,11112381,5280863,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
32,451,1,2,,11112382,5280863,Inactive,66528677.0,2908.0,,,GR-EFC Redistribution,Confirmatory,,
33,505,1,2,,10318979,5280863,Active,42821112.0,11040.0,,,"Compound Screen Assay, Human PIM2",Screening,,
34,526,1,1,,11112381,5280863,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
35,526,1,1,,11112382,5280863,Inactive,,,,,Ubiquitin-GFP Assay,Confirmatory,,
36,530,1,1,,11112381,5280863,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
37,530,1,1,,11112382,5280863,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
38,530,1,1,,17389844,5280863,Inactive,2499604.0,26414.0,,,JNK3 AlphaScreen Assay,Confirmatory,,
39,540,1,1,,17389844,5280863,Inactive,,,,,Cell Viability - N2a,Confirmatory,,
40,541,1,1,,17389844,5280863,Inconclusive,,,,,Cell Viability - NIH 3T3,Confirmatory,,
41,542,1,1,,17389844,5280863,Inactive,,,,,Cell Viability - HUV-EC-C,Confirmatory,,
42,543,1,1,,17389844,5280863,Inconclusive,,,,,Cell Viability - H-4-II-E,Confirmatory,,
43,544,2,1,,17389844,5280863,Inconclusive,,,,,Cell Viability - SH-SY5Y,Confirmatory,,
44,545,1,1,,17389844,5280863,Inactive,,,,,Cell Viability - Renal Proximal Tubule,Confirmatory,,
45,546,1,1,,17389844,5280863,Inactive,,,,,Cell Viability - Mesenchymal,Confirmatory,,
46,584,1,3,,11112381,5280863,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
47,584,1,3,,11112382,5280863,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
48,584,1,3,,17389844,5280863,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent),Confirmatory,,
49,585,1,4,,11112381,5280863,Inconclusive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
50,585,1,4,,11112382,5280863,Inactive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
51,585,1,4,,17389844,5280863,Inconclusive,119389684.0,,,,Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent),Confirmatory,,
52,587,1,5,,11112381,5280863,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
53,587,1,5,,11112382,5280863,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Texas Red Spectral Region,Other,,
54,588,1,4,,11112381,5280863,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
55,588,1,4,,11112382,5280863,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Resorufin Spectral Region,Other,,
56,589,1,3,,11112381,5280863,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
57,589,1,3,,11112382,5280863,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in 4-MU Spectral Region,Other,,
58,590,1,3,,11112381,5280863,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
59,590,1,3,,11112382,5280863,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A350 Spectral Region,Other,,
60,591,1,4,,11112381,5280863,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
61,591,1,4,,11112382,5280863,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A488 Spectral Region,Other,,
62,592,1,6,,11112381,5280863,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
63,592,1,6,,11112382,5280863,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in A647 Spectral Region,Other,,
64,593,1,4,,11112381,5280863,Inconclusive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
65,593,1,4,,11112382,5280863,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Fluorescein Spectral Region,Other,,
66,594,1,4,,11112381,5280863,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
67,594,1,4,,11112382,5280863,Inactive,,,,,qHTS Assay for Spectroscopic Profiling in Rhodamine Spectral Region,Confirmatory,,
68,595,1,3,,11112381,5280863,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
69,595,1,3,,11112382,5280863,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
70,595,1,3,,17389844,5280863,Inactive,,,,,qHTS Assay for Disrupters of an Hsp90 Co-Chaperone Interaction,Confirmatory,,
71,596,1,2,,11112381,5280863,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
72,596,1,2,,11112382,5280863,Active,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
73,596,1,2,,17389844,5280863,Inactive,92096784.0,4137.0,,,qHTS Assay for Tau Filament Binding,Confirmatory,,
74,597,1,3,,11112381,5280863,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
75,597,1,3,,11112382,5280863,Inactive,,,,,qHTS Assay for Epigenetic Modulators,Confirmatory,,
76,603,1,2,,11112381,5280863,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
77,603,1,2,,11112382,5280863,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
78,603,1,2,,17389844,5280863,Inactive,,,,,qHTS Assay for Inhibitors of DNA Polymerase III Holoenzyme System,Confirmatory,,
79,605,1,2,,11112381,5280863,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
80,605,1,2,,11112382,5280863,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
81,605,1,2,,17389844,5280863,Inactive,84028058.0,,,,qHTS Assay for Inhibitors of YjeE,Confirmatory,,
82,607,1,3,,11112381,5280863,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
83,607,1,3,,11112382,5280863,Inactive,82799486.0,5142.0,,,qHTS Assay for Inhibitors of PDE-IV,Confirmatory,,
84,654,1,1,,17389844,5280863,Inactive,,,,,Cellular Toxicity (caspase-3) HepG2,Confirmatory,,
85,655,1,1,,17389844,5280863,Inactive,,,,,Cellular Toxicity (caspase-3) Jurkat,Confirmatory,,
86,656,1,1,,17389844,5280863,Inactive,,,,,Cellular Toxicity (caspase-3) HUV-EC-C,Confirmatory,,
87,657,1,1,,17389844,5280863,Inactive,,,,,Cellular Toxicity (caspase-3) SHSY5Y,Confirmatory,,
88,658,1,1,,17389844,5280863,Inactive,,,,,Cellular Toxicity (caspase-3) BJ,Confirmatory,,
89,659,1,1,,17389844,5280863,Inactive,,,,,Cellular Toxicity (caspase-3) MRC-5,Confirmatory,,
90,660,1,1,,17389844,5280863,Inactive,,,,,Cellular Toxicity (caspase-3) Mesangial,Confirmatory,,
91,661,1,1,,17389844,5280863,Inactive,,,,,Cellular Toxicity (caspase-3) SK-N-SH,Confirmatory,,
92,662,1,1,,11112381,5280863,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
93,662,1,1,,11112382,5280863,Inactive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
94,662,1,1,,17389844,5280863,Inconclusive,,,,,Cell signaling CRE-BLA (Fsk stim),Confirmatory,,
95,663,1,1,,17389844,5280863,Inconclusive,,,,,Cellular Toxicity (caspase-3) H-4-II-E,Confirmatory,,
96,664,1,1,,17389844,5280863,Inactive,,,,,Cellular Toxicity (caspase-3) Hek293,Confirmatory,,
97,665,1,1,,17389844,5280863,Inactive,,,,,Cellular Toxicity (caspase-3) N2a,Confirmatory,,
98,666,1,1,,17389844,5280863,Inactive,,,,,Cellular Toxicity (caspase-3) NIH 3T3,Confirmatory,,
99,667,1,1,,17389844,5280863,Inactive,,,,,Cellular Toxicity (caspase-3) Renal Proximal Tubule,Confirmatory,,
100,875,1,2,,11112381,5280863,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
101,875,1,2,,17389844,5280863,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Green Fluorophore),Confirmatory,,
102,880,2,1,,11112381,5280863,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
103,880,2,1,,11112381,5280863,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
104,880,2,1,,17389844,5280863,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
105,880,2,1,,17389844,5280863,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
106,880,2,1,,50105504,5280863,Inactive,3290016.0,6002.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
107,880,2,1,,50105504,5280863,Inactive,33946324.0,2770.0,,,qHTS Assay for Inhibitors of RGS12 GoLoco Motif Activity (Red Fluorophore),Confirmatory,,
108,881,2,2,,11112381,5280863,Inactive,317373425.0,247.0,,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
109,881,2,2,,17389844,5280863,Inconclusive,317373425.0,247.0,25.1189,Potency,qHTS Assay for Inhibitors of 15-hLO-2 (15-human lipoxygenase 2),Confirmatory,,
110,883,1,3,,11112381,5280863,Inconclusive,13699818.0,1559.0,0.0013,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
111,883,1,3,,11112382,5280863,Active,13699818.0,1559.0,15.8489,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C9,Confirmatory,,
112,884,1,2,,11112381,5280863,Inconclusive,13435386.0,1576.0,7.9433,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
113,884,1,2,,17389844,5280863,Active,13435386.0,1576.0,15.8489,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 3A4,Confirmatory,,
114,885,1,2,,11112381,5280863,Inactive,13435386.0,1576.0,7.9433,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
115,885,1,2,,17389844,5280863,Inactive,13435386.0,1576.0,15.8489,Potency,qHTS Assay for Activators of Cytochrome P450 3A4,Confirmatory,,
116,886,1,2,,11112381,5280863,Inconclusive,122921310.0,,15.8489,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
117,886,1,2,,11112381,5280863,Inconclusive,122921311.0,,15.8489,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
118,886,1,2,,11112382,5280863,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
119,886,1,2,,11112382,5280863,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
120,886,1,2,,17389844,5280863,Active,122921310.0,,15.8489,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
121,886,1,2,,17389844,5280863,Active,122921311.0,,15.8489,Potency,"qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II)",Confirmatory,,
122,887,1,2,,11112381,5280863,Inconclusive,1832253.0,246.0,10.0,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
123,887,1,2,,17389844,5280863,Inconclusive,1832253.0,246.0,7.9433,Potency,qHTS Assay for Inhibitors of 15-hLO (15-human lipoxygenase),Confirmatory,,
124,889,1,3,,11112381,5280863,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
125,889,1,3,,17389844,5280863,Inactive,1730092.0,840.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-7,Confirmatory,,
126,891,1,2,,11112381,5280863,Active,40805836.0,1565.0,10.0,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
127,891,1,2,,11112382,5280863,Active,40805836.0,1565.0,15.8489,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2D6,Confirmatory,,
128,892,1,2,,11112381,5280863,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
129,892,1,2,,17389844,5280863,Inactive,159162802.0,,,Potency,qHTS Assay for Inhibitors of BRCT-Phosphoprotein Interaction (Red Fluorophore),Confirmatory,,
130,893,1,2,,11112381,5280863,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
131,893,1,2,,11112381,5280863,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
132,893,1,2,,17389844,5280863,Inactive,122921310.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
133,893,1,2,,17389844,5280863,Inactive,122921311.0,,,Potency,"qHTS Assay for Inhibitors of HSD17B4, hydroxysteroid (17-beta) dehydrogenase 4",Confirmatory,,
134,894,2,1,,11112381,5280863,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
135,894,2,1,,17389844,5280863,Inactive,31542939.0,3248.0,,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
136,894,2,1,,50105504,5280863,Active,31542939.0,3248.0,28.1838,Potency,qHTS Assay for Inhibitors of HPGD (15-Hydroxyprostaglandin Dehydrogenase),Confirmatory,,
137,899,1,2,,11112381,5280863,Inconclusive,4503219.0,1557.0,6.3096,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
138,899,1,2,,11112382,5280863,Inconclusive,4503219.0,1557.0,10.0,Potency,qHTS Assay for Inhibitors and Substrates of Cytochrome P450 2C19,Confirmatory,,
139,900,1,3,,11112381,5280863,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
140,900,1,3,,17389844,5280863,Inactive,15431328.0,834.0,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1,Confirmatory,,
141,901,1,2,,11112381,5280863,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
142,901,1,2,,17389844,5280863,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors,Confirmatory,,
143,902,1,2,,11112381,5280863,Inactive,120407068.0,7157.0,5.0119,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
144,902,1,2,,17389844,5280863,Inactive,120407068.0,7157.0,10.0,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Nonpermissive Temperature,Confirmatory,,
145,912,1,2,,11112381,5280863,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
146,912,1,2,,11112382,5280863,Inconclusive,21392848.0,,5.0119,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
147,912,1,2,,17389844,5280863,Inactive,21392848.0,,,Potency,qHTS Assay for Anthrax Lethal Toxin Internalization,Confirmatory,,
148,914,1,3,,11112381,5280863,Inconclusive,32879895.0,3091.0,1.5849,Potency,qHTS Assay for Identification of Small Molecule Agonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
149,915,1,3,,11112381,5280863,Active,32879895.0,3091.0,1.5849,Potency,qHTS Assay for Identification of Small Molecule Antagonists for Hypoxia Response Element Signaling Pathway,Confirmatory,,
150,921,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-001,Confirmatory,,
151,923,1,2,,11112381,5280863,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
152,923,1,2,,17389844,5280863,Inactive,,,,Potency,qHTS Assay for Allosteric/Competitive Inhibitors of Caspase-1: Spectroscopic Profiling in AFC Spectral Region,Confirmatory,,
153,924,1,2,,11112381,5280863,Inactive,120407068.0,7157.0,3.9811,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
154,924,1,2,,17389844,5280863,Inactive,120407068.0,7157.0,7.9433,Potency,qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53ts Cells at the Permissive Temperature,Confirmatory,,
155,925,1,2,,11112381,5280863,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
156,925,1,2,,17389844,5280863,Inactive,4504349.0,3043.0,,Potency,qHTS Assay for Modulators of Hemoglobin Beta Chain Splicing,Confirmatory,,
157,926,1,2,,11112381,5280863,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
158,926,1,2,,11112382,5280863,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
159,926,1,2,,17389844,5280863,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor,Confirmatory,,
160,927,1,3,,11112381,5280863,Inactive,188528692.0,9099.0,,Potency,qHTS Assay for Inhibitors of Ubiquitin-specific Protease USP2a,Confirmatory,,
161,938,1,2,,11112381,5280863,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
162,938,1,2,,11112382,5280863,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
163,938,1,2,,17389844,5280863,Inactive,38016895.0,7253.0,,Potency,qHTS Assay for Agonists of the Thyroid Stimulating Hormone Receptor: Activators of Intracellular cAMP Concentrations in Parental HEK 293,Confirmatory,,
164,946,1,2,,17389844,5280863,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Dead Cells,Confirmatory,,
165,947,1,2,,17389844,5280863,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-001 - Live Cells,Confirmatory,,
166,948,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 16 hr,Confirmatory,,
167,955,1,2,,17389844,5280863,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Live Cells,Confirmatory,,
168,960,1,2,,17389844,5280863,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-002 - Dead Cells,Confirmatory,,
169,961,1,2,,17389844,5280863,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Dead Cells,Confirmatory,,
170,962,1,2,,17389844,5280863,Inactive,,,,Potency,MultiTox-Fluor Cytotoxicity Assay - LYMP1-003 - Live Cells,Confirmatory,,
171,963,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 24 hr,Confirmatory,,
172,964,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP1-003 - Assay at 40 hr,Confirmatory,,
173,965,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-003,Confirmatory,,
174,966,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-004,Confirmatory,,
175,967,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-005,Confirmatory,,
176,968,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-009,Confirmatory,,
177,969,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-011,Confirmatory,,
178,970,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-013,Confirmatory,,
179,971,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-015,Confirmatory,,
180,972,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-017,Confirmatory,,
181,973,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-019,Confirmatory,,
182,974,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-021,Confirmatory,,
183,975,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-023,Confirmatory,,
184,976,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-025,Confirmatory,,
185,977,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-002,Confirmatory,,
186,978,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-006,Confirmatory,,
187,979,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-007,Confirmatory,,
188,980,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-008,Confirmatory,,
189,981,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-010,Confirmatory,,
190,982,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-012,Confirmatory,,
191,983,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-014,Confirmatory,,
192,984,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-016,Confirmatory,,
193,985,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-018,Confirmatory,,
194,986,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-020,Confirmatory,,
195,987,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-022,Confirmatory,,
196,988,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-024,Confirmatory,,
197,989,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP2-026,Confirmatory,,
198,993,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 24 hr,Confirmatory,,
199,994,1,2,,17389844,5280863,Inactive,,,,Potency,Cell Viability - LYMP1-002 - Assay at 40 hr,Confirmatory,,
200,995,1,2,,11112381,5280863,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
201,995,1,2,,17389844,5280863,Inconclusive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay,Confirmatory,,
202,1030,2,1,,11112381,5280863,Inactive,30582681.0,216.0,,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
203,1030,2,1,,17389844,5280863,Inconclusive,30582681.0,216.0,39.8107,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
204,1030,2,1,,50105504,5280863,Inconclusive,30582681.0,216.0,31.6228,Potency,qHTS Assay for Inhibitors of Aldehyde Dehydrogenase 1 (ALDH1A1),Confirmatory,,
205,1189,1,5,,48413931,5280863,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary SingleCellCall Results,Other,,
206,1194,1,3,,48413931,5280863,Active,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Salmonella Mutagenicity,Other,,
207,1204,1,2,,48421903,5280863,Active,,,,,DSSTox (NCTRER) National Center for Toxicological Research Estrogen Receptor Binding Database,Screening,,
208,1205,1,4,,48413931,5280863,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary MultiCellCall Results,Other,,
209,1208,1,3,,48413931,5280863,Inactive,,,,,DSSTox (CPDBAS) Carcinogenic Potency Database Summary Rat Bioassay Results,Other,,
210,1332,1,1,,49699293,5280863,Inactive,,,,,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
211,1376,1,2,,46501187,5280863,Inactive,15608158.0,886069.0,,IC50,Inhibitors of Mycobacterial Glucosamine-1-phosphate acetyl transferase (GlmU),Confirmatory,,
212,1379,1,2,,11112381,5280863,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
213,1379,1,2,,50105504,5280863,Inactive,1669525.0,,,Potency,Counterscreen for Luciferase (Kinase-Glo TM) Inhibition,Confirmatory,,
214,1385,2,2,,46501187,5280863,Inactive,49168602.0,5888.0,,,Homologous recombination - Rad 51,Screening,,
215,1422,1,1,,46501187,5280863,Inactive,31881630.0,5732.0,,,Inhibitors of the EP2 Prostaglandin E2 Receptor - Primary Screen,Screening,,
216,1452,1,1,,11112381,5280863,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
217,1452,1,1,,17389844,5280863,Inactive,154426292.0,239.0,,Potency,qHTS Assay for Inhibitors of 12-hLO (12-human lipoxygenase),Confirmatory,,
218,1454,1,1,,11112381,5280863,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
219,1454,1,1,,50105504,5280863,Inactive,66932916.0,5594.0,,Potency,qHTS Assay for Inhibitors of the ERK Signaling Pathway using a Homogeneous Screening Assay; Stimulation with EGF,Confirmatory,,
220,1457,1,1,,11112381,5280863,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
221,1457,1,1,,17389844,5280863,Inactive,44888968.0,83523.0,,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
222,1457,1,1,,50105504,5280863,Inactive,44888968.0,83523.0,11.2202,Potency,qHTS Assay for Identifying the Cell-Membrane Permeable IMPase Inhibitors: Potentiation with Lithium,Confirmatory,,
223,1458,1,1,,11112381,5280863,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
224,1458,1,1,,17389844,5280863,Inactive,10937869.0,6607.0,,Potency,qHTS Assay for Enhancers of SMN2 Splice Variant Expression,Confirmatory,,
225,1460,1,3,,50105504,5280863,Active,92096784.0,4137.0,12.5893,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding",Confirmatory,,
226,1463,1,1,,50105504,5280863,Inconclusive,,,15.8489,Potency,"Counterscreen qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
227,1465,1,1,,46501187,5280863,Inactive,,,,EC50,"Screen for small molecule probes relevant to Friedreich's ataxia, Single Dose and Dose Response",Confirmatory,,
228,1467,1,3,,11112381,5280863,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
229,1467,1,3,,50105504,5280863,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors of Human alpha-Galactosidase at pH 4.5.,Confirmatory,,
230,1468,1,1,,50105504,5280863,Inactive,92096784.0,4137.0,,Potency,"qHTS for Inhibitors of Tau Fibril Formation, Fluorescence Polarization",Confirmatory,,
231,1469,1,1,,11112381,5280863,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
232,1469,1,1,,17389844,5280863,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
233,1469,1,1,,26757741,5280863,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
234,1469,1,1,,50105504,5280863,Inactive,189491771.0,7068.0,,Potency,qHTS for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
235,1471,2,1,,11112381,5280863,Inconclusive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
236,1471,2,1,,11112382,5280863,Inconclusive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
237,1471,2,1,,17389844,5280863,Inconclusive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
238,1471,2,1,,50105504,5280863,Inactive,90903231.0,3064.0,,,qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Cytoprotection (ATP),Confirmatory,,
239,1476,2,1,,11112381,5280863,Inconclusive,281307097.0,,12.5893,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
240,1476,2,1,,17389844,5280863,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
241,1476,2,1,,50105504,5280863,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent),Confirmatory,,
242,1477,1,1,,11112381,5280863,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
243,1477,1,1,,17389844,5280863,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
244,1477,1,1,,50105504,5280863,Inactive,,,,Potency,qHTS Assay for Compounds Blocking the Interaction Between CBF-beta and RUNX1 for the Treatment of Acute Myeloid Leukemia,Confirmatory,,
245,1478,2,1,,11112381,5280863,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
246,1478,2,1,,17389844,5280863,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
247,1478,2,1,,50105504,5280863,Inactive,281307097.0,,,Potency,qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent),Confirmatory,,
248,1479,1,2,,11112381,5280863,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
249,1479,1,2,,17389844,5280863,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
250,1479,1,2,,26757741,5280863,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
251,1479,1,2,,50105504,5280863,Inactive,189491771.0,7068.0,,Potency,Total Fluorescence Counterscreen for Inhibitors of the Interaction of Thyroid Hormone Receptor and Steroid Receptor Coregulator 2,Confirmatory,,
252,1487,1,1,,11112381,5280863,Inconclusive,27436948.0,4000.0,3.5481,Potency,qHTS Assay for Modulators of Lamin A Splicing,Confirmatory,,
253,1490,2,1,,11112381,5280863,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
254,1490,2,1,,50105504,5280863,Inactive,10954339.0,,,Potency,qHTS Assay for Inhibitors of Bacillus subtilis Sfp phosphopantetheinyl transferase (PPTase),Confirmatory,,
255,1511,1,3,,46501187,5280863,Inactive,487738.0,3757.0,,,Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents,Screening,,
256,1519,1,3,,11112381,5280863,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
257,1519,1,3,,50105504,5280863,Inactive,,,,Potency,qHTS Assay for Lipid Storage Modulators,Confirmatory,,
258,1529,1,1,,46501187,5280863,Inactive,42794767.0,4215.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype",Screening,,
259,1530,1,1,,46501187,5280863,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase 2 mutant",Screening,,
260,1531,1,1,,46501187,5280863,Inactive,22035600.0,5871.0,,,"Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 binding to MEK Kinase 2 Wildtype",Screening,,
261,1532,1,1,,46501187,5280863,Inactive,,,,,Rml C and D inhibition 384-well mixture HTS,Screening,,
262,1554,1,1,,46501187,5280863,Inactive,,,,,MLPCN Ras selective lethality-BJeLR viability,Screening,,
263,1621,1,2,,46501187,5280863,Inactive,,,,IC50,A Cell Based Assay for the Identification of Lead Compounds with Anti-Viral Activity Against West Nile Virus,Confirmatory,,
264,1626,1,2,,46501187,5280863,Inactive,,,,IC50,High Throughput Screen to Identify Inhibitors of Mycobacterium tuberculosis H37Rv,Confirmatory,,
265,1662,1,2,,46501187,5280863,Inactive,15675770.0,901648.0,,,MLPCN Streptokinase Expression Inhibition,Screening,,
266,1663,1,2,,46501187,5280863,Inactive,,,,,MLPCN Platelet Activation -Dense Granule Release,Screening,,
267,1672,1,3,,46501187,5280863,Inactive,6680530.0,16518.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1,Screening,,
268,1766,1,1,,11112381,5280863,Inactive,18860839.0,4221.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
269,1766,1,1,,11112381,5280863,Inactive,56550039.0,4297.0,,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
270,1766,1,1,,50105504,5280863,Inconclusive,18860839.0,4221.0,39.8107,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
271,1766,1,1,,50105504,5280863,Inconclusive,56550039.0,4297.0,39.8107,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Fluorescein Labeled MLL-derived Peptide,Confirmatory,,
272,1768,1,1,,11112381,5280863,Inconclusive,18860839.0,4221.0,14.1254,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
273,1768,1,1,,11112381,5280863,Inconclusive,56550039.0,4297.0,14.1254,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
274,1768,1,1,,50105504,5280863,Inconclusive,18860839.0,4221.0,35.4813,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
275,1768,1,1,,50105504,5280863,Inconclusive,56550039.0,4297.0,35.4813,Potency,qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide,Confirmatory,,
276,1813,1,2,,46501187,5280863,Inactive,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - inhibitors,Screening,,
277,1814,1,2,,46501187,5280863,Active,,,,,MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators,Screening,,
278,1832,2,1,,46501187,5280863,Inactive,55976631.0,178296.0,,,MLPCN maternal gene expression-MEX-5 TCR-2 binding assay-Primary Screen,Screening,,
279,1850,2,1,,46501187,5280863,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella typhi,Confirmatory,,
280,1851,1,2,,11112381,5280863,Unspecified,,,,,Cytochrome panel assay with activity outcomes,Other,,
281,1851,1,2,1.0,11112381,5280863,Inconclusive,4503219.0,1557.0,,,Cytochrome panel assay with activity outcomes,Other,,
282,1851,1,2,2.0,11112381,5280863,Active,68509921.0,1565.0,,,Cytochrome panel assay with activity outcomes,Other,,
283,1851,1,2,3.0,11112381,5280863,Inconclusive,13435386.0,1576.0,,,Cytochrome panel assay with activity outcomes,Other,,
284,1851,1,2,4.0,11112381,5280863,Active,73915100.0,1544.0,,,Cytochrome panel assay with activity outcomes,Other,,
285,1851,1,2,5.0,11112381,5280863,Inconclusive,13699818.0,1559.0,,,Cytochrome panel assay with activity outcomes,Other,,
286,1863,2,1,,46501187,5280863,Inactive,,,,IC50,A small molecule screen for inhibitors of the PhoP regulon in Salmonella Typhimurium,Confirmatory,,
287,1865,1,1,,11112381,5280863,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
288,1865,1,1,,50105504,5280863,Inactive,,,,Potency,Quantitative High-Throughput Screen for Regulators of Epigenetic Control,Confirmatory,,
289,1875,2,1,,46501187,5280863,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Polyadenylation,Screening,,
290,1885,2,1,,46501187,5280863,Inactive,,,,,Luminescence Cell-Based/Microorganism Primary HTS to Identify Inhibitors of T.Cruzi Replication,Screening,,
291,1899,1,3,,46501187,5280863,Inactive,83779224.0,,,,TR-FRET-based primary biochemical high-throughput screening assay to identify inhibitors of Hepatitis C Virus (HCV) core protein dimerization,Screening,,
292,1903,2,3,,46501187,5280863,Inactive,297591903.0,29031019.0,,IC50,Identification of SV40 T antigen inhibitors: A route to novel anti-viral reagents,Confirmatory,,
293,1906,1,3,,46501187,5280863,Inactive,55958172.0,,,,QFRET-based counterscreen for PFM18AAP inhibitors: biochemical high throughput screening assay to identify inhibitors of the Cathepsin L proteinase (CTSL1).,Screening,,
294,1910,1,2,,46501187,5280863,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Transcriptional Activators of Hypoxia-Inducible Factor Pathway,Screening,,
295,1947,1,2,,46501187,5280863,Inactive,21595511.0,226016.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the serine hydrolase family member Fam108B.,Screening,,
296,1948,1,1,,11112381,5280863,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
297,1948,1,1,,17389844,5280863,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
298,1948,1,1,,50105504,5280863,Inactive,,,,Potency,qHTS Assay for Compounds that Induce Erasure of Genomic Imprints,Confirmatory,,
299,1950,1,3,,46501187,5280863,Inactive,23893623.0,3783709.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the Epstein-Barr virus nuclear antigen 1 (EBNA-1).,Screening,,
300,1956,1,1,,46501187,5280863,Inactive,,,,Conc @ Max Fold Increase,A high-throughput screen to identify small molecule compounds that augment HSV replication,Confirmatory,,
301,1962,1,2,,46501187,5280863,Inactive,68476498.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of tRNA 2'-phosphotransferase (TPT1).,Screening,,
302,1974,1,2,,46501187,5280863,Inactive,4758484.0,9446.0,,,Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1).,Screening,,
303,1979,1,1,,46501187,5280863,Inactive,994798.0,,,,Fluorescence Cell-Based Primary HTS of C.albicans growth in the presence of Fluconazole and compound,Screening,,
304,1987,1,2,,46501187,5280863,Inactive,37589898.0,5536.0,,,Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase 5 (PP5).,Screening,,
305,2016,1,3,,46501187,5280863,Inactive,1302091.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN.,Screening,,
306,2023,1,3,,46501187,5280863,Inactive,486173.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ LAP4_MLPCN.,Screening,,
307,2025,1,3,,46501187,5280863,Inactive,536029.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ RPL19A_MLPCN.,Screening,,
308,2029,1,3,,46501187,5280863,Inactive,171229.0,,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ CIT2_MLPCN.,Screening,,
309,2052,2,1,,46501187,5280863,Inactive,124486680.0,16408.0,,,HTS for developing T Cell Immune Modulators,Screening,,
310,2057,1,2,,46501187,5280863,Inactive,78070770.0,4170.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide.,Screening,,
311,2066,1,4,,46501187,5280863,Inactive,85666113.0,850333.0,,,Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ AGP1_MLPCN.,Screening,,
312,2094,1,2,,46501187,5280863,Inactive,67463988.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
313,2094,1,2,,46501187,5280863,Inactive,67463989.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
314,2094,1,2,,46501187,5280863,Inactive,166202459.0,,,,Plate Read Microorganism-Based Primary HTS to Identify Modulators of the AI-2 Quorum Sensing System,Screening,,
315,2097,1,2,,46501187,5280863,Inactive,21361340.0,2932.0,,,Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity,Screening,,
316,2098,1,1,,46501187,5280863,Inactive,62740231.0,15499.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1).,Screening,,
317,2099,1,1,,46501187,5280863,Inactive,,,,,Fluorescence Biochemical Primary HTS to Identify Inhibitors of GASC-1 Activity,Screening,,
318,2101,1,1,,11112381,5280863,Inconclusive,496369.0,2629.0,11.2202,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
319,2101,1,1,,17389844,5280863,Inconclusive,496369.0,2629.0,35.4813,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
320,2101,1,1,,50105504,5280863,Inconclusive,496369.0,2629.0,11.2202,Potency,qHTS Assay for Inhibitors and Activators of N370S glucocerebrosidase as a Potential Chaperone Treatment of Gaucher Disease,Confirmatory,,
321,2107,1,1,,11112381,5280863,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
322,2107,1,1,,17389844,5280863,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
323,2107,1,1,,50105504,5280863,Inactive,757912.0,2717.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Galactosidase From Spleen Homogenate,Confirmatory,,
324,2112,1,1,,11112381,5280863,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
325,2112,1,1,,17389844,5280863,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
326,2112,1,1,,50105504,5280863,Inactive,119393891.0,2548.0,,Potency,qHTS Assay for Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate,Confirmatory,,
327,2120,1,1,,17389844,5280863,Inactive,32879895.0,3091.0,,Potency,qHTS Assay for Identification of Small Molecule Inducers of Hypoxia Response,Confirmatory,,
328,2129,1,2,,46501187,5280863,Inactive,510901.0,598.0,,,"Primary biochemical high throughput screening assay to identify inhibitors of BCL2-related protein, long isoform (BCLXL).",Screening,,
329,2130,1,3,,46501187,5280863,Inactive,7706645.0,51400.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1).,Screening,,
330,2147,1,1,,11112381,5280863,Inconclusive,221046486.0,,15.8489,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
331,2147,1,1,,50105504,5280863,Inconclusive,221046486.0,,39.8107,Potency,qHTS Assay for Inhibitors of  Human Jumonji Domain Containing 2E (JMJD2E),Confirmatory,,
332,2156,2,2,,46501187,5280863,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ2 potassium channels,Screening,,
333,2174,1,3,,46501187,5280863,Inactive,5453722.0,10434.0,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 1 (LYPLA1).,Screening,,
334,2177,1,3,,46501187,5280863,Inactive,4581413.0,,,,Counterscreen for PME1 inhibitors: fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of lysophospholipase 2 (LYPLA2).,Screening,,
335,2216,1,3,,46501187,5280863,Inactive,,,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex,Screening,,
336,2221,1,2,,46501187,5280863,Inactive,15609874.0,888371.0,,,Fluorescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of RecA Intein Splicing Activity,Screening,,
337,2227,1,2,,46501187,5280863,Inactive,2935630.0,22066.0,,,Primary cell-based high-throughput screening assay for identification of compounds that allosterically potentiate transient receptor potential cation channel C4 (TRPC4),Screening,,
338,2234,1,2,,46501187,5280863,Inactive,82503229.0,3783744.0,,,"Counterscreen for inhibitors of EBNA-1: fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of the Epstein-Barr virus-encoded protein, ZTA.",Screening,,
339,2235,1,2,,46501187,5280863,Inactive,56790945.0,5499.0,,,Counterscreen for inhibitors of PP5: fluorescence-based biochemical high throughput primary assay to identify inhibitors of Protein Phosphatase 1 (PP1).,Screening,,
340,2237,1,2,,46501187,5280863,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that activate transient receptor potential cation channel C4 (TRPC4).,Screening,,
341,2239,1,2,,46501187,5280863,Inactive,18959272.0,170848.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels,Screening,,
342,2240,1,1,,85788890,5280863,Inactive,38156699.0,4286.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of MITF,Screening,,
343,2241,1,1,,85788890,5280863,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1,Screening,,
344,2247,1,2,,46501187,5280863,Inactive,2935630.0,22066.0,,,Primary cell-based screen for identification of compounds that inhibit transient receptor potential cation channel C4 (TRPC4).,Screening,,
345,2275,1,1,,85788890,5280863,Inactive,,,,,Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells,Screening,,
346,2280,2,3,,46501187,5280863,Inactive,17507875.0,172532.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of GLD-1 protein - TGE RNA interaction.,Screening,,
347,2300,1,3,,46501187,5280863,Inactive,216409728.0,10002.0,,,"TR-FRET-based primary biochemical high throughput screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3).",Screening,,
348,2313,1,1,,85788890,5280863,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway,Screening,,
349,2322,1,1,,85788890,5280863,Active,,,,,Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity,Screening,,
350,2330,1,1,,85788890,5280863,Inactive,12830367.0,65975.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of STK33,Screening,,
351,2380,1,2,,46501187,5280863,Inactive,,,,,uHTS identification of small molecules that induce b-cell replication in the MIN-6 cell line,Screening,,
352,2435,1,2,,46501187,5280863,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify agonists of the Oxytocin Receptor (OXTR).,Screening,,
353,2445,1,2,,46501187,5280863,Inactive,32307152.0,5021.0,,,Fluorescence-based primary cell-based high throughput screening assay to identify potentiators of Oxytocin Receptor (OXTR),Screening,,
354,2451,1,2,,11112381,5280863,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
355,2451,1,2,,50105504,5280863,Inactive,122920737.0,,,Potency,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia",Confirmatory,,
356,2462,1,1,,46501187,5280863,Inactive,20336315.0,10018.0,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
357,2462,1,1,,46501187,5280863,Inactive,167013344.0,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of A1 Apoptosis.,Screening,,
358,2472,1,2,,11112381,5280863,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
359,2472,1,2,,50105504,5280863,Inactive,7669492.0,2597.0,,,"qHTS Assay for Inhibitors of Fructose-1,6-bisphosphate Aldolase from Giardia Lamblia: Coupling assay counterscreen",Screening,,
360,2517,2,1,,11112381,5280863,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
361,2517,2,1,,17389844,5280863,Inactive,6980812.0,,,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
362,2517,2,1,,50105504,5280863,Inconclusive,6980812.0,,28.1838,Potency,qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1),Confirmatory,,
363,2520,1,4,,46501187,5280863,Inactive,4885057.0,187.0,,,uHTS identification of small molecule agonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
364,2521,1,3,,46501187,5280863,Inactive,4885057.0,187.0,,,uHTS identification of small molecule antagonists of the APJ  receptor  via a luminescent beta-arrestin assay,Screening,,
365,2524,1,2,,46501187,5280863,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of activators of human intestinal alkaline phosphatase,Screening,,
366,2528,1,2,,11112381,5280863,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
367,2528,1,2,,50105504,5280863,Inactive,4557365.0,641.0,,Potency,qHTS Assay for Inhibitors of Bloom's syndrome helicase (BLM),Confirmatory,,
368,2540,1,2,,46501187,5280863,Inactive,262118306.0,123228.0,,,HTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 8 (SENP8),Screening,,
369,2544,1,2,,46501187,5280863,Inactive,124376142.0,248.0,,,uHTS Luminescent assay for identification of inhibitors of human intestinal alkaline phosphatase,Screening,,
370,2546,1,1,,11112381,5280863,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
371,2546,1,1,,17389844,5280863,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
372,2546,1,1,,50105504,5280863,Inactive,188536040.0,19885.0,,Potency,VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
373,2549,1,1,,11112381,5280863,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
374,2549,1,1,,17389844,5280863,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
375,2549,1,1,,50105504,5280863,Inactive,282403581.0,,,Potency,qHTS Assay for Inhibitors of RecQ-Like Dna Helicase 1 (RECQ1),Confirmatory,,
376,2550,1,3,,46501187,5280863,Inactive,160333370.0,22068.0,,,High throughput screening of activators of transient receptor potential cation channel C6 (TRPC6),Screening,,
377,2551,1,1,,11112381,5280863,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
378,2551,1,1,,17389844,5280863,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
379,2551,1,1,,50105504,5280863,Inactive,188536040.0,19885.0,,Potency,qHTS for inhibitors of ROR gamma transcriptional activity,Confirmatory,,
380,2553,1,2,,46501187,5280863,Inactive,160333370.0,22068.0,,,High throughput screening of inhibitors of transient receptor potential cation channel C6 (TRPC6),Screening,,
381,2557,1,3,,46501187,5280863,Inactive,67191027.0,3676.0,,,HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library,Screening,,
382,2563,1,1,,46501187,5280863,Inactive,6323930.0,855317.0,,,Fluorescence Cell-Free Homogenous Primary HTS  to Identify Inhibitors of the Ras-converting Enzyme,Screening,,
383,2599,1,2,,46501187,5280863,Inactive,6166485.0,26054.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 6 (SENP6),Screening,,
384,2606,1,2,,46501187,5280863,Inactive,15610807.0,885176.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the membrane-associated serine protease Rv3671c in M.tuberculosis,Screening,,
385,2629,1,1,,46501187,5280863,Inactive,139472804.0,4961527.0,,,Fluorescence Polarization Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the LANA Histone H2A/H2B Interaction,Screening,,
386,2642,1,2,,46501187,5280863,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels,Screening,,
387,2648,1,2,,46501187,5280863,Inactive,32479527.0,3784.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels,Screening,,
388,2650,2,1,,46501187,5280863,Inactive,49574532.0,2931.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha,Screening,,
389,2661,1,1,,46501187,5280863,Inactive,23943882.0,65975.0,,,Luminescence Cell-Free  Homogenous Primary HTS to Identify Inhibitors of Serine/Threonine  Kinase 33  Activity,Screening,,
390,2690,1,2,,46501187,5280863,Inactive,,,,,A yeast HTS for caloric restriction mimetics that inhibit age-related superoxide,Screening,,
391,2716,1,1,,46501187,5280863,Inactive,,,,,Luminescence  Microorganism Primary HTS to Identify Inhibitors of the SUMOylation Pathway Using a Temperature Sensitive Growth Reversal Mutant Mot1-301,Screening,,
392,2717,1,2,,46501187,5280863,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Cancer Stem Cells,Screening,,
393,2718,1,1,,46501187,5280863,Inactive,13128862.0,8841.0,,,Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of Histone Deacetylase 3,Screening,,
394,2751,2,2,,46501187,5280863,Inactive,153217451.0,9581.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the prolyl oligopeptidase-like enzyme (PREPL),Screening,,
395,2796,1,4,,46501187,5280863,Inactive,4502003.0,196.0,,,Luminescence-based primary cell-based high throughput screening assay to identify activators of the Aryl Hydrocarbon Receptor (AHR),Screening,,
396,2797,1,2,,46501187,5280863,Inactive,4502331.0,552.0,,,Counterscreen for Oxytocin Receptor (OXTR) agonists: Fluorescence-based primary cell-based high throughput assay to identify agonists of the vasopressin 1 receptor (V1R),Screening,,
397,2805,2,2,,46501187,5280863,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of activators of mouse intestinal alkaline phosphatase,Screening,,
398,2806,2,2,,46501187,5280863,Inactive,124487323.0,76768.0,,,uHTS Luminescent assay for identification of inhibitors of mouse intestinal alkaline phosphatase,Screening,,
399,2825,1,2,,46501187,5280863,Inactive,219518789.0,114548.0,,,uHTS Luminescent assay for identification of inhibitors of NALP3 in yeast,Screening,,
400,17283,6,2,,103206920,5280863,Active,,,29.53,Ki,Disassociation constant (KI) was obtained from Cheng and Prusoff equation for quercetin trypsin complex,Confirmatory,9406602.0,
401,54410,6,5,,103206920,5280863,Active,,,6.0,Ki,Binding affinity towards cytochrome P450 2C9,Confirmatory,14761192.0,
402,93376,3,7,,103206920,5280863,Inactive,,,,,Antiviral activity as inhibition of HIV integrase; Inactive,Other,10090782.0,
403,93507,9,2,,103206920,5280863,Unspecified,,,97.8,IC50,IC50 was measured as concentration required to inhibit 50% of HIV-integrase cleavage,Confirmatory,7699704.0,
404,93508,9,2,,103206920,5280863,Unspecified,,,64.7,IC50,IC50 was measured as concentration required to inhibit 50% of HIV-integrase integration,Confirmatory,7699704.0,
405,150741,10,5,,103206920,5280863,Active,239938877.0,18671.0,6.7,Kd,Binding affinity to nucleotide-binding domain (NBD2) of P-Glycoprotein,Confirmatory,11140738.0,
406,150742,3,11,,103206920,5280863,Unspecified,239938877.0,18671.0,,,Percent of maximal quenching fluorescence for binding analysis to nucleotide-binding domain (NBD2) of P-Glycoprotein was determined,Other,11140738.0,
407,161145,3,11,,103206920,5280863,Unspecified,46396283.0,3778.0,,,"The compound was tested for maxi-K channel opening property at concentration of 20 uM, activity expressed as percentage of current",Other,,
408,214874,10,5,,103206920,5280863,Unspecified,205371855.0,780933.0,105.9,IC50,Inhibitory concentration of the compounds against Bovine trypsin enzyme.,Confirmatory,9406602.0,
409,215969,5,1,,103206920,5280863,Unspecified,,,,,Dose required for inhibitory activity against oxidation of L-DOPA by mushroom tyrosinase,Other,,
410,240981,9,2,,103206920,5280863,Active,,,3.5,IC50,Inhibition of glycogen synthase kinase 3,Confirmatory,15689157.0,
411,241206,9,2,,103206920,5280863,Active,,,41.0,IC50,Inhibition of cyclin-dependent kinase 1/cyclinB,Confirmatory,15689157.0,
412,241232,9,3,,103206920,5280863,Unspecified,,,51.0,IC50,Inhibition of Cyclin-dependent kinase 5-p25nck5a,Confirmatory,15689157.0,
413,242481,10,5,,103206920,5280863,Active,266423.0,1021.0,22.0,IC50,Inhibition of human cyclin-dependent kinase 6 complex with a virus-encoded cyclin from herpesvirus saimiri (Vcyclin),Confirmatory,15689157.0,
414,250527,3,5,,103206920,5280863,Unspecified,,,,,Antiproliferative effect against human colonic cell line (HT-29) after 6 hr at a concentration of 50 uM,Other,15828817.0,
415,250567,3,5,,103206920,5280863,Unspecified,,,,,Antiproliferative effect against human colonic cell line (HT-29) after 24 hr at a concentration of 50 uM,Other,15828817.0,
416,252875,3,4,,103206920,5280863,Unspecified,,,,,Caspase 3/7 activity is expressed as ratio of caspase activation in treated human colonic cell line (HT-29) to that of untreated control cells after 5 hr,Other,15828817.0,
417,257079,3,9,,103206920,5280863,Unspecified,83305339.0,5292.0,,,Inhibitory activity against PIM1 at 1 uM,Other,16302800.0,
418,257080,3,9,,103206920,5280863,Unspecified,83305339.0,5292.0,,,Inhibitory activity against PIM1 at 10 uM,Other,16302800.0,
419,265759,8,7,,103206920,5280863,Active,74844868.0,,20.0,IC50,Inhibition of FabI,Confirmatory,16722653.0,
420,265760,10,2,,103206920,5280863,Active,75020671.0,,4.0,IC50,Inhibition of FabG,Confirmatory,16722653.0,
421,265761,6,2,,103206920,5280863,Active,,,30.4,IC50,Antiplasmodial activity against chloroquine-sensitive Plasmodium falciparum NF54,Confirmatory,16722653.0,
422,265762,6,2,,103206920,5280863,Inconclusive,,,,IC50,Antiplasmodial activity against chloroquine-resistant Plasmodium falciparum K1,Confirmatory,16722653.0,
423,265763,3,10,,103206920,5280863,Inactive,74844869.0,,,,Inhibition of FabZ at 100 uM,Other,16722653.0,
424,286228,9,5,,103206920,5280863,Active,126407.0,240.0,2.7,IC50,Inhibition of 5LOX in human PBMC by EIA assay,Confirmatory,17378609.0,
425,286229,9,5,,103206920,5280863,Active,126397.0,100009114.0,2.2,IC50,Inhibition of 15LOX in rabbit reticulocytes by EIA assay,Confirmatory,17378609.0,
426,286230,9,5,,103206920,5280863,Unspecified,3915797.0,5743.0,100.0,IC50,Inhibition of human recombinant COX2 expressed in insect Sf21 cells by EIA assay,Confirmatory,17378609.0,
427,286231,9,5,,103206920,5280863,Unspecified,317373262.0,5742.0,100.0,IC50,Inhibition of human platelet COX1 by EIA assay,Confirmatory,17378609.0,
428,293297,7,1,,103206920,5280863,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 20 min,Other,17166721.0,
429,293298,8,1,,103206920,5280863,Inactive,,,,IC50,Antioxidant activity assessed as inhibition of superoxide production by xanthine/xanthine oxidase method,Confirmatory,17166721.0,
430,293299,9,1,,103206920,5280863,Unspecified,,,,,Antioxidant activity in BALB/c mouse BM cells assessed as inhibition of ROS production,Other,17166721.0,
431,295546,7,1,,103206920,5280863,Unspecified,,,,,"Effect on food intake in ddY mouse at 10 mg/kg/day, po after 14 to 15 days",Other,17400451.0,
432,295552,7,1,,103206920,5280863,Unspecified,,,,,"Reduction of epididymal fat in ddY mouse at 10 mg/kg/day, po after 14 to 15 days",Other,17400451.0,
433,295558,7,1,,103206920,5280863,Unspecified,,,,,"Reduction of mesenteric fat in ddY mouse at 10 mg/kg/day, po after 14 to 15 days",Other,17400451.0,
434,295564,7,1,,103206920,5280863,Unspecified,,,,,"Reduction of paranephric fat in ddY mouse at 10 mg/kg/day, po after 14 to 15 days",Other,17400451.0,
435,295570,7,1,,103206920,5280863,Unspecified,,,,,"Reduction of visceral fat in ddY mouse at 10 mg/kg/day, po after 14 to 15 days",Other,17400451.0,
436,295576,7,1,,103206920,5280863,Unspecified,,,,,"Effect on liver weight in ddY mouse at 10 mg/kg/day, po after 14 to 15 days",Other,17400451.0,
437,295582,7,1,,103206920,5280863,Unspecified,,,,,"Effect on liver triglyceride in ddY mouse at 10 mg/kg/day, po after 14 to 15 days",Other,17400451.0,
438,295588,7,1,,103206920,5280863,Unspecified,,,,,"Effect on plasma triglyceride in ddY mouse at 10 mg/kg/day, po after 14 to 15 days",Other,17400451.0,
439,295594,7,1,,103206920,5280863,Unspecified,,,,,"Effect on total plasma cholesterol in ddY mouse at 10 mg/kg/day, po after 14 to 15 days",Other,17400451.0,
440,295600,7,1,,103206920,5280863,Unspecified,,,,,"Effect on free fatty acid in ddY mouse plasma at 10 mg/kg/day, po after 14 to 15 days",Other,17400451.0,
441,295601,8,1,,103206920,5280863,Unspecified,,,,,Effect on D-glucose level in ddY mouse plasma at 0.1 to 10 mg/kg/day for 15 days,Other,17400451.0,
442,310882,6,2,,103206920,5280863,Unspecified,,,100.0,EC50,Inhibition of HIV1 replication,Confirmatory,17189684.0,
443,311070,7,2,,103206920,5280863,Active,,,0.027999999999999997,IC50,Inhibition of aryl hydrocarbon receptor,Confirmatory,17544277.0,
444,311071,5,2,,103206920,5280863,Active,,,,,Inhibition of cigarette smoke condensate-induced growth of immortalized human BEAS-2B cells by soft agar colony assay,Other,17544277.0,
445,311148,10,2,,103206920,5280863,Unspecified,,,,IC50,Inhibition of PIM1 kinase,Confirmatory,17637507.0,
446,311864,6,2,,103206920,5280863,Active,,,1.6,IC50,Induction of mouse osteoclast apoptosis,Confirmatory,17994703.0,
447,317349,7,1,,103206920,5280863,Active,,,,,Drug level in human plasma after 6 hrs,Other,18024139.0,
448,332640,3,9,,103206920,5280863,Unspecified,13959709.0,7153.0,,,Enhancement of human DNA topoisomerase 2-mediated Escherichia coli pUC8 DNA cleavage assessed as production of linear DNA at 100 ug/ml after 30 mins by agarose gel electrophoresis relative to control,Other,7769390.0,
449,332642,3,4,,103206920,5280863,Inactive,,,,,Binding affinity to Escherichia coli pUC8 DNA assessed as production of linear DNA at 100 ug/ml after 30 mins by agarose gel electrophoresis,Other,7769390.0,
450,332645,3,4,,103206920,5280863,Inactive,,,,,Inhibition of calf thymus DNA topoisomerase 1 catalytic domain-mediated supercoiled Escherichia coli pUC8 DNA relaxation up to 100 uM after 30 mins by agarose gel electrophoresis,Other,7769390.0,
451,332646,3,9,,103206920,5280863,Inactive,13959709.0,7153.0,,,Inhibition of human DNA topoisomerase 2 catalytic domain-mediated knotted bacteriophage P4Virl dell0 DNA unknotting up to 100 uM by agarose gel electrophoresis,Other,7769390.0,
452,332647,3,9,,103206920,5280863,Unspecified,13959709.0,7153.0,,,Enhancement of human DNA topoisomerase 2-mediated Escherichia coli pUC8 DNA cleavage after 30 mins by agarose gel electrophoresis,Other,7769390.0,
453,332648,3,9,,103206920,5280863,Unspecified,13959709.0,7153.0,,,Enhancement of human DNA topoisomerase 2-mediated Escherichia coli pUC8 DNA cleavage assessed as production of linear DNA at 100 ug/ml after 30 mins by agarose gel electrophoresis relative to total DNA,Other,7769390.0,
454,338023,3,4,,103206920,5280863,Unspecified,,,,,Inhibition of beef heart mitochondrial NADH oxidase assessed as specific activity at 0.35 mM preincubated for 15 mins relative to control,Other,2959755.0,
455,338024,3,4,,103206920,5280863,Unspecified,,,,,Inhibition of beef heart mitochondrial succinoxidase assessed as specific activity at 0.35 mM preincubated for 15 mins relative to control,Other,2959755.0,
456,338026,3,4,,103206920,5280863,Unspecified,,,,,Inhibition of rat liver mitochondrial ATPase assessed as specific activity at 0.42 mM relative to control,Other,2959755.0,
457,339009,5,1,,103206920,5280863,Unspecified,,,,,Cytotoxicity against mouse P388 cells,Other,3404159.0,
458,339056,8,1,,103206920,5280863,Active,,,1.22,ID50,Inhibition of Moloney murine leukemia virus reverse transcriptase using (riboadenylic acid)n(deoxythymidylic acid)12-18 as template primer by liquid scintillation counting,Confirmatory,1378087.0,
459,339057,8,1,,103206920,5280863,Active,,,1.29,ID50,Inhibition of Moloney murine leukemia virus reverse transcriptase using (ribocytidylic acid)n(deoxyguanylic acid)12-18 as template primer by liquid scintillation counting,Confirmatory,1378087.0,
460,339058,3,5,,103206920,5280863,Unspecified,,,,,Selectivity for Moloney murine leukemia virus reverse transcriptase over Escherichia coli DNA polymerase 1,Other,1378087.0,
461,339150,11,1,,103206920,5280863,Unspecified,,,,,Inhibition of bovine thymus p56-LCK protein tyrosine kinase activity,Other,8350096.0,
462,349305,3,4,,103206920,5280863,Unspecified,,,,,Binding affinity to GABAA receptor,Other,18158201.0,
463,355135,6,2,,103206920,5280863,Unspecified,,,,,Antimicrobial activity against Porphyromonas gingivalis ATCC 33277 by disk diffusion method,Other,8904847.0,
464,355136,6,2,,103206920,5280863,Unspecified,,,,,Antimicrobial activity against Prevotella intermedia by disk diffusion method,Other,8904847.0,
465,355137,6,2,,103206920,5280863,Unspecified,,,,,Antimicrobial activity against Streptococcus mutans Ingbritt by disk diffusion method,Other,8904847.0,
466,355138,6,2,,103206920,5280863,Unspecified,,,,,Antimicrobial activity against Actinomyces viscosus W1053 by disk diffusion method,Other,8904847.0,
467,356646,6,3,,103206920,5280863,Unspecified,,,89.7,IC50,Antioxidant activity assessed as DPPH radical scavenging activity after 30 mins,Confirmatory,14640528.0,
468,357253,6,2,,103206920,5280863,Unspecified,,,,,Inhibition of Saccharomyces cerevisiae fatty acid synthase,Other,12502337.0,
469,357254,6,2,,103206920,5280863,Unspecified,,,,,Antifungal activity against Candida albicans ATCC 90028,Other,12502337.0,
470,357255,6,2,,103206920,5280863,Unspecified,,,,,Antifungal activity against Cryptococcus neoformans ATCC 90113,Other,12502337.0,
471,358171,14,2,,103206920,5280863,Unspecified,2811086.0,1956.0,,IC50,Inhibition of EGFR in human A431 cells,Confirmatory,1479375.0,
472,359626,3,5,,103206920,5280863,Unspecified,,,,,Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 22.9 ug/ml,Other,1338212.0,
473,359627,3,5,,103206920,5280863,Unspecified,,,,,Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 34.3 ug/ml,Other,1338212.0,
474,359628,3,5,,103206920,5280863,Unspecified,,,,,Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 45.7 ug/ml,Other,1338212.0,
475,359629,3,5,,103206920,5280863,Unspecified,,,,,Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 12 ug/ml,Other,1338212.0,
476,359630,3,5,,103206920,5280863,Unspecified,,,,,Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 24.1 ug/ml,Other,1338212.0,
477,359631,3,5,,103206920,5280863,Unspecified,,,,,Antiviral activity against HSV1 in african green monkey Vero cells assessed as log reduction of virus titer at 36.2 ug/ml,Other,1338212.0,
478,359646,6,3,,103206920,5280863,Unspecified,,,,,Cytotoxicity against african green monkey Vero cells,Other,1338212.0,
479,365674,10,5,,103206920,5280863,Unspecified,215273868.0,5550.0,200.0,IC50,Inhibition of human brain prolyl oligopeptidase expressed in Escherichia coli,Confirmatory,18650094.0,
480,365675,6,4,,103206920,5280863,Unspecified,,,132.0,IC50,Inhibition of DPP4,Confirmatory,18650094.0,
481,366284,6,2,,103206920,5280863,Active,,,38.1,IC50,Inhibition of Influenza A Jinan/15/90 H3N2 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay,Confirmatory,18640042.0,
482,366285,6,2,,103206920,5280863,Unspecified,,,58.6,IC50,Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay,Confirmatory,18640042.0,
483,366286,6,2,,103206920,5280863,Active,,,46.4,IC50,Inhibition of Influenza A Jiangsu/10/2003 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay,Confirmatory,18640042.0,
484,376069,6,2,,103206920,5280863,Active,,,,,Antibacterial activity against Porphyromonas gingivalis after 48 hrs by microtiter plate method,Other,10543897.0,
485,378878,6,3,,103206920,5280863,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity,Other,10650074.0,
486,378879,6,2,,103206920,5280863,Unspecified,,,,,Antioxidant activity in human HL60 cells assessed as reduction of cytochrome-c release,Other,10650074.0,
487,379054,6,3,,103206920,5280863,Active,,,20.0,IC50,Inhibition of TNFalpha expression in LPS-stimulated human monocytes treated 30 mins before LPS challenge measured after 14 hrs by ELISA,Confirmatory,10096854.0,
488,379055,4,3,,103206920,5280863,Unspecified,,,,,Cytotoxicity against human monocytes assessed as depletion of cellular LDH activity,Other,10096854.0,
489,379189,6,3,,103206920,5280863,Inactive,,,,,Cytotoxicity against human Hep G2 cells after 3 days by MTT method,Other,17125218.0,
490,379190,6,3,,103206920,5280863,Inactive,,,,,Cytotoxicity against human Hep3B cells after 3 days by MTT method,Other,17125218.0,
491,379191,3,4,,103206920,5280863,Inactive,,,,,Cytotoxicity against human MCF7 cells after 3 days by MTT method,Other,17125218.0,
492,379192,3,4,,103206920,5280863,Inactive,,,,,Cytotoxicity against human MDA-MB-231 cells after 3 days by MTT method,Other,17125218.0,
493,379193,3,4,,103206920,5280863,Inactive,,,,,Cytotoxicity against human A549 cells after 3 days by MTT method,Other,17125218.0,
494,381802,9,5,,103206920,5280863,Active,134039205.0,2739.0,20.6,IC50,Inhibition of human recombinant His-tagged Glyoxalase 1 expressed in Sf21-Baculovirus system,Confirmatory,18258440.0,
495,381803,3,9,,103206920,5280863,Unspecified,134039205.0,2739.0,,,Inhibition of human recombinant His-tagged Glyoxalase 1 expressed in Sf21-Baculovirus system at 100 uM,Other,18258440.0,
496,381804,3,4,,103206920,5280863,Active,,,,,Antiproliferative activity against human HL60 cells at 30 uM after 48 hrs by MTS assay,Other,18258440.0,
497,385353,9,5,,103206920,5280863,Active,1168407.0,24192.0,1.33,IC50,Inhibition of rat lens aldose reductase,Confirmatory,18298080.0,
498,395150,9,1,,103206920,5280863,Unspecified,,,,,ABTS radical scavenging activity assessed as Trolox equivalent antioxidant capacity,Other,18403057.0,
499,395151,7,3,,103206920,5280863,Unspecified,,,19000.0,IC50,Antioxidant activity in Wistar rat liver microsomes assessed as inhibition of lipid peroxidation by TBA assay,Confirmatory,18403057.0,
500,397122,6,3,,103206920,5280863,Unspecified,,,,,Inhibition of HIV1 RT,Other,1710653.0,
501,397831,4,3,,103206920,5280863,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity after 20 mins by UV-visible spectrophotometry,Other,12502312.0,
502,398393,6,3,,103206920,5280863,Unspecified,,,105.9,IC50,Inhibition of bovine pancreas trypsin,Confirmatory,7673925.0,
503,398957,3,3,,103206920,5280863,Active,,,,,Antimicrobial activity against Staphylococcus aureus,Other,6736972.0,
504,398958,3,3,,103206920,5280863,Active,,,,,Antimicrobial activity against Escherichia coli,Other,6736972.0,
505,398959,3,3,,103206920,5280863,Active,,,,,Antimicrobial activity against Candida albicans,Other,6736972.0,
506,399340,9,2,,103206920,5280863,Active,,,1.06,IC50,Inhibition of xanthine oxidase assessed as decrease in uric acid production by spectrophotometry,Confirmatory,9461655.0,
507,399341,6,2,,103206920,5280863,Active,,,0.84,IC50,Antioxidant activity assessed as superoxide-scavenging activity by nitrite method,Confirmatory,9461655.0,
508,400266,9,6,,103206920,5280863,Unspecified,416783.0,140908.0,66.1,EC50,Inhibition of rat fetal brain CDK5 assessed as phosphorylated histone H1 levels by immuno-precipitation,Confirmatory,15043421.0,
509,400524,3,4,,103206920,5280863,Unspecified,,,,,Antioxidant activity assessed as DPPH radical scavenging activity at 0.1 mg/mL,Other,15043425.0,
510,400608,8,1,,103206920,5280863,Active,,,2.7,IC50,Inhibition of procoagulant activity in monocyte from human blood assessed as counteraction of IL1-induced tissue factor expression after 18 hrs,Confirmatory,8882428.0,
511,402473,6,2,,103206920,5280863,Active,,,20.0,EC50,Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality preincubated for 15 mins before TNFalpha addition measured after 24 hrs by crystal violet staining,Confirmatory,9287415.0,
512,402475,6,2,,103206920,5280863,Active,,,25.0,EC50,Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality preincubated for 15 mins before TNFalpha addition measured after 24 hrs by [methyl-3H]thymidine incorporation assay,Confirmatory,9287415.0,
513,402483,3,4,,103206920,5280863,Active,,,,,Inhibition of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality treated with drug after 2 hrs of TNFalpha treatment,Other,9287415.0,
514,402484,3,4,,103206920,5280863,Active,,,,,Potentiation of recombinant human TNF-alpha-induced cytotoxicity of mouse L929 cells assessed as survivality treated with drug after 2 hrs of TNFalpha treatment,Other,9287415.0,
515,403110,3,3,,103206920,5280863,Unspecified,,,,,Inhibition of PDE in Sprague-Dawley rat epididymal adipose tissue assessed as [14C]adenosine recovery at 200 uM by liquid scintillation counting,Other,9834158.0,
516,403633,6,2,,103206920,5280863,Active,,,15.0,IC50,Inhibition of COX2 mRNA expression in mouse RAW264.7 cells,Confirmatory,16038536.0,
517,403918,3,9,,103206920,5280863,Unspecified,2827766.0,29290.0,,,Displacement of [3H]DPCPX from adenosine A1 receptor in rat forebrain membrane assessed as fraction of receptor bound radioligand at 100 ug/mL,Other,9214739.0,
518,404692,9,5,,103206920,5280863,Unspecified,1351933.0,276.0,,IC50,Inhibition of human salivary alpha-amylase,Confirmatory,18507367.0,
519,404692,9,5,,103206920,5280863,Unspecified,1351933.0,277.0,,IC50,Inhibition of human salivary alpha-amylase,Confirmatory,18507367.0,
520,404692,9,5,,103206920,5280863,Unspecified,1351933.0,278.0,,IC50,Inhibition of human salivary alpha-amylase,Confirmatory,18507367.0,
521,406994,3,12,,103206920,5280863,Unspecified,313104233.0,3292.0,,,Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol at 20 uM,Other,18533708.0,
522,406995,10,2,,103206920,5280863,Active,313104233.0,3292.0,1.05,IC50,Inhibition of human recombinant 17beta-HSD1 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol,Confirmatory,18533708.0,
523,406996,3,11,,103206920,5280863,Unspecified,544152.0,3294.0,,,Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol at 40 uM,Other,18533708.0,
524,406997,9,6,,103206920,5280863,Active,544152.0,3294.0,0.36,IC50,Inhibition of human recombinant 17beta-HSD2 expressed in HEK293 cell lysate assessed as conversion of radiolabeled estrone to estradiol,Confirmatory,18533708.0,
525,411793,6,2,,103206920,5280863,Unspecified,,,,,Metabolic stability in human liver microsomes assessed as intrinsic clearance per mg of protein,Other,19108654.0,
526,427748,9,1,,103206920,5280863,Active,,,2.4,Ki,Inhibition of MRP1 transfected in human HeLa cells assessed as inhibition of [3H]LTC4 transport by rapid filtration assay,Confirmatory,19725578.0,
527,429115,9,1,,103206920,5280863,Unspecified,1018618719.0,367.0,,,Agonist activity at androgen receptor in human MDA-kb2 cells assessed as stimulation of luciferase activity by luciferase reporter gene assay,Other,19592245.0,
528,429117,9,1,,103206920,5280863,Unspecified,121069.0,2908.0,,,Agonist activity at glucocorticoid receptor in human MDA-kb2 cells assessed as stimulation of luciferase activity by luciferase reporter gene assay,Other,19592245.0,
529,429118,3,10,,103206920,5280863,Inactive,121069.0,2908.0,,,Antagonist activity at glucocorticoid receptor in human MDA-kb2 cells assessed as inhibition of Dex-induced luciferase activity by luciferase reporter gene assay,Other,19592245.0,
530,429119,9,2,,103206920,5280863,Active,1018618719.0,367.0,9.7,IC50,Antagonist activity at androgen receptor in human MDA-kb2 cells assessed as inhibition of DHT-induced luciferase activity by luciferase reporter gene assay,Confirmatory,19592245.0,
531,429185,8,1,,103206920,5280863,Unspecified,,,100.0,ED50,Antioxidant activity assessed as radical DPPH scavenging activity,Confirmatory,19596200.0,
532,429186,3,9,,103206920,5280863,Active,3219819.0,25155.0,,,Inhibition of Syk phosphorylation in DNP-BSA-stimulated rat RBL2H3 cells by Western blotting,Other,19596200.0,
533,429187,3,4,,103206920,5280863,Active,,,,,Inhibition of ERK phosphorylation in DNP-BSA-stimulated rat RBL2H3 cells by Western blotting,Other,19596200.0,
534,429188,3,4,,103206920,5280863,Active,,,,,Inhibition of JNK phosphorylation in DNP-BSA-stimulated rat RBL2H3 cells by Western blotting,Other,19596200.0,
535,429271,3,4,,103206920,5280863,Active,,,,,Inhibition of p38 phosphorylation in DNP-BSA-stimulated rat RBL2H3 cells by Western blotting,Other,19596200.0,
536,429272,3,4,,103206920,5280863,Active,,,,,Inhibition of ERK in DNP-BSA-stimulated rat RBL2H3 cells assessed as reduction in cPLA2 phosphorylation by Western blotting,Other,19596200.0,
537,429273,4,4,,103206920,5280863,Active,,,,,Antiallergic activity in IgE-sensitized rat RBL2H3 cells assessed as inhibition of A-23187-stimulated beta hexaminidase release relative to control,Other,19596200.0,
538,429274,3,5,,103206920,5280863,Active,,,,,Antiallergic activity in IgE-sensitized DNP-BSA-stimulated rat RBL2H3 cells assessed as decrease in intracellular Ca2+ level by fluorimetry,Other,19596200.0,
539,429276,3,10,,103206920,5280863,Active,130230.0,29337.0,,,Inhibition of PLCgamma2 phosphorylation in DNP-BSA-stimulated rat RBL2H3 cells by Western blotting,Other,19596200.0,
540,429277,3,10,,103206920,5280863,Active,130226.0,25738.0,,,Inhibition of PLCgamma1 phosphorylation in DNP-BSA-stimulated rat RBL2H3 cells by Western blotting,Other,19596200.0,
541,429278,4,4,,103206920,5280863,Active,,,,,Antiallergic activity in IgE-sensitized rat RBL2H3 cells assessed as inhibition of DNP-BSA-stimulated beta hexaminidase release relative to control,Other,19596200.0,
542,430217,6,2,,103206920,5280863,Unspecified,,,71.29,IC50,Antileishmanial activity against extracellular Leishmania peruviana promastigotes after 72 hrs,Confirmatory,19489596.0,
543,430218,6,2,,103206920,5280863,Unspecified,,,53.65,IC50,Antileishmanial activity against extracellular Leishmania braziliensis promastigotes after 72 hrs,Confirmatory,19489596.0,
544,430311,6,2,,103206920,5280863,Unspecified,,,53.67,IC50,Cytotoxicity against BALB/c mouse J774.2 cells after 72 hrs by trypan blue assay,Confirmatory,19489596.0,
545,434947,1,2,,46501187,5280863,Inactive,,,300.0,EC50_uM,Luminescence Cell-Free Homogeneous Counter Screen to Identify Inhibitors of ADP-glo Reagents,Confirmatory,,
546,434954,1,1,,46501187,5280863,Active,21361340.0,2932.0,11.59,EC50_uM,Luminescence Cell-Free Homogeneous Dose Retest to Identify Inhibitors of Glycogen Synthase Kinase-3 beta  Activity,Confirmatory,,
547,434955,1,2,,46501187,5280863,Inactive,,,,IC90,Screen to Identify Novel Compounds That Sensitize Mycobacterium Tuberculosis to Beta-lactam Antibiotics,Confirmatory,,
548,434959,1,1,,85788890,5280863,Inactive,,,,,Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression,Screening,,
549,434962,1,2,,46501187,5280863,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE),Screening,,
550,434973,1,3,,46501187,5280863,Inactive,120538355.0,57337.0,,,uHTS Luminescent assay for identification of inhibitors of Sentrin-specific protease 7 (SENP7),Screening,,
551,434989,1,1,,46501187,5280863,Inactive,222080095.0,3061.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
552,435003,1,3,,46501187,5280863,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of T-cell specific antigen receptor-induced NF-kB activation,Screening,,
553,435005,1,1,,46501187,5280863,Inactive,,,,,Luminescence Cell-Based Primary HTS to Identify Inhibitors of Beta Cell Apoptosis.,Screening,,
554,435022,2,2,,46501187,5280863,Inactive,,,,,uHTS luminescence assay for the identification of chemical inhibitors of B-cell specific antigen receptor-induced NF-kB activation,Screening,,
555,435030,1,2,,46501187,5280863,Inactive,15645703.0,899625.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
556,435030,1,2,,46501187,5280863,Inactive,15646160.0,899738.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex,Screening,,
557,439367,3,11,,103206920,5280863,Inactive,13432234.0,5468.0,,,Agonist activity at human PPARgamma expressed in HEK293 cells co-transfected with PPRE assessed as beta-galactosidase signal at 5 uM after 48 hrs by reporter gene assay relative to control,Other,19807106.0,
558,439368,3,11,,103206920,5280863,Unspecified,13432234.0,5468.0,,,Agonist activity at human PPARgamma expressed in HEK293 cells co-transfected with PPRE assessed as beta-galactosidase signal at 25 uM after 48 hrs by reporter gene assay relative to control,Other,19807106.0,
559,439371,3,11,,103206920,5280863,Unspecified,3041727.0,5465.0,,,Agonist activity at human PPARalpha expressed in HEK293 cells co-transfected with PPRE assessed as beta-galactosidase signal at 25 uM after 48 hrs by reporter gene assay relative to control,Other,19807106.0,
560,439372,3,11,,103206920,5280863,Unspecified,3041727.0,5465.0,,,Agonist activity at human PPARalpha expressed in HEK293 cells co-transfected with PPRE assessed as beta-galactosidase signal at 40 uM after 48 hrs by reporter gene assay relative to control,Other,19807106.0,
561,439378,3,7,,103206920,5280863,Unspecified,,,,,Agonist activity at PPARgamma expressed in mouse RAW264.7 cells assessed as beta-galactosidase signal at 10 uM by reporter gene assay relative to control,Other,19807106.0,
562,441659,9,5,,103206920,5280863,Active,116353.0,590.0,43.1,Ki,Inhibition of human plasma BChE by Ellman's method,Confirmatory,19879672.0,
563,441660,9,5,,103206920,5280863,Unspecified,113037.0,43.0,92.8,Ki,Inhibition of human recombinant AChE by Ellman's method,Confirmatory,19879672.0,
564,441661,3,3,,103206920,5280863,Unspecified,,,,,Stability in phosphate buffer at pH 7.4 after 90 mins by spectrophotometry,Other,19879672.0,
565,441662,4,8,,103206920,5280863,Inactive,116353.0,590.0,,,Inhibition of human plasma BChE upto 45 mins at 100 umol/L by Ellman's method,Other,19879672.0,
566,441664,3,4,,103206920,5280863,Unspecified,,,,,Cytotoxicity against human HepG2 cells upto 200 umol/L after 24 hrs by MTS assay,Other,19879672.0,
567,441665,3,4,,103206920,5280863,Unspecified,,,,,Cytotoxicity against human A549 cells upto 200 umol/L after 24 hrs by MTS assay,Other,19879672.0,
568,449728,1,2,,46501187,5280863,Inactive,,,,,Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability,Screening,,
569,449739,1,2,,46501187,5280863,Inactive,53832009.0,8912.0,,,Inhibitors of Cav3 T-type Calcium Channels: Primary Screen,Screening,,
570,449762,1,2,,46501187,5280863,Inactive,,,,IC50,High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media,Confirmatory,,
571,449763,1,3,,46501187,5280863,Inactive,,,,,uHTS identification of small molecule activators of the apoptotic arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
572,449768,1,1,,46501187,5280863,Inactive,7108463.0,6531.0,,,High Throughput Screening for Cocaine Antagonists: Primary Screen,Screening,,
573,450466,3,3,,103206920,5280863,Unspecified,,,,,Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 1 uM after 72 hrs,Other,19615910.0,
574,450467,3,3,,103206920,5280863,Unspecified,,,,,Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 3 uM after 72 hrs,Other,19615910.0,
575,450468,3,3,,103206920,5280863,Unspecified,,,,,Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 10 uM after 72 hrs,Other,19615910.0,
576,450469,3,3,,103206920,5280863,Unspecified,,,,,Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells at 30 uM after 72 hrs,Other,19615910.0,
577,450471,5,2,,103206920,5280863,Active,,,20.0,IC50,Inhibition of melanogenesis in theophylline-stimulated mouse B16-4A5 cells after 72 hrs,Confirmatory,19615910.0,
578,450472,3,3,,103206920,5280863,Unspecified,,,,,Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability at 1 uM after 68 hrs by WST8 assay,Other,19615910.0,
579,450473,3,3,,103206920,5280863,Unspecified,,,,,Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability at 3 uM after 68 hrs by WST8 assay,Other,19615910.0,
580,450474,3,3,,103206920,5280863,Unspecified,,,,,Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability at 10 uM after 68 hrs by WST8 assay,Other,19615910.0,
581,450475,3,3,,103206920,5280863,Unspecified,,,,,Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability at 30 uM after 68 hrs by WST8 assay,Other,19615910.0,
582,450476,3,3,,103206920,5280863,Unspecified,,,,,Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability at 100 uM after 68 hrs by WST8 assay,Other,19615910.0,
583,450477,5,2,,103206920,5280863,Unspecified,,,88.0,IC50,Inhibition of theophylline-stimulated mouse B16-4A5 cell proliferation assessed as cell viability after 68 hrs by WST8 assay,Confirmatory,19615910.0,
584,450478,3,10,,103206920,5280863,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 1 uM,Other,19615910.0,
585,450479,3,10,,103206920,5280863,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 3 uM,Other,19615910.0,
586,450480,3,10,,103206920,5280863,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 10 uM,Other,19615910.0,
587,450481,3,10,,103206920,5280863,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 30 uM,Other,19615910.0,
588,450482,3,10,,103206920,5280863,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 100 uM,Other,19615910.0,
589,450483,8,5,,103206920,5280863,Unspecified,6686057.0,,100.0,IC50,Inhibition of mushroom tyrosinase,Confirmatory,19615910.0,
590,455702,8,5,,103206920,5280863,Active,127825.0,,8.0,IC50,Inhibition of Clostridium perfringens neuraminidase,Confirmatory,19729316.0,
591,455703,7,1,,103206920,5280863,Active,,,,IC50,Noncompetitive inhibition of recombinant influenza A virus rvH1N1 A/Bervig_Mission/1/18 neuraminidase,Confirmatory,19729316.0,
592,455704,5,2,,103206920,5280863,Unspecified,,,300.0,CC50,Cytotoxicity against MDCK cells after 48 hrs by MTT assay,Confirmatory,19729316.0,
593,455705,5,2,,103206920,5280863,Active,,,30.2,EC50,Antiviral activity against influenza A virus H1N1 A/PR/8/34 infected in MDCK cells assessed as reduction in virus-induced cytopathic effect,Confirmatory,19729316.0,
594,455706,5,2,,103206920,5280863,Active,,,18.5,EC50,Antiviral activity against influenza A virus H9N2 A/Chicken/Korea/MS96/96 infected in MDCK cells assessed as reduction in virus-induced cytopathic effect,Confirmatory,19729316.0,
595,455707,3,4,,103206920,5280863,Unspecified,,,,,"Selectivity index, ratio of CC50 for MDCK cells to EC50 for influenza virus H1N1 A/PR/8/34",Other,19729316.0,
596,455708,3,4,,103206920,5280863,Unspecified,,,,,"Selectivity index, ratio of CC50 for MDCK cells to EC50 for influenza virus H9N2 A/Chicken/Korea/MS96/96",Other,19729316.0,
597,455709,3,4,,103206920,5280863,Active,,,,,Antiviral activity against influenza A virus H1N1 A/PR/8/34 infected in MDCK cells assessed as reduction in fluorescence positive cells at 50 uM immunofluorescence assay,Other,19729316.0,
598,456183,3,3,,103206920,5280863,Unspecified,,,,,Inhibition of reduced carboxymethylated kappa-casein fibril formation at 50 ug/mL measured every 5 mins after 1000 mins by thioflavin T staining-based binding assay,Other,19931462.0,
599,456187,5,2,,103206920,5280863,Active,,,33.0,IC50,Inhibition of reduced carboxymethylated kappa-casein fibril formation measured every 5 mins after 1000 mins by thioflavin T staining-based binding assay,Confirmatory,19931462.0,
600,456188,5,2,,103206920,5280863,Active,,,1.7,IC50,Inhibition of beta amyloid (1 to 40) fibril formation by thioflavin T staining-based binding assay,Confirmatory,19931462.0,
601,456189,5,2,,103206920,5280863,Active,,,3.2,IC50,Inhibition of beta amyloid (1 to 42) fibril formation by thioflavin T staining-based binding assay,Confirmatory,19931462.0,
602,456191,4,3,,103206920,5280863,Active,,,,,Inhibition of reduced carboxymethylated kappa-casein fibril formation assessed as formation of shorter and stunted fibrils at 1 uM by transmission electron microscopy,Other,19931462.0,
603,456192,3,3,,103206920,5280863,Unspecified,,,,,Selectivity ratio of IC50 for reduced carboxymethylated kappa-casein fibril formation to IC50 for beta amyloid (1 to 40) fibril formation,Other,19931462.0,
604,456193,3,3,,103206920,5280863,Unspecified,,,,,Selectivity ratio of IC50 for reduced carboxymethylated kappa-casein fibril formation to IC50 for beta amyloid (1 to 42) fibril formation,Other,19931462.0,
605,456268,6,2,,103206920,5280863,Unspecified,,,,,Antiallergic activity in Ca(2+)-stimulated differentiated human HeLa cells assessed as inhibition of cys-leukotriene release after 6 days by ELISA,Other,19942440.0,
606,456316,3,3,,103206920,5280863,Unspecified,,,,,ABTS radical scavenging activity assessed as trolox equivalent antioxidant capacity,Other,19944611.0,
607,456317,3,3,,103206920,5280863,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent by TEAC assay,Other,19944611.0,
608,456318,3,3,,103206920,5280863,Unspecified,,,,,DPPH radical scavenging activity assessed as trolox equivalent antioxidant capacity,Other,19944611.0,
609,456319,6,1,,103206920,5280863,Unspecified,,,,,ABTS radical scavenging activity assessed as vitamin C equivalent antioxidant capacity,Other,19944611.0,
610,462333,3,3,,103206920,5280863,Unspecified,,,,,Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 30 uM after 72 hrs,Other,20189399.0,
611,462334,3,3,,103206920,5280863,Unspecified,,,,,Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 10 uM after 72 hrs,Other,20189399.0,
612,462335,3,3,,103206920,5280863,Unspecified,,,,,Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 3 uM after 72 hrs,Other,20189399.0,
613,462336,3,3,,103206920,5280863,Unspecified,,,,,Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells at 1 uM after 72 hrs,Other,20189399.0,
614,462338,5,2,,103206920,5280863,Active,,,25.0,IC50,Inhibition of theophylline-stimulated melanogenesis in mouse B16-4A5 cells after 72 hrs,Confirmatory,20189399.0,
615,462339,3,3,,103206920,5280863,Unspecified,,,,,Toxicity in mouse B16-4A5 cells assessed as inhibition of cell proliferation at 1 uM in presence of 1 mM theophylline after 72 hrs by WST8 dye reduction assay,Other,20189399.0,
616,462340,4,2,,103206920,5280863,Unspecified,,,,,Toxicity in mouse B16-4A5 cells assessed as inhibition of cell proliferation at 3 uM in presence of 1 mM theophylline after 72 hrs by WST8 dye reduction assay,Other,20189399.0,
617,462341,4,2,,103206920,5280863,Unspecified,,,,,Toxicity in mouse B16-4A5 cells assessed as inhibition of cell proliferation at 10 uM in presence of 1 mM theophylline after 72 hrs by WST8 dye reduction assay,Other,20189399.0,
618,462342,3,3,,103206920,5280863,Unspecified,,,,,Toxicity in mouse B16-4A5 cells assessed as inhibition of cell proliferation at 30 uM in presence of 1 mM theophylline after 72 hrs by WST8 dye reduction assay,Other,20189399.0,
619,462344,3,10,,103206920,5280863,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 1 uM,Other,20189399.0,
620,462345,3,10,,103206920,5280863,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 3 uM,Other,20189399.0,
621,462346,3,10,,103206920,5280863,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 10 uM,Other,20189399.0,
622,462347,3,10,,103206920,5280863,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 30 uM,Other,20189399.0,
623,462348,3,10,,103206920,5280863,Unspecified,6686057.0,,,,Inhibition of mushroom tyrosinase at 100 uM,Other,20189399.0,
624,462367,4,9,,103206920,5280863,Inactive,6686057.0,,,,Inhibition of mushroom tyrosinase assessed as inhibition of melanin production from dopachrome by autoxidation at 100 uM,Other,20189399.0,
625,463079,1,2,,46501187,5280863,Inactive,,,,,Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based assay to identify antagonists of the parental CHO cell line,Screening,,
626,463082,1,1,,46501187,5280863,Inactive,270133071.0,7941.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH),Screening,,
627,463104,1,2,,46501187,5280863,Inactive,,,,,uHTS identification of small molecule activators of the adaptive arm of the Unfolded Protein response via a luminescent-based reporter assay,Screening,,
628,463111,1,1,,46501187,5280863,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate regulator of G-protein signaling 4 (RGS4),Screening,,
629,463141,1,2,,46501187,5280863,Inactive,14790119.0,836.0,,,Absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-3,Screening,,
630,463165,1,1,,46501187,5280863,Inactive,5032039.0,5999.0,,,Primary cell-based high-throughput screening assay for identification of compounds that inhibit regulator of   G-protein signaling 4 (RGS4),Screening,,
631,463190,1,2,,46501187,5280863,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10-1 yeast via a luminescent assay,Screening,,
632,463195,1,2,,46501187,5280863,Inactive,285809906.0,856395.0,,,uHTS identification of small molecule inhibitors of tim10 yeast via a luminescent assay,Screening,,
633,463210,1,2,,46501187,5280863,Inactive,55960760.0,,,,Counterscreen for procaspase-3 activators: absorbance-based primary biochemical high throughput screening assay to identify activators of procaspase-7,Screening,,
634,463212,1,1,,46501187,5280863,Inactive,285814664.0,855751.0,,,uHTS identification of small molecule inhibitors of tim23-1 yeast via a luminescent assay,Screening,,
635,466937,5,2,,103206920,5280863,Unspecified,,,110.0,IC50,"Inhibition of Trypanosoma cruzi trans-sialidase containing catalytic domain (N58F, R200K) and lectin-like domain (S495 K, V496G, E520K, D593G, I597D, H599R) mutation expressed in Escherichia coli JM109 assessed as MuNANA substrate hydrolysis in presence of 0.1% Triton X-100 by discontinuous fluorimetric assay",Confirmatory,20097567.0,
636,466938,9,5,,103206920,5280863,Unspecified,229462907.0,4759.0,230.0,IC50,Inhibition of human Neu2 assessed as MuNANA substrate hydrolysis in presence of 0.1% Triton X-100 by discontinuous fluorimetric assay,Confirmatory,20097567.0,
637,466939,3,3,,103206920,5280863,Unspecified,,,,,Selectivity for Trypanosoma cruzi trans-sialidase mutant over human Neu2,Other,20097567.0,
638,467951,3,4,,103206920,5280863,Inactive,,,,,Induction of CYP1A1 expression in human MCF7 cells at 0.5 uM to 10 uM after 24 hrs by RT PCR and DNA electrophoresis,Other,19601638.0,
639,475504,3,3,,103206920,5280863,Inactive,,,,,Binding affinity to amyloid beta (1 to 42) fibrils by change in fluorescence at 100 uM after 10 mins,Other,19640715.0,
640,475505,3,3,,103206920,5280863,Inactive,,,,,Binding affinity to amyloid beta (1 to 42) oligomers by change in fluorescence at 100 uM after 10 mins,Other,19640715.0,
641,481717,10,2,,103206920,5280863,Unspecified,143955315.0,,,,Inhibition of Influenza A PR/8/34 H1N1 virus neuraminidase activity by MUN-ANA substrate based fluorimetric assay,Other,20116898.0,
642,485270,1,1,,46501187,5280863,Inactive,222080095.0,3061.0,,,FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1),Screening,,
643,485272,1,1,,46501187,5280863,Inactive,216548487.0,23569.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Arginine Deiminase 4 (PAD4) (1536 HTS),Screening,,
644,485273,2,1,,46501187,5280863,Inactive,4507793.0,7334.0,,,uHTS identification of UBC13 Polyubiquitin Inhibitors via a TR-FRET Assay,Screening,,
645,485275,1,3,,46501187,5280863,Inactive,,,,,Phenotypic HTS multiplex for antifungal efflux pump inhibitors,Screening,,
646,485281,1,1,,11112381,5280863,Inactive,254220970.0,,,Potency,qHTS Assay for Identification of Novel General Anesthetics,Confirmatory,,
647,485290,1,1,,11112381,5280863,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
648,485290,1,1,,17389844,5280863,Inactive,20150581.0,,,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
649,485290,1,1,,50105504,5280863,Inactive,20150581.0,,1.9953,Potency,qHTS Assay for Inhibitors of Tyrosyl-DNA Phosphodiesterase (TDP1),Confirmatory,,
650,485317,1,2,,46501187,5280863,Inactive,54112432.0,2671.0,,,HTS-Luminescent assay for inhibitors of ALR by detection of hydrogen peroxide production Measured in Biochemical System Using Plate Reader - 2036-02_Inhibitor_SinglePoint_HTS,Screening,,
651,485346,1,1,,46501187,5280863,Inactive,88702791.0,4194.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
652,485346,1,1,,46501187,5280863,Inactive,89993689.0,4193.0,,,uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format.,Screening,,
653,485350,1,2,,92126042,5280863,Inactive,126642418.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme BasE,Screening,,
654,488839,1,1,,49674535,5280863,Inactive,20072248.0,8851.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
655,488839,1,1,,49674535,5280863,Inactive,48146199.0,1020.0,,,Development of CDK5 inhibitors   Measured in Biochemical System Using Plate Reader - 2083-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
656,488847,1,3,,46501187,5280863,Inactive,148539876.0,156.0,,,RNA aptamer-based HTS for inhibitors of GRK2,Screening,,
657,488862,1,1,,49674535,5280863,Inactive,,,,,Inhibitors of Prion Protein 5' UTR mRNA Measured in Cell-Based System Using Plate Reader - 2078-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
658,488890,1,2,,46501187,5280863,Inactive,,,,IC50,"Elucidation of physiology of non-replicating, drug-tolerant Mycobacterium tuberculosis",Confirmatory,,
659,488895,1,2,,49674535,5280863,Inactive,90111653.0,948321.0,,,High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
660,488896,1,1,,49674535,5280863,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
661,488899,1,1,,49674535,5280863,Inactive,40807040.0,4286.0,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
662,488922,1,2,,46501187,5280863,Inactive,7706135.0,,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9,Screening,,
663,488965,1,2,,49674535,5280863,Inactive,218891639.0,,,,Fluorescent Biochemical Primary HTS to Identify Inhibitors of P. aeruginosa PvdQ acylase Measured in Biochemical System Using Plate Reader and Imaging Combination - 2091-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
664,488966,1,1,,49674535,5280863,Inactive,,,,IC50,Primary and Confirmatory Screening for Inhibitors of Bacterial Capsule Biogenesis,Confirmatory,,
665,488975,1,2,,46501187,5280863,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that inhibit the Choline Transporter (CHT),Screening,,
666,488977,1,2,,46501187,5280863,Inactive,11141885.0,60482.0,,,Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT),Screening,,
667,489030,2,1,,46501187,5280863,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of inhibitors of Apaf-1,Screening,,
668,489031,2,1,,46501187,5280863,Inactive,187952397.0,317.0,,,uHTS Fluorescent assay for identification of activators of Apaf-1,Screening,,
669,492953,1,1,,49674535,5280863,Inactive,296080766.0,5049.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1b, catalytic subunit 2 (PAFAH1B2)",Screening,,
670,492956,1,1,,49674535,5280863,Inactive,4758878.0,5051.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet activating factor acetylhydrolase 2 (PAFAH2),Screening,,
671,492967,1,2,,92126042,5280863,Inactive,47566732.0,,,,A screen for compounds that inhibit the CapD enzyme of Bacillus anthracis,Other,,
672,492972,1,1,,49674535,5280863,Active,225543099.0,5050.0,,,"Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3)",Screening,,
673,493000,1,1,,46501187,5280863,Inactive,5032039.0,5999.0,,,Counter screen for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4): Non-induced cells with the primary screen assay,Screening,,
674,493001,1,1,,46501187,5280863,Inactive,5032039.0,5999.0,,,Second counter screen for identification of compounds that inhibit regulator of G-protein signaling 4 (RGS4): Non-induced cells with the primary screen assay without carbachol activation,Screening,,
675,493005,1,1,,46501187,5280863,Inactive,5454140.0,7251.0,,Potency,qHTS Assay for Iinhibitors of HIV-1 Budding by Blocking the Interaction of PTAP/TSG101,Confirmatory,,
676,493008,1,1,,49674535,5280863,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
677,493008,1,1,,49674535,5280863,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
678,493008,1,1,,49674535,5280863,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
679,493008,1,1,,49674535,5280863,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify activators of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
680,493011,1,1,,46501187,5280863,Inactive,21955158.0,200315.0,,,uHTS identification of APOBEC3A DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
681,493012,1,1,,46501187,5280863,Inactive,13399304.0,60489.0,,,uHTS identification of APOBEC3G DNA Deaminase Inhibitors via a fluorescence-based single-stranded DNA deaminase assay,Screening,,
682,493032,1,1,,49674535,5280863,Inactive,225543099.0,5050.0,,,"Fluorescence polarization-based biochemical high throughput confirmation assay for inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3)",Screening,,
683,493033,1,2,,92126042,5280863,Inactive,614089026.0,,,,A screen for compounds that inhibit the bacterial siderophore biosynthetic enzyme MbtI,Other,,
684,493036,1,2,,46501187,5280863,Inactive,110611243.0,4923.0,,,Image-Based HTS for Selective Agonists for NTR1,Screening,,
685,493087,1,1,,49674535,5280863,Inactive,155969707.0,3416.0,,,Fluorescence polarization-based cell-based primary high throughput screening assay to identify activators of insulin-degrading enzyme (IDE),Screening,,
686,493091,1,1,,46501187,5280863,Active,10864009.0,58190.0,,,uHTS Colorimetric assay for identification of inhibitors of Scp-1,Screening,,
687,493098,1,1,,46501187,5280863,Inactive,37187860.0,1235.0,,,uHTS identification of small molecule antagonists of the CCR6 receptor via a luminescent beta-arrestin assay,Screening,,
688,493131,1,1,,49674535,5280863,Inactive,6679827.0,14282.0,,,Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity,Screening,,
689,493140,1,1,,103914511,5280863,Inactive,,,,,Screening small molecules to find regulators of human embryonic stem cell survival.,Screening,,
690,493160,1,1,,46501187,5280863,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of inhibitors of hexokinase domain containing  I (HKDC1),Screening,,
691,493187,1,2,,46501187,5280863,Inactive,156151420.0,80201.0,,,uHTS Fluorescent assay for identification of activators of hexokinase domain containing  I (HKDC1),Screening,,
692,493244,1,1,,49674535,5280863,Inactive,1927.0,100037999.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
693,493244,1,1,,49674535,5280863,Inactive,4507615.0,7134.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
694,493244,1,1,,49674535,5280863,Inactive,48255881.0,7139.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
695,493244,1,1,,49674535,5280863,Inactive,151101270.0,7137.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the calcium sensitivity of cardiac Regulated Thin Filaments (RTF),Screening,,
696,502292,2,3,,103206920,5280863,Unspecified,,,,,Antioxidant activity assessed as DDPH radical scavenging activity,Other,20692831.0,
697,502473,2,9,,103206920,5280863,Active,117144.0,1544.0,0.716,IC50,Inhibition of human CYP1A2 by EROD assay,Confirmatory,20696580.0,
698,502474,2,9,,103206920,5280863,Active,117139.0,1543.0,0.632,IC50,Inhibition of human CYP1A1 by EROD assay,Confirmatory,20696580.0,
699,502475,6,5,,103206920,5280863,Active,48429256.0,1545.0,0.047,IC50,Inhibition of human CYP1B1 by EROD assay,Confirmatory,20696580.0,
700,503235,2,3,,103206920,5280863,Unspecified,,,,,Activity at Streptomyces antibioticus wild-type OleD assessed as as rate of glucoside formation measured as nanomoles of product formed per minute per mg of enzyme,Other,17828251.0,
701,503236,2,4,,103206920,5280863,Unspecified,,,,,Activity of Streptomyces antibioticus OleD P67T mutant assessed as as rate of glucoside formation measured as nanomoles of product formed per minute per mg of enzyme,Other,17828251.0,
702,503237,2,3,,103206920,5280863,Unspecified,,,,,Activity of Streptomyces antibioticus OleD S123F mutant assessed as as rate of glucoside formation measured as nanomoles of product formed per minute per mg of enzyme,Other,17828251.0,
703,503238,2,4,,103206920,5280863,Unspecified,,,,,Activity of Streptomyces antibioticus OleD A242V mutant assessed as as rate of glucoside formation measured as nanomoles of product formed per minute per mg of enzyme,Other,17828251.0,
704,503239,2,4,,103206920,5280863,Unspecified,,,,,Activity of Streptomyces antibioticus OleD P67T/S132F/A242V mutant assessed as as rate of glucoside formation measured as nanomoles of product formed per minute per mg of enzyme,Other,17828251.0,
705,504326,1,2,,49674535,5280863,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
706,504326,1,2,,49674535,5280863,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
707,504327,1,1,,11112381,5280863,Inactive,153791535.0,2648.0,,Potency,qHTS Assay for Inhibitors of GCN5L2,Confirmatory,,
708,504329,1,1,,49674535,5280863,Inactive,227977143.0,23308111.0,,IC50,Discovery of Small Molecule Probes for H1N1 Influenza NS1A,Confirmatory,,
709,504332,1,1,,11112381,5280863,Inactive,168985070.0,,,Potency,qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a,Confirmatory,,
710,504339,1,1,,46501187,5280863,Inconclusive,162330054.0,,79.4328,Potency,qHTS Assay for Inhibitors of JMJD2A-Tudor Domain,Confirmatory,,
711,504357,1,1,,49674535,5280863,Inactive,63477962.0,4985.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
712,504357,1,1,,49674535,5280863,Inactive,117940060.0,4988.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of heterodimerization of the mu 1 (OPRM1) and delta 1 (OPRD1) opioid receptors,Screening,,
713,504406,1,1,,46501187,5280863,Inactive,15610945.0,886142.0,,,Inhibitors of Mycobacterium tuberculosis UDP-galactopyranose mutase (UGM) enzyme - High throughput screening using Fluorescent polarization assay Measured in Biochemical System Using Plate Reader - 2105-01_Inhibitor_SinglePoint_HTS_Activity_Set6,Screening,,
714,504408,2,1,,46501187,5280863,Inactive,,,,,Heat Shock Factor-1 (HSF-1) Measured in Cell-Based System Using Plate Reader - 2038-01_Activator_SinglePoint_HTS_Activity,Screening,,
715,504411,1,1,,49674535,5280863,Inactive,218931251.0,221955.0,,,"Fluorescence-based primary biochemical high throughput screening assay to identify inhibitors of human diacylglycerol lipase, beta (DAGLB)",Screening,,
716,504414,1,1,,49674535,5280863,Inactive,9966877.0,57120.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
717,504414,1,1,,49674535,5280863,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with Cer CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
718,504423,1,1,,49674535,5280863,Inactive,312275222.0,,,,C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
719,504441,1,1,,49674535,5280863,Active,6978787.0,25255.0,,,Dyrk1 A HTS Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
720,504444,1,1,,46501187,5280863,Inactive,224028257.0,4780.0,,Potency,Nrf2 qHTS screen for inhibitors,Confirmatory,,
721,504454,1,3,,49674535,5280863,Inactive,4501969.0,154.0,,,HTS for Beta-2AR agonists via FAP method,Screening,,
722,504462,1,1,,46501187,5280863,Inactive,47132611.0,23192.0,,,uHTS fluorescent assay for identification of inhibitors of ATG4B,Screening,,
723,504490,1,2,,49674535,5280863,Inactive,13177715.0,408.0,,,Assay for Inhibitors of the beta-Arrestin-Adaptor Protein 2 Interaction That Mediate GPCR Degradation and Recycling,Screening,,
724,504523,1,1,,49674535,5280863,Inactive,45269145.0,9817.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
725,504523,1,1,,49674535,5280863,Inactive,224028257.0,4780.0,,,Fluorescence polarization to screen for inhibitors that disrupt the protein-protein interaction between Keap1 and Nrf2   Measured in Biochemical System Using Plate Reader - 2119-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
726,504558,1,1,,49674535,5280863,Inactive,23893668.0,3783750.0,,,Inhibitors of Epstein-Barr LMP1 inducible NF-kappaB luciferase reporter Measured in Cell-Based System Using Plate Reader - 2122-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
727,504577,2,2,,49674535,5280863,Inactive,6325022.0,855842.0,,,HTS of Small Molecules that Regulate V-ATPase Proton Transport in Yeast using pHLuorin,Screening,,
728,504582,2,1,,49674535,5280863,Inactive,124809271.0,811941.0,,,In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
729,504634,1,1,,49674535,5280863,Inactive,13236497.0,3361.0,,,Counterscreen for inverse agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify inverse agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
730,504648,1,1,,46501187,5280863,Inactive,,,,Potency,Nrf2 qHTS screen for inhibitors: counterscreen for cytotoxicity,Confirmatory,,
731,504690,1,3,,46501187,5280863,Inactive,12381848.0,,,,uHTS identification of small molecule inhibitors of Plasmodium falciparum Glucose-6-phosphate dehydrogenase via a fluorescence intensity assay,Screening,,
732,504692,2,2,,49674535,5280863,Inactive,13236497.0,3361.0,,,Counterscreen for agonists of OPRM1-OPRD1 heterodimerization: luminescence-based cell-based full-deck high throughput screening assay to identify agonists of 5-hydroxytryptamine (serotonin) 5A receptor (HTR5A),Screening,,
733,504700,1,1,,49674535,5280863,Inactive,46909587.0,5567.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
734,504700,1,1,,49674535,5280863,Inactive,47132585.0,5577.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R2B (PKA-R2B) complex,Screening,,
735,504707,1,1,,49674535,5280863,Inactive,6755076.0,18749.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
736,504707,1,1,,49674535,5280863,Inactive,115496662.0,615074.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex,Screening,,
737,504720,1,1,,46501187,5280863,Inactive,16130689.0,947252.0,,,uHTS identification of MazEF TA System activators  via a fluorescence-based single-stranded RNase assay,Screening,,
738,504734,1,1,,49674535,5280863,Inactive,194068499.0,54106.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of TLR9-MyD88 binding.,Screening,,
739,504766,2,1,,49674535,5280863,Inactive,5016090.0,190.0,,,"Luminescence-based primary cell-based high throughput screening assay to identify inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1)",Screening,,
740,504775,1,1,,49674535,5280863,Inactive,14389423.0,20778.0,,,HTS using DiI-HDL to assay lipid transfer in ldlA[SR-BI] cells Measured in Cell-Based System Using Plate Reader - 2085-01_Activator_SinglePoint_HTS_Activity,Screening,,
741,504803,1,1,,49674535,5280863,Inactive,121945198.0,,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the HTRA serine peptidase 1 (HTRA1),Screening,,
742,504845,1,1,,46501187,5280863,Inactive,86301163.0,5999.0,,Potency,Inhibitors of Regulator of G Protein Signaling (RGS) 4: qHTS,Confirmatory,,
743,504847,1,1,,11112381,5280863,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
744,504847,1,1,,46501187,5280863,Inactive,63054845.0,7421.0,,Potency,Inhibitors of the vitamin D receptor (VDR): qHTS,Confirmatory,,
745,504865,1,1,,11112381,5280863,Inconclusive,118600387.0,7398.0,39.8107,Potency,Inhibitors of USP1/UAF1: Pilot qHTS,Confirmatory,,
746,504884,1,2,,49674535,5280863,Inactive,115347926.0,1175052.0,,,Inhibitors of Y. pestis Topo-I using cleavage product accumulation Measured in Biochemical System Using Plate Reader - 2123-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
747,504891,1,1,,46501187,5280863,Inactive,5453898.0,5300.0,,Potency,qHTS Assay to Find Inhibitors of Pin1,Confirmatory,,
748,504894,1,1,,46501187,5280863,Inactive,553160.0,,,Potency,Activators of T cell receptors: qHTS campaign,Confirmatory,,
749,504937,1,2,,46501187,5280863,Inactive,179095.0,6609.0,,Potency,Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS,Confirmatory,,
750,510243,2,6,,103206920,5280863,Unspecified,,,,,Inhibition of NOX4 expressed in HEK293 FS cells at 10 uM assessed as H2O2 production by H2O2/Tyr/LPO assay,Other,20731357.0,
751,510244,7,1,,103206920,5280863,Active,,,1.2,IC50,Inhibition of NOX4 expressed in HEK293 FS cells assessed as H2O2 production by H2O2/Tyr/LPO assay,Confirmatory,20731357.0,
752,510245,1,4,,103206920,5280863,Unspecified,,,,,Cytotoxicity against human free style HEK293 cells after 72 hrs,Other,20731357.0,
753,510246,3,5,,103206920,5280863,Unspecified,,,,,Inhibition of NOX4 expressed in HEK293 FS cells at 10 uM assessed as H2O2 production by H2O2/Tyr/LPO assay substituted with 3 uM H2O2,Other,20731357.0,
754,510837,6,1,,103206920,5280863,Unspecified,,,100.0,IC50,Cytotoxicity against human HeLa cells after 72 hrs by XTT assay,Confirmatory,20619940.0,
755,510838,6,1,,103206920,5280863,Unspecified,,,100.0,IC50,Cytotoxicity against human A549 cells after 72 hrs by XTT assay,Confirmatory,20619940.0,
756,510839,6,1,,103206920,5280863,Unspecified,,,100.0,IC50,Cytotoxicity against human HT-29 cells after 72 hrs by XTT assay,Confirmatory,20619940.0,
757,515157,2,6,,103206920,5280863,Unspecified,,,,,Antimutagenic activity in Salmonella Typhimurium TA98 assessed as inhibition of 3-nitrofluoranthene-induced mutation by Ames test,Other,20696502.0,
758,517389,2,7,,103206920,5280863,Active,341940616.0,108079.0,,,Inhibition of AMPK-mediated adipocyte differentiation in mouse 3T3L1 cells,Other,20822902.0,
759,517390,2,10,,103206920,5280863,Active,13432235.0,19016.0,,,Inhibition of PPAR-gamma-mediated adipocyte differentiation in mouse 3T3L1 cells,Other,20822902.0,
760,517391,2,4,,103206920,5280863,Unspecified,,,,,Cytotoxicity against mouse 3T3L1 cells at 20 uM after 24 hrs,Other,20822902.0,
761,538208,4,2,,103206920,5280863,Unspecified,,,,,Cytotoxicity against human HepG2 cells by MTT assay,Other,21106454.0,
762,538209,5,3,,103206920,5280863,Unspecified,,,,,Cytotoxicity against human Hep3B cells by MTT assay,Other,21106454.0,
763,538210,4,2,,103206920,5280863,Unspecified,,,,,Cytotoxicity against human Ca9-22 cells by MTT assay,Other,21106454.0,
764,538211,4,2,,103206920,5280863,Unspecified,,,,,Cytotoxicity against human A549 cells by MTT assay,Other,21106454.0,
765,538212,4,2,,103206920,5280863,Unspecified,,,,,Cytotoxicity against human MCF7 cells by MTT assay,Other,21106454.0,
766,538213,4,2,,103206920,5280863,Unspecified,,,,,Cytotoxicity against human MDA-MB-231 cells by MTT assay,Other,21106454.0,
767,538214,5,2,,103206920,5280863,Unspecified,,,,,Antiaggregatory activity in human platelets assessed as inhibition of collagen-induced platelet aggregation by aggregometry,Other,21106454.0,
768,538215,5,2,,103206920,5280863,Unspecified,,,,,Antiaggregatory activity in human platelets assessed as inhibition of thrombin-induced platelet aggregation by aggregometry,Other,21106454.0,
769,539042,6,2,,103206920,5280863,Unspecified,6686057.0,,171.4,IC50,Inhibition of mushroom tyrosinase after 20 mins by spectrophotometric analysis,Confirmatory,21050756.0,
770,540253,1,1,,46501187,5280863,Inconclusive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
771,540253,1,1,,46501187,5280863,Inconclusive,5453555.0,5901.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
772,540253,1,1,,46501187,5280863,Inconclusive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation,Confirmatory,,
773,540263,1,1,,46501187,5280863,Inactive,5031833.0,10073.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
774,540263,1,1,,46501187,5280863,Inactive,19923142.0,3837.0,,Potency,qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation,Confirmatory,,
775,540267,1,1,,46501187,5280863,Inactive,,,,,Small Molecules that selectively kill Giardia lamblia: qHTS,Screening,,
776,540281,1,1,,46501187,5280863,Active,10864009.0,58190.0,,,Single concentration confirmation of uHTS hits for Scp-1 phosphatase using a colorimetric assay,Screening,,
777,540295,1,1,,49674535,5280863,Inactive,119508433.0,4160.0,,,TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R,Screening,,
778,540297,1,1,,46501187,5280863,Active,10864009.0,58190.0,9.933,IC50,Dose Response confirmation of uHTS hits for Scp-1 phosphatase using a colorimetric assay,Confirmatory,,
779,540299,1,2,,92126042,5280863,Inactive,15607688.0,887529.0,,,A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis,Other,20850304.0,
780,540303,1,1,,46501187,5280863,Inactive,6679377.0,18792.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
781,540303,1,1,,46501187,5280863,Inactive,7242179.0,18793.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
782,540303,1,1,,46501187,5280863,Inactive,257471003.0,18815.0,,Potency,qHTS for Inhibitors of Cell Surface uPA Generation,Confirmatory,,
783,540308,1,1,,49674535,5280863,Inactive,119508433.0,4160.0,,,Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R,Screening,,
784,540313,1,1,,46501187,5280863,Inactive,10864009.0,58190.0,,,Single concentration colorimetric interference counterscreen of uHTS hits for Scp-1 phosphatase,Screening,,
785,540317,1,1,,46501187,5280863,Inactive,187960037.0,10951.0,,Potency,HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails,Confirmatory,,
786,540329,1,1,,46501187,5280863,Active,10864009.0,58190.0,,,Differential Scanning Fluorimetry (Thermal Shift) Binding Assay for validation of Inhibitors of Scp-1 phosphatase,Other,,
787,540336,1,1,,49674535,5280863,Inactive,68474550.0,3639678.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
788,540336,1,1,,49674535,5280863,Inactive,68488893.0,3646682.0,,,Rtt109/Vps75 Measured in Biochemical System Using Plate Reader - 2106-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
789,540364,1,2,,49674535,5280863,Inactive,,2395.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter,Screening,,
790,550523,4,5,,103206920,5280863,Unspecified,,,100.0,IC50,Displacement of fluorescent SM5F peptide from XIAP linker BIR3 domain after 3 hrs by fluorescence polarization assay,Confirmatory,21087868.0,
791,553081,1,5,,103206920,5280863,Inactive,,,,,Insulin mimetic activity in rat L6 cells assessed as stimulation of 2-deoxyglucose uptake at 1 nM by enzymatic method relative to untreated control,Other,24900249.0,
792,578564,4,2,,103206920,5280863,Unspecified,,,60.2,IC50,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced nitric oxide production after 24 hrs by Griess method,Confirmatory,21353543.0,
793,578565,4,2,,103206920,5280863,Unspecified,,,80.3,IC50,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNF-alpha secretion after 18 hrs,Confirmatory,21353543.0,
794,578568,1,4,,103206920,5280863,Unspecified,,,,,Cytotoxicity against mouse RAW264.7 cells assessed as cell viability by MTT assay,Other,21353543.0,
795,578570,2,4,,103206920,5280863,Active,,,,,Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as nitrite level at 1 to 100 uM after 24 hrs by Griess method,Other,21353543.0,
796,578664,1,4,,103206920,5280863,Unspecified,,,,,Antiinflammatory activity in LPS-stimulated mouse RAW264.7 cells assessed as TNF-alpha level at 1 to 100 uM after 18 hrs,Other,21353543.0,
797,578759,7,1,,103206920,5280863,Active,,,4.7,IC50,Inhibition of BCRP expressed in MDCK cells using Hoechst 33342 staining,Confirmatory,21354800.0,
798,578760,7,1,,103206920,5280863,Active,,,6.2,IC50,Inhibition of BCRP expressed in MCF-7 MX cells using Hoechst 33342 staining,Confirmatory,21354800.0,
799,578765,3,3,,103206920,5280863,Inactive,,,,,Inhibition of P-gp expressed in A2780adr cells at 10 uM by calcein AM accumulation assay relative to verapamil,Other,21354800.0,
800,578843,1,4,,103206920,5280863,Inactive,,,,,Cytotoxicity against human A2780 cells assessed as intracellular ATP level at 10 uM after 72 hrs by luminometry,Other,21354800.0,
801,578844,1,4,,103206920,5280863,Inactive,,,,,Cytotoxicity against human MCF7 cells assessed as intracellular ATP level at 10 uM after 72 hrs by luminometry,Other,21354800.0,
802,588334,1,1,,49674535,5280863,Inactive,,,,,MITF Measured in Cell-Based System Using Plate Reader - 2084-01_Activator_SinglePoint_HTS_Activity,Screening,,
803,588335,1,1,,49674535,5280863,Inactive,,,,,Counterscreen for inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis: Absorbance-based biochemical high throughput Glycerophosphate Dehydrogenase-Triosephosphate Isomerase (GDH-TPI) full deck assay to identify assay artifacts,Screening,,
804,588345,1,1,,49674535,5280863,Active,6978787.0,25255.0,1.2590000000000001,AC50_uM,MLPCN Dyrk1A Kinase Measured in Biochemical System Using Plate Reader - 2124-01_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
805,588348,1,1,,49674535,5280863,Inactive,,,,AC50_uM,MLPCN Dyrk1A Artifact Assay Measured in Biochemical System Using Plate Reader - 2124-02_Inhibitor_Dose_CherryPick_Activity,Confirmatory,,
806,588352,1,2,,49674535,5280863,Inactive,32307126.0,8202.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 3 (SRC3; NCOA3),Screening,,
807,588354,1,1,,49674535,5280863,Inactive,22538455.0,8648.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 1 (SRC1; NCOA1),Screening,,
808,588358,1,2,,49674535,5280863,Inactive,,,,,HTS to Find Inhibitors of Pathogenic Pemphigus Antibodies,Screening,,
809,588379,1,2,,124882309,5280863,Inactive,13399304.0,60489.0,,Potency,qHTS for inhibitors of Vif-A3G interactions: Validation,Confirmatory,,
810,588405,1,1,,49674535,5280863,Inactive,78486550.0,171071.0,,,HTS Assay for Peg3 Promoter Inhibitors,Screening,,
811,588413,1,2,,46501187,5280863,Inactive,6009644.0,14632.0,,,uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay,Screening,,
812,588436,1,1,,49674535,5280863,Inactive,,,,,"Cholera Quorum: HTS for inducers of light production in the absence ofautoinducers using BH1578 (luxS deficient, cqsA deficient) Measured in Microorganism System Using Plate Reader - 2132-01_Agonist_SinglePoint_HTS_Activity",Screening,,
813,588453,1,1,,46501187,5280863,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
814,588456,1,1,,46501187,5280863,Inactive,8659577.0,58819.0,,Potency,qHTS Assay for Substrates of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS,Confirmatory,,
815,588458,1,1,,49674535,5280863,Inactive,4503351.0,1786.0,,,uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay,Screening,,
816,588473,1,1,,46501187,5280863,Inactive,30219.0,1393.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
817,588473,1,1,,46501187,5280863,Inactive,38349113.0,1395.0,,,uHTS identification of agonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
818,588475,1,2,,46501187,5280863,Inactive,30219.0,1393.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
819,588475,1,2,,46501187,5280863,Inactive,38349113.0,1395.0,,,uHTS identification of antagonists of the CRF-binding protein and CRF-R2 receptor complex,Screening,,
820,588478,1,2,,124811880,5280863,Inactive,4877999.0,51377.0,,,"A screen for small molecule inhibitors of the human deubiquitinating enzyme, UCH37",Other,,
821,588489,1,1,,49674535,5280863,Inactive,46367787.0,26986.0,,,uHTS identification of microRNA-mediated mRNA deadenylation inhibitors by fluoresence polarization assay,Screening,,
822,588492,1,1,,49674535,5280863,Inactive,,,,,uHTS identification of small molecule modulators of myocardial damage,Screening,,
823,588493,1,2,,49674535,5280863,Inactive,16306916.0,10213.0,,,uHTS identification of inhibitors of Rpn11 in a Fluorescent Polarization assay,Screening,,
824,588497,1,2,,49674535,5280863,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,16604538.0,
825,588497,1,2,,49674535,5280863,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20035615.0,
826,588497,1,2,,49674535,5280863,Inactive,168184763.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set",Screening,20938917.0,
827,588499,1,3,,49674535,5280863,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,16604538.0,
828,588499,1,3,,49674535,5280863,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20035615.0,
829,588499,1,3,,49674535,5280863,Inactive,148378801.0,5185061.0,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set",Screening,20938917.0,
830,588501,1,2,,49674535,5280863,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,16604538.0,
831,588501,1,2,,49674535,5280863,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20035615.0,
832,588501,1,2,,49674535,5280863,Inactive,21392848.0,,,,"High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set",Screening,20938917.0,
833,588511,1,2,,46501187,5280863,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that inhibit/block calcium-activated chloride channels (TMEM16A),Screening,,
834,588513,1,1,,17389844,5280863,Inactive,348019627.0,2099.0,,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
835,588513,1,1,,26757741,5280863,Inconclusive,348019627.0,2099.0,,Potency,qHTS assay for small molecule antagonists of estrogen receptor alpha signaling,Confirmatory,,
836,588514,1,1,,17389844,5280863,Active,348019627.0,2099.0,7.9433,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
837,588514,1,1,,26757741,5280863,Active,348019627.0,2099.0,8.9125,Potency,qHTS assay for small molecule agonists of estrogen receptor alpha signaling,Confirmatory,,
838,588515,1,1,,17389844,5280863,Inconclusive,124375976.0,367.0,35.4813,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
839,588515,1,1,,26757741,5280863,Inconclusive,124375976.0,367.0,28.1838,Potency,qHTS assay for small molecule agonists of androgen receptor signaling,Confirmatory,,
840,588516,1,1,,17389844,5280863,Inconclusive,124375976.0,367.0,19.9526,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
841,588516,1,1,,26757741,5280863,Inactive,124375976.0,367.0,,Potency,qHTS assay for small molecule antagonists of androgen receptor signaling,Confirmatory,,
842,588519,1,2,,92126042,5280863,Inactive,52695378.0,,,,A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities,Other,21722674.0,
843,588526,1,1,,17389844,5280863,Inconclusive,325495553.0,9971.0,39.8107,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
844,588526,1,1,,26757741,5280863,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule antagonists of farnesoid X receptor signaling,Confirmatory,,
845,588527,1,1,,17389844,5280863,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
846,588527,1,1,,26757741,5280863,Inactive,325495553.0,9971.0,,Potency,qHTS assay for small molecule agonists of farnesoid X receptor signaling,Confirmatory,,
847,588532,1,1,,17389844,5280863,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
848,588532,1,1,,26757741,5280863,Inactive,311348376.0,2908.0,,Potency,qHTS assay for small molecule agonists of glucocorticoid receptor signaling,Confirmatory,,
849,588533,1,1,,17389844,5280863,Inconclusive,311348376.0,2908.0,17.7828,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
850,588533,1,1,,26757741,5280863,Inconclusive,311348376.0,2908.0,44.6684,Potency,qHTS assay for small molecule antagonists of glucocorticoid receptor signaling,Confirmatory,,
851,588534,1,1,,17389844,5280863,Inconclusive,216409690.0,5467.0,28.1838,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
852,588534,1,1,,26757741,5280863,Inconclusive,216409690.0,5467.0,35.4813,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
853,588535,1,1,,17389844,5280863,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
854,588535,1,1,,26757741,5280863,Inactive,216409690.0,5467.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor delta signaling,Confirmatory,,
855,588536,1,1,,17389844,5280863,Inconclusive,216409692.0,5468.0,12.5893,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
856,588536,1,1,,26757741,5280863,Inconclusive,216409692.0,5468.0,0.0141,Potency,qHTS assay for small molecule agonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
857,588537,1,1,,17389844,5280863,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
858,588537,1,1,,26757741,5280863,Inactive,216409692.0,5468.0,,Potency,qHTS assay for small molecule antagonists of peroxisome proliferator-activated receptor gamma signaling,Confirmatory,,
859,588541,1,1,,17389844,5280863,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
860,588541,1,1,,26757741,5280863,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule antagonists of vitamin D receptor signaling,Confirmatory,,
861,588543,1,1,,17389844,5280863,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
862,588543,1,1,,26757741,5280863,Inactive,216409708.0,7421.0,,Potency,qHTS assay for small molecule agonists of vitamin D receptor signaling,Confirmatory,,
863,588544,1,1,,17389844,5280863,Inconclusive,325495497.0,6256.0,22.3872,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
864,588544,1,1,,26757741,5280863,Inactive,325495497.0,6256.0,,Potency,qHTS assay for small molecule agonists of retinoid X receptor alpha signaling,Confirmatory,,
865,588545,1,1,,17389844,5280863,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
866,588545,1,1,,26757741,5280863,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule agonists of thyroid hormone receptor beta signaling,Confirmatory,,
867,588546,1,1,,17389844,5280863,Inconclusive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
868,588546,1,1,,26757741,5280863,Inconclusive,325495497.0,6256.0,,Potency,qHTS assay for small molecule antagonists of retinoid X receptor alpha signaling,Confirmatory,,
869,588547,1,1,,17389844,5280863,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
870,588547,1,1,,26757741,5280863,Inactive,189491771.0,7068.0,,Potency,qHTS assay for small molecule antagonists of thyroid hormone receptor beta signaling,Confirmatory,,
871,588549,1,1,,49674535,5280863,Inactive,1781172.0,,,,Fluorescence polarization to screen for inhibitor that competite the binding of FadD28 to bisubstrate Measured in Biochemical System Using Plate Reader - 2147-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
872,588579,1,1,,11112381,5280863,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
873,588579,1,1,,46501187,5280863,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
874,588579,1,1,,124882309,5280863,Inactive,7705344.0,51426.0,,Potency,qHTS for Inhibitors of Polymerase Kappa,Confirmatory,,
875,588590,1,1,,46501187,5280863,Active,154350220.0,11201.0,79.4328,Potency,qHTS for Inhibitors of Polymerase Iota,Confirmatory,,
876,588591,1,1,,46501187,5280863,Active,5729982.0,5429.0,25.1189,Potency,qHTS for Inhibitors of Polymerase Eta,Confirmatory,,
877,588621,1,1,,49674535,5280863,Inactive,90652859.0,84867.0,,,uHTS identification of small molecule inhibitors of Striatal-Enriched Phosphatase via a fluorescence intensity assay,Screening,,
878,588627,1,1,,46501187,5280863,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that activate MrgX1 receptor signaling,Screening,,
879,588664,1,2,,49674535,5280863,Inactive,62362414.0,25.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
880,588664,1,2,,49674535,5280863,Inactive,68989256.0,9610.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl)",Screening,,
881,588674,1,2,,49674535,5280863,Inactive,,,,,Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Based System Using Plate Reader - 2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
882,588675,1,1,,46501187,5280863,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that allosterically activate MrgX1 receptor signaling,Screening,,
883,588676,1,1,,46501187,5280863,Inactive,195969650.0,259249.0,,,Primary cell-based high-throughput screening for identification of compounds that antagonize MrgX1 receptor signaling,Screening,,
884,588689,1,1,,49674535,5280863,Inactive,219689243.0,,,IC50,Primary and Confirmatory Screening for Flavivirus Genomic Capping Enzyme Inhibition,Confirmatory,,
885,588692,2,1,,49674535,5280863,Inactive,,,,,Luciferase Reporter Cell Based HTS to identify inhibitors of N-linked Glycosylation Measured in Cell-Based System Using Plate Reader - 2146-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
886,588726,1,2,,49674535,5280863,Inactive,15607504.0,886474.0,,,Fluorescence-based biochemical primary high throughput screening assay to identify inhibitors of the fructose-bisphosphate aldolase (FBA) of M. tuberculosis,Screening,,
887,588727,1,1,,49674535,5280863,Inactive,,,,IC50,"A Cell-Based Confirmatory Screen for Compounds that Inhibit VEEV, TC-83",Confirmatory,,
888,588795,1,1,,46501187,5280863,Inconclusive,4758356.0,2237.0,50.1187,Potency,qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1).,Confirmatory,,
889,588814,1,3,,49674535,5280863,Active,37622910.0,1128.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 1 (CHRM1)",Screening,,
890,588819,1,4,,49674535,5280863,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1).,Screening,,
891,588832,1,1,,49674535,5280863,Inactive,7300964.0,,,,Hedgehog Measured in Biochemical System Using Plate Reader - 2070-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
892,588834,2,1,,17389844,5280863,Inconclusive,325651834.0,3757.0,0.0022,Potency,qHTS Assay for Small Molecule Inhibitors of the Human hERG Channel Activity,Confirmatory,,
893,588850,1,1,,49674535,5280863,Inactive,90421313.0,1080.0,,,uHTS identification of cystic fibrosis induced NFkb Inhibitors in a fluoresence assay,Screening,,
894,588852,1,3,,49674535,5280863,Inactive,37622910.0,1128.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1),Screening,,
895,588855,1,1,,46501187,5280863,Inactive,18418623.0,4088.0,,Potency,qHTS for Inhibitors of TGF-b,Confirmatory,,
896,588856,1,1,,46501187,5280863,Inactive,,,,Potency,qHTS for Inhibitors of TGF-b: Cytotox Counterscreen,Confirmatory,,
897,596450,1,4,,103206920,5280863,Unspecified,,,,,"Induction of insulin-stimulated 2-deoxy-D- 2,6-[3H]-glucose uptake in differentiated mouse 3T3L1 cells at 3 uM compound treated for 20 mins with insulin by liquid scintillation counting (Rvb = 100.0 %)",Other,21493073.0,
898,596451,1,4,,103206920,5280863,Unspecified,,,,,"Induction of insulin-stimulated 2-deoxy-D- 2,6-[3H]-glucose uptake in differentiated mouse 3T3L1 cells at 10 uM compound treated for 20 mins with insulin by liquid scintillation counting (Rvb = 100.0 %)",Other,21493073.0,
899,596452,1,4,,103206920,5280863,Unspecified,,,,,"Induction of insulin-stimulated 2-deoxy-D- 2,6-[3H]-glucose uptake in differentiated mouse 3T3L1 cells at 30 uM compound treated for 20 mins with insulin by liquid scintillation counting (Rvb = 100.0 %)",Other,21493073.0,
900,596453,2,4,,103206920,5280863,Unspecified,,,,,"Inhibition of insulin-stimulated 2-deoxy-D- 2,6-[3H]-glucose uptake in differentiated mouse 3T3L1 cells compound treated for 20 mins with insulin by liquid scintillation counting (Rvb = 100.0 %)",Other,21493073.0,
901,596670,1,4,,103206920,5280863,Unspecified,,,,,Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 1 uM on day 8 relative to control,Other,21493073.0,
902,596671,1,4,,103206920,5280863,Unspecified,,,,,Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 3 uM on day 8 relative to control,Other,21493073.0,
903,596672,1,4,,103206920,5280863,Unspecified,,,,,Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 10 uM on day 8 relative to control,Other,21493073.0,
904,596673,1,4,,103206920,5280863,Unspecified,,,,,Induction of adipogenesis in mouse 3T3L1 cells assessed as increase in triglyceride level at 30 uM on day 8 relative to control,Other,21493073.0,
905,598341,3,4,,103206920,5280863,Active,,,0.75,Ki,Inhibition of CYP1A1 EROD activity assessed as inhibition of deethylation of 7-ethoxyresorufin to resorufin,Confirmatory,21482471.0,
906,598342,3,4,,103206920,5280863,Active,,,0.043,Ki,Inhibition of CYP1B1 EROD activity assessed as inhibition of deethylation of 7-ethoxyresorufin to resorufin,Confirmatory,21482471.0,
907,602123,1,1,,49674535,5280863,Inactive,16128424.0,945085.0,,,Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon),Screening,,
908,602141,1,1,,49674535,5280863,Inactive,,,,,uHTS determination of small molecule cytotoxicity in a fluorescence assay to identify cystic fibrosis induced NFkb Inhibitors,Screening,,
909,602162,1,1,,49674535,5280863,Inactive,9955963.0,10058.0,,,Flow Cytometric HTS Screen for inhibitors of the ABC transporter ABCB6 for MLPCN Compound Set,Screening,,
910,602163,1,1,,49674535,5280863,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify activators of Methionine sulfoxide reductase A (MsrA),Screening,,
911,602179,1,2,,46501187,5280863,Inactive,89573979.0,3417.0,,Potency,qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS,Confirmatory,,
912,602229,1,1,,49674535,5280863,Inactive,216409728.0,10002.0,,,"Luminescence-based cell-based high throughput primary screening assay to identify agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3)",Screening,,
913,602233,1,1,,46501187,5280863,Inactive,115503961.0,4357161.0,,Potency,qHTS Assay to Find Inhibitors of Phosphoglycerate Kinase,Confirmatory,,
914,602244,1,2,,49674535,5280863,Inactive,5730106.0,10663.0,,,uHTS identification of CXCR6 Inhibitors in a B-arrestin luminescence assay,Screening,,
915,602247,1,2,,49674535,5280863,Inactive,,,,,Full deck counterscreen for positive allosteric modulators (PAMs) of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
916,602248,1,2,,49674535,5280863,Inactive,,,,,Full deck counterscreen for agonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective activators and assay artifacts using the parental CHOK1 cell line,Screening,,
917,602250,1,2,,49674535,5280863,Inactive,,,,,Full deck counterscreen for antagonists of the human M1 muscarinic receptor (CHRM1): Fluorescence-based cell-based high throughput screening assay to identify nonselective inhibitors and assay artifacts using the parental CHOK1 cell line,Screening,,
918,602252,1,1,,49674535,5280863,Inactive,62868213.0,57120.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
919,602252,1,1,,49674535,5280863,Inactive,90421313.0,1080.0,,,Fluorescence Polarization with CAL-PDZ Measured in Biochemical System Using Plate Reader - 2109-02_Inhibitor_SinglePoint_HTS_Activity,Screening,,
920,602261,1,1,,49674535,5280863,Inactive,41872631.0,2194.0,,,uHTS identification of small molecule inhibitors of  the thioesterase domain of fatty acid synthase via a fluorescence intensity assay,Screening,,
921,602274,1,2,,49674535,5280863,Inactive,,,,,uHTS luminescent assay for identification of compounds that enhance the survival of human induced pluripotent stem cells when cultured as single cells,Screening,,
922,602281,1,1,,49674535,5280863,Inactive,31542303.0,51099.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
923,602281,1,1,,49674535,5280863,Inactive,116292172.0,440503.0,,,"Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5)",Screening,,
924,602310,1,2,,46501187,5280863,Inactive,13399304.0,60489.0,,Potency,qHTS for Inhibitors of Vif-A3G Interactions: qHTS,Confirmatory,,
925,602313,1,1,,46501187,5280863,Inactive,22907044.0,200316.0,,Potency,qHTS for Inhibitors of Vif-A3F Interactions: qHTS,Confirmatory,,
926,602314,1,2,,92126042,5280863,Inactive,151220867.0,,,,A screen for compounds that modulate the activity of the Staphylococcus aureus MgrA protein,Other,,
927,602329,1,1,,49674535,5280863,Inactive,216548193.0,8438.0,,,Identification of inhibitors of RAD54 Measured in Biochemical System Using Plate Reader - 2159-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
928,602332,1,1,,11112381,5280863,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
929,602332,1,1,,46501187,5280863,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
930,602332,1,1,,124882309,5280863,Inactive,168984549.0,,,Potency,qHTS for Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in Human Glioma: qHTS,Confirmatory,,
931,602340,1,2,,49674535,5280863,Inactive,,,,,HTS for suppressors of simvastatin-induced mytoxicity in differentiated C2C12 cells Measured in Cell-Based System Using Plate Reader - 2112-01_Suppressor_SinglePoint_HTS_Activity,Screening,,
932,602342,2,1,,49674535,5280863,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
933,602346,1,1,,49674535,5280863,Inactive,9629361.0,155459.0,,,Identification of VIF Inhibitors Measured in Cell-Based System Using Imaging - 2108-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
934,602363,1,1,,49674535,5280863,Inactive,,,,,Whole cell Yeast HTS to identify compounds modulating the fidelity of the start codon recognition in eukaryotes. Measured in Whole Organism System Using Plate Reader - 2155-01_Other_SinglePoint_HTS_Activity,Screening,,
935,602393,1,1,,49674535,5280863,Inactive,291463269.0,20586.0,,,Screen for inhibitors of the SWI/SNF chromatin remodeling complex (esBAF) in mouse embryonic stem cells with Luciferase reporter assay Measured in Cell-Based System Using Plate Reader - 2141-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
936,602396,1,2,,49674535,5280863,Inactive,4504343.0,2494.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inverse agonists of the liver receptor homolog-1 (LRH-1; NR5A2),Screening,,
937,602399,1,2,,49674535,5280863,Inactive,15927174.0,,,,uHTS identification of inhibitors of NadD in a Colorimetric assay,Screening,,
938,602405,1,1,,49674535,5280863,Inactive,75495260.0,,,,PgID: DNTB colorimetric HTS to detect inhibitor of PgID Measured in Biochemical System Using Plate Reader - 2164-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
939,602410,1,1,,49674535,5280863,Inactive,11093520.0,3777.0,,,Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK3,Screening,,
940,602429,1,1,,49674535,5280863,Inactive,1762973.0,7341.0,,,uHTS identification of SUMO1-mediated protein-protein interactions,Screening,,
941,602438,1,1,,49674535,5280863,Inactive,160877737.0,,,,uHTS identification of modulators of interaction between CendR and NRP-1 using Fluorescence Polarization assay,Screening,,
942,602440,1,1,,49674535,5280863,Inactive,262118306.0,123228.0,,,uHTS Fluorescent Assay Using Nedd8 Protein Substrate for Identification of Inhibitors of Sentrin-Specific Protease 8 (SENP8),Screening,,
943,602449,1,2,,49674535,5280863,Inactive,,,,,uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay,Screening,,
944,602481,1,1,,49674535,5280863,Inactive,378544807.0,,,,Mycobacterium tuberculosis BioA enzyme inhibitor Measured in Biochemical System Using Plate Reader - 2163-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
945,611697,3,2,,103206920,5280863,Active,,,27.57,IC50,Inhibition of Escherichia coli beta-glucuronidase assessed as inhibition of p-nitrophenyl-beta-D-glucuronide hydrolysis preincubated for 30 mins measured 30 mins after substrate addition by spectrophotometry,Confirmatory,21619045.0,
946,611698,1,4,,103206920,5280863,Unspecified,,,,,Inhibition of Escherichia coli beta-glucuronidase assessed as inhibition of p-nitrophenyl-beta-D-glucuronide hydrolysis at 0.20 mM preincubated for 30 mins measured 30 mins after substrate addition by spectrophotometry,Other,21619045.0,
947,611702,6,5,,103206920,5280863,Inconclusive,74823252.0,,,IC50,Inhibition of Plasmodium falciparum Enoyl-ACP reductase using crotonyl-CoA as substrate peincubated for 5 mins measured after 10 mins of substrate addition by UV-vis spectrophotometry,Confirmatory,21619045.0,
948,611780,1,9,,103206920,5280863,Unspecified,74823252.0,,,,Inhibition of Plasmodium falciparum Enoyl-ACP reductase using crotonyl-CoA as substrate at 0.25 mM peincubated for 5 mins measured after 10 mins of substrate addition by UV-vis spectrophotometry,Other,21619045.0,
949,615921,3,2,,103206920,5280863,Active,,,6.76083,Kd,Binding affinity to ABCB1 nucleotide binding domain 2,Confirmatory,21723648.0,
950,616482,2,3,,103206920,5280863,Unspecified,,,,,Antioxidant activity assessed as DPPH free radical scavenging activity,Other,21821414.0,
951,623870,1,1,,49674535,5280863,Inactive,2702319.0,405.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
952,623870,1,1,,49674535,5280863,Inactive,5454102.0,10460.0,,,ARNT-TAC3: AlphaScreen HTS to detect disruption of ARNT/TAC3 interactions Measured in Biochemical System Using Plate Reader - 2158-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
953,623877,1,1,,49674535,5280863,Inactive,334278898.0,101772.0,,,Primary cell-based high-throughput screening for identification of compounds that activate/potentiate calcium-activated chloride channels (TMEM16A),Screening,,
954,623901,1,1,,49674535,5280863,Inactive,,,,,Small molecule inhibitors of miR122  Measured in Cell-Based System Using Plate Reader - 2144-01_Activator_SinglePoint_HTS_Activity,Screening,,
955,624037,1,3,,49674535,5280863,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
956,624038,1,3,,49674535,5280863,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
957,624040,1,3,,49674535,5280863,Inactive,7108336.0,1133.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 5 (CHRM5)",Screening,,
958,624101,1,2,,85788890,5280863,Inactive,62203298.0,3417.0,,,Development of  IDH1/2 inhibitors (CTD2project) Measured in Biochemical System Using Plate Reader - 2107-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
959,624125,1,4,,49674535,5280863,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
960,624126,1,3,,49674535,5280863,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify positive allosteric modulators (PAMs) of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
961,624127,1,2,,49674535,5280863,Inactive,52426748.0,1132.0,,,"Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human cholinergic receptor, muscarinic 4 (CHRM4)",Screening,,
962,624156,1,1,,85788890,5280863,Inactive,,,,,Fluorescence Cell-Based Primary  HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity,Screening,,
963,624168,1,1,,49674535,5280863,Inactive,47678551.0,9215.0,,,uHTS identification of small molecule activators of alpha dystroglycan glycosylation,Screening,,
964,624169,1,1,,49674535,5280863,Inactive,27753985.0,15558.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A),Screening,,
965,624170,1,1,,46501187,5280863,Inactive,71051501.0,2744.0,,Potency,qHTS for Inhibitors of Glutaminase (GLS),Confirmatory,,
966,624171,1,1,,46501187,5280863,Inactive,693842.0,4780.0,,Potency,qHTS of Nrf2 Activators,Confirmatory,,
967,624172,1,1,,46501187,5280863,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Agonists,Confirmatory,,
968,624173,1,3,,46501187,5280863,Inactive,62359610.0,,,Potency,qHTS of Trypanosoma Brucei Inhibitors,Confirmatory,,
969,624178,1,1,,46501187,5280863,Unspecified,179095.0,6609.0,,Potency,qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate,Confirmatory,,
970,624202,1,1,,46501187,5280863,Inactive,1698399.0,672.0,,Potency,qHTS Assay to Identify Small Molecule Activators of BRCA1 Expression,Confirmatory,,
971,624204,1,2,,49674535,5280863,Inactive,7657550.0,,,,"uHTS identification of small molecule inhibitors of the catalytic domain of the SUMO protease, SENP1 in a FRET assay",Screening,,
972,624246,1,1,,46501187,5280863,Inactive,343478176.0,2078.0,,Potency,qHTS for Small Molecule Inhibitors of the ERG Ets/DNA interaction,Confirmatory,,
973,624256,1,2,,49674535,5280863,Inactive,,3205.0,,,HTS to identify compounds that promote myeloid differentiation with MLPCN compound set,Screening,,
974,624263,1,1,,46501187,5280863,Inactive,3063388.0,5071.0,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
975,624263,1,1,,46501187,5280863,Inactive,37183032.0,,,Potency,A Quantitative High throughput Screen to Identify Chemical Modulators of PINK1 Expression,Confirmatory,,
976,624267,1,2,,49674535,5280863,Inactive,4506537.0,8767.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
977,624267,1,2,,49674535,5280863,Inactive,119603173.0,64127.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify inhibitors of the interaction of nucleotide-binding oligomerization domain containing 2 (NOD2) and the receptor-interacting serine-threonine kinase 2 (RIPK2),Screening,,
978,624268,1,3,,49674535,5280863,Inactive,71746704.0,3662741.0,,,Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of Trypanosoma brucei methionyl tRNA synthetase (MetRS),Screening,,
979,624288,1,1,,46501187,5280863,Inactive,52000961.0,2778.0,,Potency,"qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS",Confirmatory,,
980,624291,1,1,,46501187,5280863,Inactive,121312.0,1081.0,,Potency,qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy,Confirmatory,,
981,624296,1,1,,46501187,5280863,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells.,Confirmatory,,
982,624297,1,1,,46501187,5280863,Inactive,7705682.0,51053.0,,Potency,A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells.,Confirmatory,,
983,624300,1,1,,49674535,5280863,Inactive,,,,CC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP -  HeLa Cytotoxicity,Confirmatory,,
984,624304,1,2,,49674535,5280863,Inactive,25148072.0,177343.0,,,uHTS identification of SKN-1 Inhibitors in a fluoresence assay,Screening,,
985,624330,1,2,,49674535,5280863,Active,21361397.0,29127.0,44.49,IC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP -  Primary and Confirmatory Screens,Confirmatory,,
986,624349,1,2,,121363713,5280863,Inactive,,,,,A screen for compounds that inhibit liver stage malaria,Other,,
987,624351,1,1,,49674535,5280863,Active,,,34.5,IC50,Discovery of small molecule inhibitors of the oncogenic and cytokinetic protein MgcRacGAP - Counter Screen Coupled Enzyme,Confirmatory,,
988,624352,1,1,,49674535,5280863,Inactive,40254439.0,2034.0,,,uHTS identification of HIF-2a Inhibitors in a luminesence assay,Screening,,
989,624354,1,1,,49674535,5280863,Inactive,224494019.0,8795.0,,,uHTS identification of Caspase-8 TRAIL sensitizers in a luminesence assay,Screening,,
990,624377,1,1,,49674535,5280863,Inactive,351542238.0,50807.0,,,"Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 (ASAP1)",Screening,,
991,624416,1,1,,49674535,5280863,Inactive,9629363.0,155971.0,,,"TRFRET-based biochemical primary high throughput screening assay to identify small molecules that bind to the HIV-1-gp120 binding antibody, PG9",Screening,,
992,624417,1,1,,46501187,5280863,Inactive,1724069.0,2740.0,,Potency,qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode),Confirmatory,,
993,624418,1,1,,46501187,5280863,Inactive,,,,Potency,qHTS of GLP-1 Receptor Inverse Agonists: Cytotox Screen,Confirmatory,,
994,624463,1,1,,46501187,5280863,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Antagonists,Other,,
995,624464,1,1,,46501187,5280863,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Potentiators,Other,,
996,624465,1,1,,46501187,5280863,Inactive,4503385.0,1813.0,,,Beta-Arrestin HTS for Positive Allosteric Modulators of the Human D2 Dopamine Receptor: Agonists,Other,,
997,624466,1,3,,49674535,5280863,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
998,624467,1,1,,49674535,5280863,Inactive,21264324.0,134864.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify agonists of the human trace amine associated receptor 1 (TAAR1),Screening,,
999,624483,1,1,,49674535,5280863,Inactive,,,,,Counterscreen of compound fluorescence effects on High-throughput multiplex microsphere screening for inhibitors of toxin protease,Screening,,
1000,639825,5,5,,103206920,5280863,Active,113596.0,231.0,10.0,IC50,Inhibition of human recombinant aldose reductase using D-glyceraldehyde as substrate preincubated for 10 mins before substrate addition measured for every 10 secs for 50 mins by spectrophotometry,Confirmatory,22261024.0,
1001,642414,1,9,,103206920,5280863,Unspecified,544257.0,2099.0,,,Estrogenic activity at ERalpha in human MVLN cells at 100 ug/mL after 24 hrs by luciferase reporter gene assay relative to E2,Other,22137340.0,
1002,642415,1,9,,103206920,5280863,Unspecified,544257.0,2099.0,,,Estrogenic activity at ERalpha in human MVLN cells at 20 ug/mL after 24 hrs by luciferase reporter gene assay relative to E2,Other,22137340.0,
1003,651550,1,1,,46501187,5280863,Inactive,60391226.0,207.0,,,HTS Assay for Inhibitors of Akt Phophorylation: Primary Screen,Screening,,
1004,651560,1,1,,49674535,5280863,Inactive,1709543.0,52.0,,,"uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay",Screening,,
1005,651572,1,2,,49674535,5280863,Inactive,21489979.0,246310.0,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors of ADP-ribosylation factor GTPase activating protein 1 (ARFGAP1),Screening,,
1006,651602,1,1,,49674535,5280863,Inactive,16130723.0,947287.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1007,651602,1,1,,49674535,5280863,Inactive,16130724.0,947286.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1008,651602,1,1,,49674535,5280863,Inactive,16130726.0,947294.0,,,Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage),Screening,,
1009,651631,4,1,,144208363,5280863,Inconclusive,269849759.0,7157.0,6.8311,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
1010,651631,4,1,,144213678,5280863,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
1011,651632,4,1,,144208363,5280863,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
1012,651632,4,1,,144213678,5280863,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
1013,651633,4,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
1014,651633,4,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
1015,651634,4,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
1016,651634,4,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
1017,651635,1,3,,11112381,5280863,Inactive,171543895.0,6311.0,15.8489,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
1018,651635,1,3,,46501187,5280863,Inactive,171543895.0,6311.0,,Potency,qHTS for Inhibitors of ATXN expression,Confirmatory,,
1019,651636,1,1,,49674535,5280863,Inactive,4826706.0,1880.0,,,uHTS identification of small molecule antagonists of the EBI2 receptor via a luminescent beta-arrestin assay,Screening,,
1020,651640,1,1,,49674535,5280863,Inactive,,,,,DENV2 CPE-Based HTS Measured in Cell-Based and Microorganism Combination System Using Plate Reader - 2149-01_Other_SinglePoint_HTS_Activity,Screening,,
1021,651644,1,1,,46501187,5280863,Inactive,28872817.0,155807.0,,Potency,qHTS Assay for Inhibitors of the HIV-1 protein Vpr,Confirmatory,,
1022,651647,1,1,,49674535,5280863,Inactive,4826834.0,4323.0,,,uHTS identification of inhibitors of MT1-MMP activation in a fluoresence assay,Screening,,
1023,651654,1,1,,49674535,5280863,Inactive,,,,,HTS for the detection of C. neoformans cell lysis via adenylate kinase (AK) release Measured in Microorganism System Using Plate Reader - 2162-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1024,651658,1,1,,49674535,5280863,Inactive,10190672.0,27006.0,,,Small Molecule Inhibitors of FGF22-Mediated Excitatory Synaptogenesis & Epilepsy Measured in Biochemical System Using RT-PCR - 7012-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1025,651661,2,1,,49674535,5280863,Inactive,,,,,Luminescence Cell-Based Primary HTS to identify inhibitors of the oncoprotein EWS/Fli transcriptional activity Measured in Cell-Based System Using Plate Reader - 7014-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1026,651687,1,1,,49674535,5280863,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1027,651699,1,1,,49674535,5280863,Inactive,4502169.0,8883.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
1028,651699,1,1,,49674535,5280863,Inactive,4507791.0,9040.0,,,uHTS identification of inhibitors of cullin neddylation in a TR-FRET assay,Screening,,
1029,651702,1,2,,49674535,5280863,Inactive,,,,,Flow Cytometric HTS Screening for Inhibitors of Lytic Granule Exocytosis with MLPCN Compound Library,Screening,,
1030,651704,2,1,,49674535,5280863,Inactive,156104889.0,4300.0,,,Inhibition of the MLL-AF4-AF9 Interaction in Pediatric Leukemia Measured in Biochemical System Using Plate Reader - 2160-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1031,651710,1,1,,49674535,5280863,Inactive,109637798.0,5893.0,,,FRET-based HTS for detection of RAD52 Inhibitors Measured in Biochemical System Using Plate Reader - 7018-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1032,651711,2,1,,49674535,5280863,Inactive,2501205.0,10130.0,,,Turbidometric Biochemical  Primary HTS  to identify inhibitors of ERp5 Measured in Biochemical System Using Plate Reader - 7002-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1033,651718,1,2,,49674535,5280863,Inactive,73586699.0,281312.0,,,Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of Methionine sulfoxide reductase A (MsrA),Screening,,
1034,651719,1,2,,49674535,5280863,Inactive,4503907.0,8484.0,,,Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the Galanin Receptor 3 (GalR3),Screening,,
1035,651723,1,1,,49674535,5280863,Inactive,,,,,MLPCN PGC1a Modulators Measured in Cell-Based System Using Plate Reader - 2139-01_Activator_SinglePoint_HTS_Activity,Screening,,
1036,651724,1,1,,46501187,5280863,Inactive,1730321.0,5932.0,,,qHTS Assay for Inhibitors of the CtBP/E1A Interaction,Screening,,
1037,651725,1,1,,46501187,5280863,Inactive,1246761.0,6495.0,,,qHTS Assay for Inhibitors of the Six1/Eya2 Interaction,Screening,,
1038,651741,1,1,,17389844,5280863,Inconclusive,20149576.0,4780.0,29.8493,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1039,651741,1,1,,26757741,5280863,Active,20149576.0,4780.0,21.6899,Potency,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1040,651743,1,1,,17389844,5280863,Inactive,269849759.0,7157.0,,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
1041,651743,1,1,,26757741,5280863,Inactive,269849759.0,7157.0,,Potency,qHTS assay for small molecule activators of the p53 signaling pathway,Confirmatory,,
1042,651749,1,1,,17389844,5280863,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
1043,651749,1,1,,26757741,5280863,Inactive,34577122.0,4790.0,,Potency,qHTS assay for small molecule activators of the nuclear factor-kappa B (NF-kB) signaling pathway,Confirmatory,,
1044,651751,1,1,,17389844,5280863,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
1045,651751,1,1,,26757741,5280863,Inactive,5702233.0,84385.0,,Potency,qHTS assay for small molecule activators of the rat pregnane X receptor (rPXR) signaling pathway,Confirmatory,,
1046,651754,1,1,,17389844,5280863,Active,,,5.308,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 1 hr assay,Confirmatory,,
1047,651755,1,1,,17389844,5280863,Active,,,8.4127,Potency,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - 5 hr assay,Confirmatory,,
1048,651757,1,1,,17389844,5280863,Inconclusive,25952111.0,7124.0,,Potency,qHTS assay to identify small molecules that stimulate Tumor Necrosis Factor-alpha (TNF-alpha) secretion,Confirmatory,,
1049,651758,1,1,,17389844,5280863,Inconclusive,186368.0,3576.0,,Potency,qHTS assay to identify small molecules that stimulate interleukin-8 (IL-8) secretion,Confirmatory,,
1050,651768,1,2,,46501187,5280863,Inactive,3719421.0,7486.0,,Potency,qHTS for Inhibitors of WRN Helicase,Confirmatory,,
1051,651777,1,1,,17389844,5280863,Inconclusive,51095037.0,196.0,56.2341,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
1052,651777,1,1,,26757741,5280863,Inconclusive,51095037.0,196.0,44.6684,Potency,qHTS assay for environmental chemicals that activate the Aryl hydrocarbon Receptor (AhR) signaling pathway,Confirmatory,,
1053,651778,1,1,,17389844,5280863,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
1054,651778,1,1,,26757741,5280863,Inactive,3041727.0,5465.0,,Potency,qHTS assay for small molecule agonists of the peroxisome proliferator-activated receptor alpha (PPARalpha) signaling pathway,Confirmatory,,
1055,651800,1,1,,49674535,5280863,Inactive,2358024.0,6955.0,,,Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe,Screening,,
1056,651802,1,1,,17389844,5280863,Inconclusive,49066040.0,6097.0,74.97800000000001,Potency,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1057,651819,1,1,,46501187,5280863,Inactive,83758679.0,153562.0,,,High-Throughput Screening for Modulators of Cytosolic Chaperonin Activity,Screening,,
1058,651820,1,1,,46501187,5280863,Active,,,6.3096,Potency,qHTS Assay for Inhibitors of Hepatitis C Virus (HCV),Confirmatory,,
1059,651821,2,4,,49674535,5280863,Inactive,,,,,Fluorescence-based biochemical primary high throughput screening assay to identify molecules that bind r(CAG) RNA repeats,Screening,,
1060,651838,1,1,,17389844,5280863,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1061,651838,1,1,,26757741,5280863,Unspecified,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1062,651838,1,1,1.0,17389844,5280863,Active,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1063,651838,1,1,1.0,26757741,5280863,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1064,651838,1,1,2.0,17389844,5280863,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1065,651838,1,1,2.0,26757741,5280863,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1066,651838,1,1,3.0,17389844,5280863,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1067,651838,1,1,3.0,26757741,5280863,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1068,651838,1,1,4.0,17389844,5280863,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1069,651838,1,1,4.0,26757741,5280863,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1070,651838,1,1,5.0,17389844,5280863,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1071,651838,1,1,5.0,26757741,5280863,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1072,651838,1,1,6.0,17389844,5280863,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1073,651838,1,1,6.0,26757741,5280863,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1074,651838,1,1,7.0,17389844,5280863,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1075,651838,1,1,7.0,26757741,5280863,Inconclusive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1076,651838,1,1,8.0,17389844,5280863,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1077,651838,1,1,8.0,26757741,5280863,Inactive,,,,,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against a panel of isogenic chicken DT40 cell lines with known DNA damage response pathways,Other,,
1078,651957,1,1,,49674535,5280863,Inactive,5729858.0,10499.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of the Steroid Receptor Coactivator 2 (SRC2; NCOA2),Screening,,
1079,651958,1,1,,49674535,5280863,Active,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening primary assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
1080,651965,1,1,,46501187,5280863,Inactive,2668494.0,,,Potency,qHTS Assay for Activators of ClpP,Confirmatory,,
1081,651999,1,1,,49674535,5280863,Inactive,38027923.0,10987.0,,,"uHTS identification of small molecule inhibitors of Csn-mediated Deneddylation of Cullin-Ring Ligases, vis a fluorescence polarization assay",Screening,,
1082,652010,1,1,,49674535,5280863,Inactive,5016090.0,190.0,,,"Luminescence-based cell-based primary high throughput screening assay for inhibitors of the orphan nuclear receptor subfamily 0, group B, member 1 (DAX1; NR0B1): repression of SF-1 (NR5A1) activated StAR promoter by full-length DAX-1",Screening,,
1083,652017,1,1,,49674535,5280863,Inactive,119579215.0,6595.0,,,"Luminescence-based cell-based primary high throughput screening assay to identify activators of the function of SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 (SMARCA2, BRM)",Screening,,
1084,652025,1,1,,46501187,5280863,Inactive,7110653.0,16183.0,,Potency,qHTS of IL-2 Activators,Confirmatory,,
1085,652039,1,1,,49674535,5280863,Inactive,21327705.0,5650.0,,,Fluorescence Intensity-based biochemical primary high throughput screening assay to identify activators of kallikrein-7 (K7) zymogen,Screening,,
1086,652048,1,2,,46501187,5280863,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Agonist: qHTS,Screening,,
1087,652051,1,1,,46501187,5280863,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Potentiators: qHTS,Screening,,
1088,652054,1,1,,46501187,5280863,Inactive,89191863.0,1814.0,,,qHTS of D3 Dopamine Receptor Antagonist: qHTS,Screening,,
1089,652067,1,4,,49674535,5280863,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite H. contortus (hcDAF-12),Screening,,
1090,652104,1,1,,46501187,5280863,Inactive,20140568.0,23435.0,,Potency,qHTS of TDP-43 Inhibitors,Confirmatory,,
1091,652105,1,1,,46501187,5280863,Active,18266879.0,5305.0,,Potency,qHTS for Inhibitors of phosphatidylinositol 5-phosphate 4-kinase (PI5P4K),Confirmatory,,
1092,652106,1,1,,46501187,5280863,Inactive,586067.0,6622.0,,Potency,qHTS of alpha-syn Inhibitors,Confirmatory,,
1093,652115,1,1,,49674535,5280863,Inactive,38258652.0,23408.0,,,MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5,Screening,,
1094,652126,1,3,,49674535,5280863,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify activators of the DAF-12 from the parasite S. stercoralis (ssDAF-12),Screening,,
1095,652142,1,1,,49674535,5280863,Inactive,186910300.0,29127.0,,,Biochemical MgcRacGAP assay detecting GTPase activation of the target GTPase Rac1 through the measurement of inorganic phosphate.,Other,,
1096,652162,2,1,,49674535,5280863,Inactive,126698238.0,4914074.0,,,C. difficile toxins: HTS for inhibitors of TcdB glycohydrolase activity Measured in Biochemical System Using Plate Reader - 7074-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1097,652163,1,1,,49674535,5280863,Inactive,47496637.0,6275.0,,,S100A4: HTS Measured in Biochemical System Using Plate Reader - 7045-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1098,652197,1,1,,49674535,5280863,Inactive,21315078.0,51752.0,,,MLPCN ERAP1 Measured in Biochemical System Using Plate Reader - 7016-01_Inhibitor_SinglePoint_HTS_Activity,Screening,,
1099,652257,1,1,,49674535,5280863,Inactive,32425330.0,3276.0,,,Primary biochemical fluorescence polarization-based high throughput screening assay to identify inhibitors of protein arginine methyltransferase 1 (PRMT1),Screening,,
1100,654746,6,2,,103206920,5280863,Unspecified,137757.0,1489078.0,,IC50,Inhibition of GST-tagged Human papillomavirus 16 protein E6 interaction with His-tagged human caspase 8 expressed in Escherichia coli after 1 hr incubation followed by overnight incubation by Alpha screening technique,Confirmatory,22300659.0,
1101,654749,1,8,,103206920,5280863,Unspecified,137757.0,1489078.0,,,Inhibition of GST-tagged Human papillomavirus 16 protein E6 interaction with His-tagged human FADD expressed in Escherichia coli after 1 hr incubation followed by overnight incubation by Alpha screening technique,Other,22300659.0,
1102,658254,1,5,,103206920,5280863,Unspecified,,,,,Antiviral activity against HCV JFH-1 J399EM infected in Human Huh7.5.1 cells assessed as suppression of viral replication at 50 uM after 72 hrs by EGFP assay,Other,22445328.0,
1103,658255,2,3,,103206920,5280863,Unspecified,,,50.0,CC50,Cytotoxicity against human Huh7.5.1 cells by MTT assay,Confirmatory,22445328.0,
1104,669363,1,4,,103206920,5280863,Unspecified,,,,,Fe2+ chelating activity of the compound incubated for 5 mins prior to ferrozine-addition measured after 10 mins by spectrophotometry,Other,22546674.0,
1105,671213,2,2,,103206920,5280863,Unspecified,,,40.0,IC50,Antiproliferative activity against human 22Rv1 cells incubated up to 144 hrs by Coulter particle count and size analyzer,Confirmatory,22789812.0,
1106,671217,1,3,,103206920,5280863,Unspecified,,,,,Inhibition of androgen receptor expression in human 22Rv1 cells assessed as AR protein level at 10 uM after 72 hrs by densitometry relative to untreated control,Other,22789812.0,
1107,671218,1,3,,103206920,5280863,Unspecified,,,,,Inhibition of androgen receptor expression in human 22Rv1 cells assessed as AR protein level at 20 uM after 72 hrs by densitometry relative to untreated control,Other,22789812.0,
1108,671219,1,3,,103206920,5280863,Unspecified,,,,,Inhibition of prostate specific antigen expression in human 22Rv1 cells assessed as PSA protein level at 10 uM after 72 hrs by densitometry relative to untreated control,Other,22789812.0,
1109,671220,1,3,,103206920,5280863,Unspecified,,,,,Inhibition of prostate specific antigen expression in human 22Rv1 cells assessed as PSA protein level at 20 uM after 72 hrs by densitometry relative to untreated control,Other,22789812.0,
1110,671761,1,2,,103206920,5280863,Inactive,,,,,Inhibition of SARS coronavirus nsP13 helicase activity expressed in Escherichia coli Rosetta assessed inhibition of DNA unwinding activity at 10 uM by FRET assay,Other,22578462.0,
1111,671762,1,2,,103206920,5280863,Inactive,,,,,Inhibition of HCV NS3 helicase overexpressed in Escherichia coli BL21(DE3) assessed as inhibition of DNA unwinding activity at 10 uM by FRET assay,Other,22578462.0,
1112,671764,1,2,,103206920,5280863,Inactive,,,,,Inhibition of HCV NS3 helicase ATP hydrolysis activity overexpressed in Escherichia coli BL21(DE3) assessed as inhibition of inorganic phosphate release by AM/MG-based colometric analysis in the presence of M13 ssDNA,Other,22578462.0,
1113,679336,3,6,,103206920,5280863,Unspecified,296439301.0,4363.0,2.4,Ki,TP_TRANSPORTER: inhibition of LTC4 uptake in membrane vesicle from MRP1-expressing HeLa cells,Confirmatory,11306701.0,
1114,681156,1,8,,103206920,5280863,Unspecified,67462103.0,9429.0,,,TP_TRANSPORTER: drug resistance (SN-38) in BCRP-expressing K562 cells,Other,15205350.0,
1115,681185,1,8,,103206920,5280863,Unspecified,67462103.0,9429.0,,,"TP_TRANSPORTER: increase in mitoxantrone intracellular accumulation (Mitoxantrone: 20 uM, Kaempferol: 50 uM) in BCRP-expressing NCI-H460 cells",Other,15102949.0,
1116,681199,1,8,,103206920,5280863,Unspecified,67462103.0,9429.0,,,"TP_TRANSPORTER: increase in mitoxantrone intracellular accumulation (Mitoxantrone: 100 uM, Kaempferol: 50 uM) in BCRP-expressing MCF-7 cells",Other,15102949.0,
1117,681314,1,8,,103206920,5280863,Unspecified,296439301.0,4363.0,,,"TP_TRANSPORTER: increase in Vinblastine intracellular accumulation (Vinblastine: 0.05 uM, Kaempherol: 100 uM) in Panc-1 cells",Other,12532374.0,
1118,681324,1,8,,103206920,5280863,Unspecified,296439301.0,4363.0,,,"TP_TRANSPORTER: increase in Daunomycin intracellular accumulation (Daunomycin: 0.05 uM, Kaempferol: 100 uM) in Panc-1 cells",Other,12532374.0,
1119,681587,1,8,,103206920,5280863,Unspecified,67462103.0,9429.0,,,TP_TRANSPORTER: drug resistance (Mitoxantrone) in BCRP-expressing K562 cells,Other,15205350.0,
1120,685117,1,3,,103206920,5280863,Active,,,,,Cytotoxicity against human U87 cells assessed as reduction in cell viability at 5 to 40 uM after 72 hrs by MTT assay,Other,22871217.0,
1121,685118,1,3,,103206920,5280863,Active,,,,,Cytotoxicity against human BxPC3 cells assessed as reduction in cell viability at 5 to 40 uM after 72 hrs by MTT assay,Other,22871217.0,
1122,685119,1,3,,103206920,5280863,Active,,,,,Cytotoxicity against human NCI-H2126 cells assessed as reduction in cell viability at 5 to 40 uM after 72 hrs by MTT assay,Other,22871217.0,
1123,685120,1,3,,103206920,5280863,Active,,,,,Cytotoxicity against human PANC1 cells assessed as reduction in cell viability at 5 to 40 uM after 72 hrs by MTT assay,Other,22871217.0,
1124,685121,1,3,,103206920,5280863,Active,,,,,Cytotoxicity against human A549 cells assessed as reduction in cell viability at 5 to 40 uM after 72 hrs by MTT assay,Other,22871217.0,
1125,685122,1,3,,103206920,5280863,Active,,,,,Cytotoxicity against human MCF7 cells assessed as reduction in cell viability at 5 to 40 uM after 72 hrs by MTT assay,Other,22871217.0,
1126,685123,1,3,,103206920,5280863,Active,,,,,Cytotoxicity against human MDA-MB-231 cells assessed as reduction in cell viability at 5 to 40 uM after 72 hrs by MTT assay,Other,22871217.0,
1127,685124,1,3,,103206920,5280863,Active,,,,,Cytotoxicity against human SMMC7721 cells assessed as reduction in cell viability at 5 to 40 uM after 72 hrs by MTT assay,Other,22871217.0,
1128,685125,1,3,,103206920,5280863,Active,,,,,Cytotoxicity against human HepG2 cells assessed as reduction in cell viability at 5 to 40 uM after 72 hrs by MTT assay,Other,22871217.0,
1129,685126,1,3,,103206920,5280863,Active,,,,,Cytotoxicity against human AGS cells assessed as reduction in cell viability at 5 to 40 uM after 72 hrs by MTT assay,Other,22871217.0,
1130,685127,1,3,,103206920,5280863,Unspecified,,,,,Cytotoxicity against human MIHA cells assessed as reduction in cell viability at 5 to 40 uM after 72 hrs by MTT assay,Other,22871217.0,
1131,685132,1,3,,103206920,5280863,Active,,,,,Cytotoxicity against human A375 cells assessed as reduction in cell viability at 5 to 40 uM after 72 hrs by MTT assay,Other,22871217.0,
1132,686940,1,1,,49674535,5280863,Inactive,14149746.0,7026.0,,,Luminescence-based cell-based primary high throughput screening assay to identify inhibitors of COUP-TFII (NR2F2),Screening,,
1133,686964,1,1,,49674535,5280863,Inactive,21595776.0,8932.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of 5-meCpG-binding domain protein 2 (MBD2)-DBD binding to methylated oligonucleotide,Screening,,
1134,686970,1,2,,46501187,5280863,Inactive,49168486.0,3417.0,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line,Confirmatory,,
1135,686971,1,2,,46501187,5280863,Inactive,,,,Potency,qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-IDH1KD cell line,Confirmatory,,
1136,686976,1,1,,49674535,5280863,Inactive,76364066.0,2943075.0,,,Fluorescence-based biochemical high throughput screening confirmation assay to identify inhibitors of Crimean-Congo Hemorrhagic Fever (CCHF) viral ovarian tumor domain protease (vOTU): Pep-AMC substrate,Screening,,
1137,686977,2,1,,49699293,5280863,Inactive,9657203.0,2615631.0,,IC50,Vibrio cholerae assay for pro-quorum sensing small molecules,Confirmatory,,
1138,686978,1,1,,46501187,5280863,Inconclusive,79154014.0,55775.0,20.5962,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1139,686978,1,1,,124882309,5280863,Inconclusive,79154014.0,55775.0,21.136,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT,Confirmatory,,
1140,686979,1,1,,46501187,5280863,Inactive,79154014.0,55775.0,,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1141,686979,1,1,,124882309,5280863,Inconclusive,79154014.0,55775.0,23.715,Potency,qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT,Confirmatory,,
1142,686996,1,1,,49674535,5280863,Inactive,13325293.0,839.0,,,VEID(2) R110 Enzymatic Primary HTS to identify Inhibitors of Caspase 6 Measured in Biochemical System Using Plate Reader - 7052-01_Inhibitor_SinglePoint_HTS_Activity_Set2,Screening,,
1143,687014,1,1,,49674535,5280863,Active,71987181.0,181263.0,,,Luminescence-based cell-based primary high throughput screening assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).,Screening,,
1144,687016,1,1,,49674535,5280863,Inactive,115430235.0,29128.0,,,Counterscreen for inhibitors of 5-meCpG-binding domain protein 2 (MBD2): TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of binding of ubiquitin-like with PHD and ring finger domains 1 (UHRF1) to methylated oligonucleotide,Screening,,
1145,690143,1,2,,103206920,5280863,Unspecified,,,,,Inhibition of oleic acid-induced triglyceride over-accumulation in human HepG2 cells incubated for 24 hrs relative to untreated control,Other,21824690.0,
1146,690144,1,2,,103206920,5280863,Unspecified,,,,,Antioxidant activity in human HepG2 cells assessed as reduction of oleic acid-induced ROS generation incubated for 24 hrs by DHCF-DA based fluorimetric assay relative to untreated control,Other,21824690.0,
1147,690145,1,2,,103206920,5280863,Unspecified,,,,,Cytotoxicity against human HepG2 cells incubated for 24 hrs by MTT assay,Other,21824690.0,
1148,690148,1,2,,103206920,5280863,Unspecified,,,,,Reducing activity assessed as chlorogenic acid equivalent per mmol standard at 37 degC for 30 mins by Folin-Ciocalteu reagent assay assay,Other,21824690.0,
1149,690149,1,2,,103206920,5280863,Unspecified,,,,,Reducing activity by cyclic voltammetry,Other,21824690.0,
1150,696769,2,2,,103206920,5280863,Unspecified,,,400.0,IC50,Cytotoxicity against human HepG2 cells by MTT assay,Confirmatory,21726077.0,
1151,697064,2,2,,103206920,5280863,Active,,,10.4,IC50,Inhibition of duck liver FASN,Confirmatory,21726077.0,
1152,697852,1,7,,103206920,5280863,Unspecified,14916521.0,,,,Inhibition of electric eel AChE at 2 mg/ml by Ellman's method,Other,23062825.0,
1153,697853,1,7,,103206920,5280863,Unspecified,21362409.0,100033901.0,,,Inhibition of horse BChE at 2 mg/ml by Ellman's method,Other,23062825.0,
1154,720504,1,1,,46501187,5280863,Inactive,21359873.0,5347.0,,Potency,qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen,Confirmatory,,
1155,720508,1,1,,49674535,5280863,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn7) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
1156,720509,1,1,,49674535,5280863,Inactive,28373962.0,,,,Fluorescence polarization-based biochemical primary high throughput screening assay to identify inhibitors that disrupt the binding of a cyclic peptide (Tn6) to the fibrin proteolytic product D-Dimer and fragment E complex [DD(E )],Screening,,
1157,720511,1,1,,49674535,5280863,Inactive,89348172.0,1080.0,,,Identification of Small Molecule Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Delta508 Mutation Function in Human Bronchial Epithelial Cells. Measured in Cell-Based System Using Plate Reader - 7017-01_Other_SinglePoint_HTS_Activity,Screening,,
1158,720516,2,1,,144208363,5280863,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1159,720516,2,1,,144213678,5280863,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
1160,720532,1,1,,11112381,5280863,Inactive,420597.0,,7.0795,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1161,720532,1,1,,124882309,5280863,Inactive,420597.0,,11.2202,Potency,qHTS for Inhibitors of binding or entry into cells for Marburg Virus,Confirmatory,,
1162,720533,1,1,,11112381,5280863,Inactive,,,,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1163,720533,1,1,,124882309,5280863,Inactive,,,31.6228,Potency,qHTS for Inhibitors of binding or entry into cells for Lassa Virus,Confirmatory,,
1164,720542,1,2,,46501187,5280863,Inactive,23496270.0,810891.0,25.1189,Potency,qHTS for Inhibitors of AMA1-RON; Towards Development of Antimalarial Drug Lead: Primary Screen,Confirmatory,,
1165,720543,1,1,,49674535,5280863,Inactive,326937491.0,105501.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of alpha/beta hydrolase domain containing 4 (ABHD4).,Screening,,
1166,720551,1,2,,46501187,5280863,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Wildtype qHTS,Confirmatory,,
1167,720552,2,1,,144208363,5280863,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1168,720552,2,1,,144213678,5280863,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
1169,720553,1,2,,46501187,5280863,Inactive,342840031.0,3757.0,,Potency,qHTS for Inhibitors of KCHN2 3.1: Mutant qHTS,Confirmatory,,
1170,720579,2,1,,46501187,5280863,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: mCherry Reporter Primary qHTS,Confirmatory,,
1171,720580,1,1,,46501187,5280863,Inactive,222762.0,3707576.0,,Potency,qHTS for Stage-Specific Inhibitors of Vaccinia Orthopoxvirus: Venus Reporter Primary qHTS,Confirmatory,,
1172,720582,1,1,,49674535,5280863,Active,2393947.0,102.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM10.,Screening,,
1173,720596,1,1,,49674535,5280863,Inactive,4506113.0,5621.0,,,TRFRET-based cell-based primary high throughput screening assay to identify inhibitors of cell surface Prion Protein (PRPC),Screening,,
1174,720634,2,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1175,720634,2,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
1176,720635,2,1,,144208363,5280863,Active,,,3.8414,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1177,720635,2,1,,144213678,5280863,Active,,,0.3278,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
1178,720636,1,1,,17389844,5280863,Inconclusive,20149576.0,4780.0,8.4127,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
1179,720636,1,1,,26757741,5280863,Inconclusive,20149576.0,4780.0,15.3553,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity,Confirmatory,,
1180,720637,2,1,,144208363,5280863,Active,,,5.63839,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1181,720637,2,1,,144213678,5280863,Active,,,1.16291,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
1182,720647,1,2,,49674535,5280863,Inactive,,,,,Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition,Screening,,
1183,720648,1,1,,49674535,5280863,Active,73747889.0,6868.0,,,QFRET-based biochemical primary high throughput screening assay to identify exosite inhibitors of ADAM17.,Screening,,
1184,720652,1,1,,17389844,5280863,Inconclusive,,,74.97800000000001,Potency-Replicate_1,qHTS assay for small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1185,720653,1,1,,17389844,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
1186,720653,1,1,,26757741,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway measured by Nrf2-dependant transcriptional activity - cell viability counter screen,Confirmatory,,
1187,720659,1,1,,17389844,5280863,Inconclusive,325495557.0,8856.0,31.6228,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
1188,720659,1,1,,26757741,5280863,Active,325495557.0,8856.0,44.6684,Potency-Replicate_1,qHTS assay for small molecule activators of the human pregnane X receptor (PXR) signaling pathway,Confirmatory,,
1189,720674,2,2,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1190,720674,2,2,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
1191,720675,2,2,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1192,720675,2,2,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
1193,720678,2,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1194,720678,2,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
1195,720679,2,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1196,720679,2,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
1197,720680,2,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1198,720680,2,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
1199,720681,2,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1200,720681,2,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
1201,720682,2,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1202,720682,2,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
1203,720683,2,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1204,720683,2,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
1205,720684,2,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1206,720684,2,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
1207,720685,2,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1208,720685,2,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
1209,720686,2,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1210,720686,2,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
1211,720687,2,2,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1212,720687,2,2,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
1213,720691,4,1,,144208363,5280863,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1214,720691,4,1,,144213678,5280863,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1215,720692,3,1,,144208363,5280863,Inconclusive,311348376.0,2908.0,21.7975,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1216,720692,3,1,,144213678,5280863,Inconclusive,311348376.0,2908.0,37.0994,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
1217,720693,3,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1218,720693,3,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
1219,720700,1,4,,49674535,5280863,Inactive,223459640.0,5335.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-gamma1).,Screening,,
1220,720702,1,1,,49674535,5280863,Inactive,23510348.0,51567.0,,,Epi Absorbance-based biochemical primary high throughput screening assay to identify inhibitors of human tyrosyl-DNA phosphodiesterase 2 (TDP2),Screening,,
1221,720704,1,4,,49674535,5280863,Inactive,148745659.0,5331.0,,,Fluorescence-based biochemical high throughput primary assay to identify inhibitors of phospholipase C isozymes (PLC-beta3).,Screening,,
1222,720707,1,2,,46501187,5280863,Inactive,317373593.0,10411.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
1223,720708,1,2,,46501187,5280863,Inactive,32171491.0,11069.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 2 (EPAC2): primary screen,Confirmatory,,
1224,720709,1,2,,46501187,5280863,Inactive,317373593.0,10411.0,,Potency,qHTS for Antagonist of cAMP-regulated guanine nucleotide exchange factor 3 (EPAC1): primary screen,Confirmatory,,
1225,720711,1,2,,46501187,5280863,Inactive,32171491.0,11069.0,,Potency,qHTS for Agonist of cAMP-regulated guanine nucleotide exchange factor 4 (EPAC2): primary screen,Confirmatory,,
1226,720717,1,3,,92126042,5280863,Inactive,1718329.0,,,,Chemical Probes of Kaposi's Sarcoma Herpes Virus Latent Infection,Other,,
1227,720719,2,1,,144208363,5280863,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1228,720719,2,1,,144213678,5280863,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1229,720725,2,1,,144208363,5280863,Active,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1230,720725,2,1,,144213678,5280863,Inconclusive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
1231,730326,1,3,,103206920,5280863,Unspecified,,,50.0,GI50,Cytotoxicity against human RS4:11 cells harboring wild type FLT3 after 72 hrs by tetrazolium based Ez CyTox cell viability assay,Confirmatory,23411073.0,
1232,730327,1,2,,103206920,5280863,Active,,,3.34,GI50,Cytotoxicity against human MV4-11 cells harboring FLT3 mutation after 72 hrs by tetrazolium based Ez CyTox cell viability assay,Confirmatory,23411073.0,
1233,730328,2,5,,103206920,5280863,Active,156630887.0,2322.0,2.32,IC50,Inhibition of recombinant FLT3 (unknown origin) by TR-FRET assay,Confirmatory,23411073.0,
1234,736341,1,6,,103206920,5280863,Unspecified,417522.0,5467.0,,,Agonist activity at human PPARdelta expressed in HEK293 cells cotransfected with PPREx4-TK-luc assessed as beta-galactosidase activity at 50 uM measured after 48 hrs relative to vehicle control,Other,23265844.0,
1235,736345,1,6,,103206920,5280863,Unspecified,417522.0,5467.0,,,Agonist activity at human PPARdelta expressed in HEK293 cells cotransfected with PPREx4-TK-luc assessed as beta-galactosidase activity at 25 uM measured after 48 hrs relative to vehicle control,Other,23265844.0,
1236,743012,3,1,,144208363,5280863,Inconclusive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1237,743012,3,1,,144213678,5280863,Active,,,32.7752,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
1238,743014,3,1,,144208363,5280863,Inconclusive,,,60.882,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1239,743014,3,1,,144213678,5280863,Active,,,11.6291,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
1240,743015,3,1,,144208363,5280863,Inconclusive,,,68.3107,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1241,743015,3,1,,144213678,5280863,Active,,,36.7744,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
1242,743033,3,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1243,743033,3,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
1244,743035,2,1,,144208363,5280863,Inconclusive,124375976.0,367.0,10.9246,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1245,743035,2,1,,144213678,5280863,Inconclusive,124375976.0,367.0,13.1634,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1246,743036,2,1,,144208363,5280863,Inconclusive,124375976.0,367.0,10.9246,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1247,743036,2,1,,144213678,5280863,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
1248,743040,3,1,,144208363,5280863,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1249,743040,3,1,,144213678,5280863,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1250,743041,3,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1251,743041,3,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
1252,743042,3,1,,144208363,5280863,Inconclusive,124375976.0,367.0,68.3107,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1253,743042,3,1,,144213678,5280863,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
1254,743050,1,1,,49674535,5280863,Inactive,71987181.0,181263.0,,,Luminescence-based cell-based high throughput confirmation assay to identify agonists of the DAF-12 from the parasite H. glycines (hgDAF-12).,Screening,,
1255,743051,1,1,,49674535,5280863,Inactive,85362735.0,7376.0,,,Counterscreen for agonists of the daf-12 abnormal Dauer Formation: Luminescence-based cell-based screening assay to identify agonists of the Liver-X-Receptor (LXR),Screening,,
1256,743053,2,1,,144208363,5280863,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1257,743053,2,1,,144213678,5280863,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1258,743054,2,1,,144208363,5280863,Inconclusive,124375976.0,367.0,72.3584,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1259,743054,2,1,,144213678,5280863,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
1260,743063,2,1,,144208363,5280863,Active,124375976.0,367.0,26.4083,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1261,743063,2,1,,144213678,5280863,Inconclusive,124375976.0,367.0,26.2643,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
1262,743064,3,1,,144208363,5280863,Inconclusive,,,68.3107,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1263,743064,3,1,,144213678,5280863,Inconclusive,,,46.2962,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
1264,743065,3,1,,144208363,5280863,Inconclusive,399498506.0,24831.0,68.3107,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1265,743065,3,1,,144213678,5280863,Inconclusive,399498506.0,24831.0,46.2962,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1266,743066,3,1,,144208363,5280863,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1267,743066,3,1,,144213678,5280863,Inconclusive,399498506.0,24831.0,11.6291,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
1268,743067,2,1,,144208363,5280863,Inconclusive,399498506.0,24831.0,60.882,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1269,743067,2,1,,144213678,5280863,Inconclusive,399498506.0,24831.0,46.2962,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
1270,743069,2,1,,144208363,5280863,Active,348019627.0,2099.0,27.4414,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1271,743069,2,1,,144213678,5280863,Inconclusive,348019627.0,2099.0,13.1634,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1272,743074,2,1,,144208363,5280863,Inconclusive,,,54.7528,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1273,743074,2,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
1274,743075,2,1,,144208363,5280863,Active,348019627.0,2099.0,21.7975,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1275,743075,2,1,,144213678,5280863,Active,348019627.0,2099.0,26.2643,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
1276,743077,2,1,,144208363,5280863,Active,348019627.0,2099.0,21.7975,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1277,743077,2,1,,144213678,5280863,Active,348019627.0,2099.0,33.0402,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1278,743078,2,1,,144208363,5280863,Active,348019627.0,2099.0,33.246,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1279,743078,2,1,,144213678,5280863,Inconclusive,348019627.0,2099.0,16.5717,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
1280,743079,3,1,,144208363,5280863,Active,348019627.0,2099.0,24.2376,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1281,743079,3,1,,144213678,5280863,Active,348019627.0,2099.0,18.4309,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1282,743080,3,1,,144208363,5280863,Inconclusive,348019627.0,2099.0,68.3107,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1283,743080,3,1,,144213678,5280863,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
1284,743081,3,1,,144208363,5280863,Inconclusive,,,60.882,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1285,743081,3,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
1286,743083,3,1,,144208363,5280863,Inconclusive,119597822.0,1588.0,48.3603,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1287,743083,3,1,,144213678,5280863,Inconclusive,119597822.0,1588.0,18.4309,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
1288,743084,3,1,,144208363,5280863,Inconclusive,,,68.3107,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1289,743084,3,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
1290,743085,3,1,,144208363,5280863,Inconclusive,51095037.0,196.0,43.1011,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1291,743085,3,1,,144213678,5280863,Inconclusive,51095037.0,196.0,41.2616,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
1292,743086,3,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1293,743086,3,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
1294,743091,2,1,,144208363,5280863,Inconclusive,348019627.0,2099.0,64.4895,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1295,743091,2,1,,144213678,5280863,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
1296,743094,3,1,,144208363,5280863,Inconclusive,216409692.0,5468.0,15.4314,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1297,743094,3,1,,144213678,5280863,Inconclusive,216409692.0,5468.0,33.0649,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1298,743122,2,1,,144208363,5280863,Active,51095037.0,196.0,30.5133,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1299,743122,2,1,,144213678,5280863,Active,51095037.0,196.0,44.5532,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
1300,743126,1,1,,49674535,5280863,Inactive,119580345.0,50487.0,,,QFRET-based biochemical high throughput primary assay to identify inhibitors of human group III secreted phospholipase A2 enzyme (HGIII-sPLA2),Screening,,
1301,743139,2,1,,144208363,5280863,Inconclusive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1302,743139,2,1,,144213678,5280863,Active,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
1303,743140,2,1,,144208363,5280863,Active,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1304,743140,2,1,,144213678,5280863,Active,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1305,743191,3,1,,144208363,5280863,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1306,743191,3,1,,144213678,5280863,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
1307,743194,3,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1308,743194,3,1,,144213678,5280863,Inconclusive,,,33.0649,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
1309,743199,2,1,,144208363,5280863,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1310,743199,2,1,,144213678,5280863,Inconclusive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
1311,743202,4,1,,144208363,5280863,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1312,743202,4,1,,144213678,5280863,Inconclusive,20149576.0,4780.0,32.7752,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
1313,743203,3,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1314,743203,3,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
1315,743208,1,1,,49674535,5280863,Inactive,2393947.0,102.0,,,QFRET-based biochemical high throughput confirmation assay to identify exosite inhibitors of ADAM10.,Screening,,
1316,743209,3,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1317,743209,3,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
1318,743210,4,1,,144208363,5280863,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1319,743210,4,1,,144213678,5280863,Inconclusive,4504517.0,3315.0,20.8625,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
1320,743211,3,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1321,743211,3,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1322,743212,3,1,,144208363,5280863,Inconclusive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1323,743212,3,1,,144213678,5280863,Inconclusive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1324,743213,3,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1325,743213,3,1,,144213678,5280863,Inconclusive,,,9.3189,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
1326,743214,1,1,,49674535,5280863,Inactive,73747889.0,6868.0,,,Counterscreen for exosite inhibitors of ADAM10: QFRET-based biochemical high throughput screening assay to identify inhibitors of ADAM17,Screening,,
1327,743215,3,1,,144208363,5280863,Inconclusive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1328,743215,3,1,,144213678,5280863,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
1329,743217,3,1,,144208363,5280863,Inconclusive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1330,743217,3,1,,144213678,5280863,Inconclusive,325495553.0,9971.0,29.4691,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1331,743218,3,1,,144208363,5280863,Inconclusive,,,54.7528,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1332,743218,3,1,,144213678,5280863,Inconclusive,,,29.4691,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1333,743219,3,1,,144208363,5280863,Inactive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1334,743219,3,1,,144213678,5280863,Inconclusive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
1335,743220,3,1,,144208363,5280863,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1336,743220,3,1,,144213678,5280863,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
1337,743221,3,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1338,743221,3,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
1339,743222,3,1,,144208363,5280863,Inconclusive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1340,743222,3,1,,144213678,5280863,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1341,743223,3,1,,144208363,5280863,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1342,743223,3,1,,144213678,5280863,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
1343,743224,3,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1344,743224,3,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1345,743225,3,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1346,743225,3,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
1347,743226,2,1,,144208363,5280863,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1348,743226,2,1,,144213678,5280863,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1349,743227,2,1,,144208363,5280863,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1350,743227,2,1,,144213678,5280863,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
1351,743228,3,1,,144208363,5280863,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1352,743228,3,1,,144213678,5280863,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
1353,743239,2,1,,144208363,5280863,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1354,743239,2,1,,144213678,5280863,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1355,743240,2,1,,144208363,5280863,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1356,743240,2,1,,144213678,5280863,Inconclusive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
1357,743241,2,1,,144208363,5280863,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1358,743241,2,1,,144213678,5280863,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1359,743242,2,1,,144208363,5280863,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1360,743242,2,1,,144213678,5280863,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
1361,743255,1,1,,46501187,5280863,Inactive,118600387.0,7398.0,,Potency,Inhibitors of USP1/UAF1: Primary Screen,Confirmatory,,
1362,743256,1,1,,49674535,5280863,Inactive,2393947.0,102.0,,,Counterscreen for exosite inhibitors of ADAM17: Fluorescence resonance energy transfer (FRET)-based biochemical high throughput screening assay to identify inhibitors of ADAM10,Screening,,
1363,743257,1,1,,49674535,5280863,Inactive,73747889.0,6868.0,,,QFRET-based biochemical high throughput confirmation assay to identify exosite inhibitors of ADAM17,Screening,,
1364,743266,1,2,,46501187,5280863,Inactive,296080761.0,5745.0,,Potency,qHTS of PTHR Inhibitors: Primary Screen,Confirmatory,,
1365,743269,1,1,,49674535,5280863,Inactive,2853980.0,,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1366,743269,1,1,,49674535,5280863,Inactive,6708281.0,11168.0,,,TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of HIV-1 LEDGF/p75 DNA Integration,Screening,,
1367,743279,1,2,,46501187,5280863,Inactive,10835145.0,3553.0,,,qHTS for Inhibitors of Inflammasome Signaling:  IL-1-beta AlphaLISA Primary Screen,Screening,,
1368,743287,1,1,,49674535,5280863,Inactive,,,,,Luminescent GLuc Reporter Gene Assay Primary HTS to Identify Small Molecule Activator of Glucose Dependent Insulin Secretion Measured in Cell-Based System Using Plate Reader - 7055-01_Activator_SinglePoint_HTS_Activity,Screening,,
1369,743288,1,1,,17389844,5280863,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
1370,743288,1,1,,26757741,5280863,Inactive,,,,Potency,qHTS assay for cell viability of HEK293 cells,Confirmatory,,
1371,743292,1,1,,17389844,5280863,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
1372,743292,1,1,,26757741,5280863,Inactive,,,,Potency,qHTS assay for cell viability of the p53RE-bla HCT-116 cell line,Confirmatory,,
1373,743344,1,1,,174007227,5280863,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (3D7) proliferation,Confirmatory,,
1374,743345,1,1,,174007227,5280863,Inactive,,,0.0841,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation,Confirmatory,,
1375,743346,1,1,,174007227,5280863,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (DD2) proliferation (Rep 2),Confirmatory,,
1376,743347,1,1,,174007227,5280863,Inactive,,,,Potency,qHTS profiling of the MIPE4 collection as inhibitors of Plasmodium falciparum (HB3) proliferation,Confirmatory,,
1377,743398,1,1,,49674535,5280863,Inactive,,,,,Wnt/Beta-catenin HTS Measured in Cell-Based System Using Plate Reader - 2161-01_Activator_SinglePoint_HTS_Activity,Screening,,
1378,748011,2,3,,103206920,5280863,Active,215274146.0,2101.0,9.64,IC50,Inverse agonist activity at human GAL4-DBD-fused ERRalpha-LBD transfected in human HepG2 cells assessed as disruption of interaction with PGC-1alpha after 24 hrs by dual luciferase reporter gene assay,Confirmatory,23656512.0,
1379,749998,1,5,,103206920,5280863,Unspecified,308153572.0,5444.0,,,Binding affinity to recombinant paraoxonase-1 (unknown origin) expressed in Escherichia coli,Other,23623675.0,
1380,749999,1,5,,103206920,5280863,Unspecified,308153572.0,5444.0,,,Binding affinity to recombinant paraoxonase-1 (unknown origin) expressed in Escherichia coli after 5 mins by Trp-fluorescence quenching method,Other,23623675.0,
1381,752786,1,1,,103206920,5280863,Active,,,,,Antiobesity activity in mouse 3T3L1 cells assessed as reduction of fat accumulation at 100 uM by oil Red O staining-based ELISA,Other,23642481.0,
1382,752787,1,5,,103206920,5280863,Active,6686288.0,100157809.0,,,Inhibition of porcine pancreatic lipase using para-nitrophenyl butyrate as substrate at 100 uM by ELISA,Other,23642481.0,
1383,773798,1,1,,103206920,5280863,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent of DPPH scavenging activity after 4 mins by spectrophotometry,Other,24050300.0,
1384,773799,1,1,,103206920,5280863,Unspecified,,,,,Antioxidant activity assessed as trolox equivalent of ferric ion reducing activity using fe3+-TPTZ after 4 mins by FRAP assay,Other,24050300.0,
1385,977611,3,1,,170484817,5280863,Active,422919337.0,,2.1,Kd,Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB,Other,22842046.0,
1386,1053175,2,1,,124811880,5280863,Inactive,,,,,A screen for compounds that inhibit growth of Escherichia coli,Other,,
1387,1053197,1,1,,49674535,5280863,Active,74734243.0,54414.0,,,Fluorescence polarization-based biochemical high throughput primary assay to identify inhibitors of sialic acid acetylesterase (SIAE),Screening,,
1388,1066694,2,3,,103206920,5280863,Unspecified,74764753.0,,55.0,IC50,Inhibition of Leishmania amazonensis recombinant arginase expressed in Escherichia coli Rosetta (DE3) pLysS using L-arginine as substrate incubated for 10 mins prior to substrate addition measured after 10 mins by colorimetry,Confirmatory,24521209.0,
1389,1070386,1,1,,103206920,5280863,Unspecified,,,,,Cytotoxicity against mouse HT22 cells assessed as cell viability after 24 hrs by MTT assay,Other,24245939.0,
1390,1070387,1,1,,103206920,5280863,Unspecified,,,,,Neuroprotective activity in mouse HT22 cells assessed as reduction of glutamate-induced oxidative stress after 24 hrs by MTT assay,Other,24245939.0,
1391,1070388,1,1,,103206920,5280863,Inactive,,,,,Neuroprotective activity in mouse HT22 cells assessed as reduction of t-BOOH-induced oxidative stress at 40 uM preincubated for 3 hrs followed by t-BOOH induction measured after 20 hrs by MTT assay,Other,24245939.0,
1392,1070389,1,1,,103206920,5280863,Inactive,,,,,Neuroprotective activity in mouse HT22 cells assessed as reduction of t-BOOH-induced oxidative stress at 40 uM preincubated for 3 hrs followed by t-BOOH induction measured for 20 hrs by time-resolved ECIS analysis,Other,24245939.0,
1393,1070435,1,4,,103206920,5280863,Inactive,25453452.0,4780.0,,,Activation of Nrf2 (unknown origin) expressed in CHO-ARE luc cells at 10 to 30 uM after 18 hrs by luciferase reporter gene assay,Other,24476568.0,
1394,1082425,1,1,,103206920,5280863,Unspecified,,,,,Stimulation of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 30 mg/mL,Other,21905729.0,
1395,1082430,1,1,,103206920,5280863,Inactive,,,,,Inhibition of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 30 mg/mL,Other,21905729.0,
1396,1082432,1,1,,103206920,5280863,Inactive,,,,,Inhibition of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 60 mg/mL,Other,21905729.0,
1397,1082435,1,1,,103206920,5280863,Inactive,,,,,Inhibition of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 0.1 mg/mL,Other,21905729.0,
1398,1082436,1,1,,103206920,5280863,Unspecified,,,,,Inhibition of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 1 mg/mL,Other,21905729.0,
1399,1082437,1,1,,103206920,5280863,Inactive,,,,,Inhibition of fruit-infesting behavior of Cydia pomonella (codling moth) neonates infested in apple fruit plugs assessed as feeding deterrence index at 10 mg/mL,Other,21905729.0,
1400,1083154,1,1,,103206920,5280863,Unspecified,,,,,Antifungal activity against Diplodia seriata BoF98-1 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
1401,1083155,1,1,,103206920,5280863,Unspecified,,,,,Antifungal activity against Diplodia seriata BoF99-1 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
1402,1083156,1,1,,103206920,5280863,Unspecified,,,,,Antifungal activity against Diplodia seriata LAT28 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
1403,1083157,1,1,,103206920,5280863,Unspecified,,,,,Antifungal activity against Lasiodiplodia theobromae CBS116460 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
1404,1083158,1,1,,103206920,5280863,Unspecified,,,,,Antifungal activity against Diplodia seriata PLU03 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
1405,1083159,1,1,,103206920,5280863,Unspecified,,,,,Antifungal activity against Diplodia mutila BRA08 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
1406,1083160,1,1,,103206920,5280863,Unspecified,,,,,Antifungal activity against Neofusicoccum luteum CBS110299 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
1407,1083161,1,1,,103206920,5280863,Unspecified,,,,,Antifungal activity against Neofusicoccum parvum PER20 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
1408,1083162,1,1,,103206920,5280863,Unspecified,,,,,Antifungal activity against Neofusicoccum parvum Bp0014 assessed as growth inhibition measured after 1 to 10 days,Other,23145924.0,
1409,1083163,1,1,,103206920,5280863,Unspecified,,,,,Antifungal activity against Botryosphaeria dothidea OGE14 assessed as growth inhibition measured after 1 to 10 days relative to control,Other,23145924.0,
1410,1083168,1,1,,103206920,5280863,Inactive,,,,,Antifungal activity against Eutypa lata BX1-10 assessed as growth inhibition at 500 uM measured after 1 to 10 days relative to control,Other,23145924.0,
1411,1083171,1,1,,103206920,5280863,Inactive,,,,,Antifungal activity against Togninia minima SO21 assessed as susceptibility at 500 uM measured after 1 to 10 days,Other,23145924.0,
1412,1084380,1,4,,103206920,5280863,Unspecified,75651200.0,,,,Inhibition of Avian myeloblastosis virus reverse transcriptase,Other,,
1413,1087143,1,4,,103206920,5280863,Unspecified,126716.0,,,,Inhibition of baker's yeast alpha-glucosidase using p-nitrophenyl-alpha-D-glucopyranoside as substrate by spectrophotometry,Other,,
1414,1094164,1,3,,103206920,5280863,Unspecified,,,,,Antioxidant activity assessed as inhibition of DPPH radical production at 33 uM after 5 min by spectrophotometric analysis,Other,,
1415,1095229,2,3,,103206920,5280863,Active,266423.0,1021.0,22.0,IC50,Inhibition of Homo sapiens (human) cyclin-dependent kinase 6,Confirmatory,,
1416,1095400,1,3,,103206920,5280863,Unspecified,,,,,Antioxidant activity assessed as inhibition of DPPH radical production after 30 min by spectrophotometric analysis,Other,,
1417,1095401,1,2,,103206920,5280863,Unspecified,,,,,Antioxidant activity assessed as inhibition of ABTS radical production after 10 min by spectrophotometric analysis,Other,,
1418,1095886,1,3,,103206920,5280863,Unspecified,,,,,Antioxidant activity assessed as inhibition of DPPH radical production after 30 min by microplate assay,Other,,
1419,1095888,1,3,,103206920,5280863,Unspecified,,,,,Antioxidant activity assessed as inhibition of DPPH radical production at 54.05 ug/ml after 30 min by microplate assay,Other,,
1420,1095890,2,3,,103206920,5280863,Unspecified,81885339.0,367562.0,59.54,IC50,Inhibition ofRattus norvegicus alpha-glucosidase isolated from intestine using PNPG as substrate incubated for 15 min prior to substrate addition measured after 15 min by spectrophotometric analysis,Confirmatory,,
1421,1095892,1,4,,103206920,5280863,Unspecified,81885339.0,367562.0,,,Inhibition ofRattus norvegicus alpha-glucosidase isolated from intestine using PNPG as substrate at 0.03 uM incubated for 15 min prior to substrate addition measured after 15 min by spectrophotometric analysis,Other,,
1422,1095894,1,2,,103206920,5280863,Unspecified,,,61.83,IC50,Inhibition of alpha-glucosidase (unknown origin) using PNPG as substrate incubated for 15 min prior to substrate addition measured after 15 min by spectrophotometric analysis,Confirmatory,,
1423,1095896,1,2,,103206920,5280863,Unspecified,,,,,Inhibition of alpha-glucosidase (unknown origin) using PNPG as substrate at 0.03 uM incubated for 15 min prior to substrate addition measured after 15 min by spectrophotometric analysis,Other,,
1424,1097036,1,2,,103206920,5280863,Unspecified,,,,,Antiamoebic activity against Entamoeba histolytica,Other,,
1425,1102124,1,1,,103206920,5280863,Unspecified,,,,,Phytotoxicity in Solanum lycopersicum (tomato) assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
1426,1102127,1,1,,103206920,5280863,Unspecified,,,,,Phytotoxicity in Triticum aestivum (wheat) assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
1427,1102131,1,1,,103206920,5280863,Active,,,,,Phytotoxicity in Linaria genistifolia subsp. dalmatica assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
1428,1102136,1,1,,103206920,5280863,Active,,,,,Phytotoxicity in Centaurea diffusa assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
1429,1102137,1,1,,103206920,5280863,Unspecified,,,,,Phytotoxicity in Arabidopsis thaliana assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
1430,1102141,1,1,,103206920,5280863,Active,,,,,Phytotoxicity in Bassia scoparia assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
1431,1102142,1,1,,103206920,5280863,Inactive,,,,,Phytotoxicity in Centaurea maculosa assessed as inhibition of seed germination at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
1432,1102145,1,1,,103206920,5280863,Unspecified,,,,,Phytotoxicity in Solanum lycopersicum (tomato) assessed as increase in mortality at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
1433,1102146,1,1,,103206920,5280863,Active,,,,,Phytotoxicity in Triticum aestivum (wheat) assessed as increase in mortality at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
1434,1102147,1,1,,103206920,5280863,Unspecified,,,,,Phytotoxicity in Arabidopsis thaliana assessed as increase in mortality at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
1435,1102148,1,1,,103206920,5280863,Active,,,,,Phytotoxicity in Bassia scoparia assessed as increase in mortality at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
1436,1102149,1,1,,103206920,5280863,Active,,,,,Phytotoxicity in Linaria genistifolia subsp. dalmatica assessed as increase in mortality at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
1437,1102150,1,1,,103206920,5280863,Active,,,,,Phytotoxicity in Centaurea diffusa assessed as increase in mortality at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
1438,1102151,1,1,,103206920,5280863,Inactive,,,,,Phytotoxicity in Centaurea maculosa assessed as increase in mortality at 250 ug/mL measured on day 14 relative to untreated control,Other,12568546.0,
1439,1114437,1,2,,103206920,5280863,Inactive,,,,,Antitubercular activity against Mycobacterium tuberculosis H37Rv ATCC 27294 at 100 ug/ml measured every 24 hr by BACTEC 460 radiometric assay,Other,,
1440,1115243,1,2,,103206920,5280863,Active,,,38.1,IC50,inhibition of Influenza A virus H3N2 neuraminidase,Confirmatory,,
1441,1115334,1,2,,103206920,5280863,Active,,,10.0,IC50,Inhibition of NADPH oxidase in Homo sapiens (human) HUVEC cells,Confirmatory,,
1442,1115336,2,3,,103206920,5280863,Active,296434407.0,23621.0,14.7,IC50,Inhibition of BACE1 (unknown origin),Confirmatory,,
1443,1159509,1,1,,144208363,5280863,Inconclusive,119626539.0,4790.0,61.4337,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
1444,1159509,1,1,,144213678,5280863,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
1445,1159515,1,1,,144208363,5280863,Inconclusive,,,21.7975,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
1446,1159515,1,1,,144213678,5280863,Inconclusive,,,13.1634,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
1447,1159516,1,1,,144208363,5280863,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
1448,1159516,1,1,,144213678,5280863,Inconclusive,119611100.0,22926.0,14.7695,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
1449,1159517,1,1,,144208363,5280863,Inconclusive,,,9.7366,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
1450,1159517,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
1451,1159518,1,1,,144208363,5280863,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
1452,1159518,1,1,,144213678,5280863,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
1453,1159519,1,1,,144208363,5280863,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
1454,1159519,1,1,,144213678,5280863,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
1455,1159520,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1456,1159520,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
1457,1159521,1,1,,144208363,5280863,Inactive,15928672.0,19885.0,21.6017,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1458,1159521,1,1,,144213678,5280863,Inactive,15928672.0,19885.0,16.4265,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
1459,1159523,1,1,,144208363,5280863,Inconclusive,15928672.0,19885.0,21.6017,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
1460,1159523,1,1,,144213678,5280863,Inconclusive,15928672.0,19885.0,13.0481,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
1461,1159524,1,1,,46501187,5280863,Inactive,,,12.5893,Potency,High Throughput Screening for Foot and Mouth Disease Virus Antivirals,Confirmatory,,
1462,1159525,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
1463,1159525,1,1,,144213678,5280863,Inconclusive,,,29.4691,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
1464,1159526,1,1,,144208363,5280863,Inconclusive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
1465,1159526,1,1,,144213678,5280863,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
1466,1159527,1,1,,144208363,5280863,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
1467,1159527,1,1,,144213678,5280863,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
1468,1159528,1,1,,144208363,5280863,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
1469,1159528,1,1,,144213678,5280863,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
1470,1159529,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
1471,1159529,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
1472,1159531,1,1,,144208363,5280863,Inconclusive,325495497.0,6256.0,34.5467,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
1473,1159531,1,1,,144213678,5280863,Inconclusive,325495497.0,6256.0,27.8206,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
1474,1159551,1,1,,144208363,5280863,Inconclusive,,,21.6017,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
1475,1159551,1,1,,144213678,5280863,Inconclusive,,,13.0481,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
1476,1159552,1,1,,144208363,5280863,Inactive,325495463.0,5914.0,7.6646,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1477,1159552,1,1,,144213678,5280863,Inactive,325495463.0,5914.0,14.6402,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1478,1159553,2,1,,144208363,5280863,Inconclusive,325495463.0,5914.0,2.7195,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1479,1159553,2,1,,144213678,5280863,Active,325495463.0,5914.0,18.4309,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
1480,1159555,1,1,,144208363,5280863,Inconclusive,325495463.0,5914.0,7.098319999999999,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1481,1159555,1,1,,144213678,5280863,Inconclusive,325495463.0,5914.0,6.5395199999999996,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
1482,1159606,1,1,,49674535,5280863,Inactive,,,,,"uHTS identification of small molecule inhibitors of TWEAK-Fn14 interactions, using a cell-based reporter assay",Other,,
1483,1159607,2,1,,312596173,5280863,Inactive,,,,,Screen for inhibitors of RMI FANCM (MM2) intereaction,Other,26962873.0,
1484,1162595,1,2,,103206920,5280863,Active,21542418.0,4790.0,,,Inhibition of PMA-stimulated NF-kappaB signaling (unknown origin) expressed in MDA-MB-231 cells at 5 uM incubated for 16 hrs by luciferase reporter gene assay,Other,25190466.0,
1485,1162595,1,2,,103206920,5280863,Active,62906901.0,5970.0,,,Inhibition of PMA-stimulated NF-kappaB signaling (unknown origin) expressed in MDA-MB-231 cells at 5 uM incubated for 16 hrs by luciferase reporter gene assay,Other,25190466.0,
1486,1162595,1,2,,103206920,5280863,Active,116242678.0,4791.0,,,Inhibition of PMA-stimulated NF-kappaB signaling (unknown origin) expressed in MDA-MB-231 cells at 5 uM incubated for 16 hrs by luciferase reporter gene assay,Other,25190466.0,
1487,1162612,1,2,,103206920,5280863,Inactive,21542418.0,4790.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated MMP9 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method,Other,25190466.0,
1488,1162612,1,2,,103206920,5280863,Inactive,62906901.0,5970.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated MMP9 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method,Other,25190466.0,
1489,1162612,1,2,,103206920,5280863,Inactive,116242678.0,4791.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated MMP9 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method,Other,25190466.0,
1490,1162613,1,2,,103206920,5280863,Inactive,21542418.0,4790.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated COX2 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method,Other,25190466.0,
1491,1162613,1,2,,103206920,5280863,Inactive,62906901.0,5970.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated COX2 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method,Other,25190466.0,
1492,1162613,1,2,,103206920,5280863,Inactive,116242678.0,4791.0,,,Inhibition of NF-kappaB signaling in human MDA-MB-231 cells assessed as reduction in PMA-stimulated COX2 mRNA expression at 25 uM pre-incubated before PMA stimulation by quantitative RT-PCR method,Other,25190466.0,
1493,1186044,1,1,,103206920,5280863,Active,,,,,Cytotoxicity against human HL60 cells assessed as cell survival at 50 uM after 72 hrs by CCK8 assay,Other,25074815.0,
1494,1186763,1,2,,103206920,5280863,Unspecified,143955318.0,,85.2,IC50,Inhibition of influenza A virus (A/California/07/2009(H1N1)) pdm09 neuraminidase using MUNANA substrate pre-incubated for 30 mins before substrate addition by fluorometric assay,Confirmatory,25096296.0,
1495,1186764,1,2,,103206920,5280863,Active,143955318.0,,42.2,IC50,Inhibition of influenza A virus (A/Perth/16/2009(H3N2)) neuraminidase using MUNANA substrate pre-incubated for 30 mins before substrate addition by fluorometric assay,Confirmatory,25096296.0,
1496,1186765,1,1,,103206920,5280863,Unspecified,,,90.8,IC50,Inhibition of influenza B virus (B/Brisbane/60/2008) neuraminidase using MUNANA substrate pre-incubated for 30 mins before substrate addition by fluorometric assay,Confirmatory,25096296.0,
1497,1186766,1,1,,103206920,5280863,Unspecified,,,581.3,CC50,Cytotoxicity against MDCK cells,Confirmatory,25096296.0,
1498,1186767,1,1,,103206920,5280863,Unspecified,,,,,"Selectivity index, ratio of CC50 for MDCK cells to IC50 for influenza A virus (A/Perth/16/2009(H3N2))",Other,25096296.0,
1499,1190380,1,1,,103206920,5280863,Active,,,37.8,IC50,Inhibition of dengue virus 2 NS2B-NS3 serine protease assessed as reduction in hydrolysis of Boc-Gly-Arg-Arg-7-amino-4-methylcumarin substrate,Confirmatory,25564380.0,
1500,1190381,1,1,,103206920,5280863,Active,,,22.3,Ki,Inhibition of dengue virus 2 NS2B-NS3 serine protease assessed as reduction in hydrolysis of Boc-Gly-Arg-Arg-7-amino-4-methylcumarin substrate by Dixon plot,Confirmatory,25564380.0,
1501,1190383,1,1,,103206920,5280863,Active,,,27.7,IC50,Inhibition of dengue virus 3 NS2B-NS3 serine protease assessed as reduction in hydrolysis of Boc-Gly-Arg-Arg-7-amino-4-methylcumarin substrate,Confirmatory,25564380.0,
1502,1190384,1,1,,103206920,5280863,Active,,,24.2,Ki,Inhibition of dengue virus 3 NS2B-NS3 serine protease assessed as reduction in hydrolysis of Boc-Gly-Arg-Arg-7-amino-4-methylcumarin substrate by Dixon plot,Confirmatory,25564380.0,
1503,1191756,1,2,,103206920,5280863,Unspecified,206729922.0,4350.0,,,"Inhibition of human purified MPG pre-incubated with compound for 10 mins followed by addition of 1,N6 ethenoadenine containing 32P-labeled duplex oligonucleotide substrates at 20 uM by gel-based excision activity assay",Other,25650313.0,
1504,1198219,1,1,,103206920,5280863,Unspecified,,,,,Cytotoxicity against rat L6 cells assessed as viable cells at 10 uM after 72 hrs by MTT assay relative to control,Other,25659770.0,
1505,1198220,1,1,,103206920,5280863,Unspecified,,,,,Cytotoxicity against rat L6 cells assessed as viable cells at 1 uM after 72 hrs by MTT assay relative to control,Other,25659770.0,
1506,1198221,1,1,,103206920,5280863,Unspecified,,,53.7,IC50,Cytotoxicity against mouse B16 cells assessed as cell viability after 48 hrs by MTT assay,Confirmatory,25659770.0,
1507,1198222,1,1,,103206920,5280863,Unspecified,,,,,Antivascular activity in human EAhy926 cells assessed as concentration require to adopt rounding shape after 2 hrs by microscopic analysis,Other,25659770.0,
1508,1198225,1,1,,103206920,5280863,Active,,,27.56,IC50,Leishmanicidal activity against promastigote stage of Leishmania amazonensis MHOM/BR/PH8 after 48 hrs by MTT assay,Confirmatory,25659770.0,
1509,1198226,1,1,,103206920,5280863,Unspecified,,,,,Antiplasmodial activity against Plasmodium falciparum FcB1/Columbia infected in human red blood cells assessed as parasite growth inhibition at 10 uM after 48 hrs by [3H]-hypoxanthine incorporation assay relative to control,Other,25659770.0,
1510,1198228,1,1,,103206920,5280863,Unspecified,,,,,Antitrypanosomal activity against Trypanosoma brucei gambiense Feo assessed as parasite growth inhibition at 50 uM after 72 hrs by fluorescence assay relative to control,Other,25659770.0,
1511,1198229,1,1,,103206920,5280863,Unspecified,,,,,Antitrypanosomal activity against Trypanosoma brucei gambiense Feo assessed as parasite growth inhibition at 10 uM after 72 hrs by fluorescence assay relative to control,Other,25659770.0,
1512,1204216,1,2,,103206920,5280863,Unspecified,6686288.0,100157809.0,,,Inhibition of porcine pancreatic lipase using p-nitrophenylbutyrate as substrate assessed as formation of p-nitrophenol at 100 uM preincubated for 15 mins followed by substrate addition measured after 15 mins relative to control,Other,25935644.0,
1513,1204217,1,2,,103206920,5280863,Unspecified,6686288.0,100157809.0,70.0,IC50,Inhibition of porcine pancreatic lipase using p-nitrophenylbutyrate as substrate assessed as formation of p-nitrophenol preincubated for 15 mins followed by substrate addition measured after 15 mins,Confirmatory,25935644.0,
1514,1224824,1,1,,174007227,5280863,Inactive,,,11.7704,Potency,High-throughput drug toxicity screening in the BPDCN cell line Gen2.2,Confirmatory,,
1515,1224825,1,1,,174007227,5280863,Inactive,,,,Potency,High-throughput drug toxicity screening in the BPDCN cell line Cal-1,Confirmatory,,
1516,1224834,3,1,,144208363,5280863,Inconclusive,,,60.882,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1517,1224834,3,1,,144213678,5280863,Inconclusive,,,36.7744,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
1518,1224835,1,1,,144208363,5280863,Active,160794.0,,31.6021,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1519,1224835,1,1,,144213678,5280863,Active,160794.0,,42.7244,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
1520,1224836,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1521,1224836,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1522,1224837,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1523,1224837,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
1524,1224838,1,1,,144208363,5280863,Inactive,66775687.0,9970.0,68.3107,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1525,1224838,1,1,,144213678,5280863,Inactive,66775687.0,9970.0,41.2616,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1526,1224839,1,1,,144208363,5280863,Inconclusive,66775687.0,9970.0,68.3107,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1527,1224839,1,1,,144213678,5280863,Active,66775687.0,9970.0,36.7744,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
1528,1224840,3,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1529,1224840,3,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
1530,1224841,3,1,,144208363,5280863,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1531,1224841,3,1,,144213678,5280863,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1532,1224842,3,1,,144208363,5280863,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1533,1224842,3,1,,144213678,5280863,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
1534,1224843,1,1,,144208363,5280863,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1535,1224843,1,1,,144213678,5280863,Inconclusive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1536,1224844,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1537,1224844,1,1,,144213678,5280863,Inconclusive,,,14.7695,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
1538,1224845,1,1,,144208363,5280863,Inconclusive,344243002.0,100757539.0,56.4638,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1539,1224845,1,1,,144213678,5280863,Inconclusive,344243002.0,100757539.0,68.0311,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
1540,1224846,1,1,,144208363,5280863,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1541,1224846,1,1,,144213678,5280863,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
1542,1224847,1,1,,144208363,5280863,Inconclusive,,,22.4786,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1543,1224847,1,1,,144213678,5280863,Inconclusive,,,21.5133,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
1544,1224848,3,1,,144208363,5280863,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1545,1224848,3,1,,144213678,5280863,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1546,1224849,3,1,,144208363,5280863,Inconclusive,325495545.0,2101.0,27.195,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1547,1224849,3,1,,144213678,5280863,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
1548,1224857,2,1,,174007227,5280863,Inconclusive,,,20.930999999999997,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human iPSC derived neural progenitor cells (hNPCs),Confirmatory,,
1549,1224859,2,1,,174007227,5280863,Inconclusive,,,11.7704,Potency,qHTS assay for measurement of the activity of small molecule inhibitors on Zika virus induced Caspase-3 activity in human astrocytoma cells,Confirmatory,,
1550,1224865,1,2,,49674535,5280863,Inactive,578162.0,,,,Identify inhibitors of HNF4 alpha protein binding to DNA,Screening,,
1551,1224867,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1552,1224867,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
1553,1224868,1,1,,144208363,5280863,Inconclusive,,,48.7985,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1554,1224868,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
1555,1224869,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1556,1224869,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
1557,1224870,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1558,1224870,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
1559,1224871,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1560,1224871,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
1561,1224872,1,1,,144208363,5280863,Inconclusive,,,43.4917,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1562,1224872,1,1,,144213678,5280863,Inconclusive,,,20.8625,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
1563,1224873,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1564,1224873,1,1,,144213678,5280863,Inconclusive,,,29.4691,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
1565,1224874,1,1,,144208363,5280863,Inconclusive,,,48.7985,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1566,1224874,1,1,,144213678,5280863,Inconclusive,,,29.4691,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
1567,1224875,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1568,1224875,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
1569,1224876,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1570,1224876,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
1571,1224877,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1572,1224877,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
1573,1224878,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1574,1224878,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
1575,1224879,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1576,1224879,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
1577,1224880,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1578,1224880,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
1579,1224881,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1580,1224881,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
1581,1224882,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1582,1224882,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
1583,1224883,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1584,1224883,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
1585,1224884,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1586,1224884,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
1587,1224885,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1588,1224885,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
1589,1224886,1,1,,144208363,5280863,Inconclusive,,,43.4917,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1590,1224886,1,1,,144213678,5280863,Inconclusive,,,26.2643,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
1591,1224887,1,1,,144208363,5280863,Inconclusive,,,43.4917,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1592,1224887,1,1,,144213678,5280863,Inconclusive,,,10.456,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
1593,1224888,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1594,1224888,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
1595,1224889,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1596,1224889,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
1597,1224890,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1598,1224890,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
1599,1224892,1,1,,144208363,5280863,Inconclusive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1600,1224892,1,1,,144213678,5280863,Active,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1601,1224893,1,1,,144208363,5280863,Inconclusive,66775687.0,9970.0,27.195,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1602,1224893,1,1,,144213678,5280863,Inconclusive,66775687.0,9970.0,41.2616,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
1603,1224894,1,1,,144208363,5280863,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1604,1224894,1,1,,144213678,5280863,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
1605,1224895,1,1,,144208363,5280863,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1606,1224895,1,1,,144213678,5280863,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1607,1224896,1,1,,144208363,5280863,Inconclusive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1608,1224896,1,1,,144213678,5280863,Inconclusive,344243002.0,100757539.0,68.0311,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
1609,1238320,1,1,,103206920,5280863,Unspecified,2506326.0,7498.0,,,Inhibition of xanthine oxidase (unknown origin) using xanthine as substrate at 33 to 100 umol/L after 10 mins by HPLC method relative to control,Other,26096677.0,
1610,1239713,1,1,,103206920,5280863,Inactive,,,,,Anti-platelet activity in rat platelet rich plasma assessed as inhibition of ADP and calcium-induced platelet aggregation at 100 uM pre-incubated at 37 degC for 10 mins and measured 30 mins after ADP and calcium addition,Other,26096681.0,
1611,1242901,1,1,,103206920,5280863,Unspecified,6686288.0,100157809.0,100.0,IC50,Inhibition of porcine pancreatic lipase pre-incubated for 15 mins before p-nitrophenylbutyrate substrate addition by microplate reader based method,Confirmatory,26227773.0,
1612,1242902,1,1,,103206920,5280863,Unspecified,6686288.0,100157809.0,,,Inhibition of porcine pancreatic lipase at 100 ug/ml pre-incubated for 15 mins before p-nitrophenylbutyrate substrate addition by microplate reader based method,Other,26227773.0,
1613,1247840,1,1,,103206920,5280863,Active,317373595.0,1612.0,10.0,IC50,Displacement of ANS from DAPK1 catalytic domain (1 to 285) (unknown origin) after 30 mins by fluorescence assay,Confirmatory,26322379.0,
1614,1247842,1,1,,103206920,5280863,Active,,,1.0,IC50,Inhibition of recombinant human CK2 expressed in Escherichia coli using RRRADDSDDDDD as substrate after 10 mins,Confirmatory,26322379.0,
1615,1254155,1,1,,103206920,5280863,Unspecified,115449.0,759.0,10.0,Ki,Inhibition of human recombinant carbonic anhydrase 1 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay,Confirmatory,26498393.0,
1616,1254156,1,1,,103206920,5280863,Active,115456.0,760.0,9.5257,Ki,Inhibition of human recombinant carbonic anhydrase 2 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay,Confirmatory,26498393.0,
1617,1254157,1,1,,103206920,5280863,Unspecified,115465.0,762.0,10.0,Ki,Inhibition of human recombinant carbonic anhydrase 4 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay,Confirmatory,26498393.0,
1618,1254158,1,1,,103206920,5280863,Active,1168744.0,766.0,0.025,Ki,Inhibition of human recombinant carbonic anhydrase 7 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay,Confirmatory,26498393.0,
1619,1254159,1,1,,103206920,5280863,Active,5915866.0,771.0,0.1459,Ki,Inhibition of human recombinant carbonic anhydrase 12 preincubated for 15 mins at room temperature/6 hrs at 4 deg C by stopped-flow CO2 hydration assay,Confirmatory,26498393.0,
1620,1256912,1,1,,103206920,5280863,Unspecified,21903432.0,3417.0,,,Inhibition of human IDH1 R132H mutant expressed in IPTG-induced Escherichia coli BL21 cells assessed as oxidation of NADPH to NADP+ after 5 mins by spectrophotometry,Other,26508549.0,
1621,1256913,1,1,,103206920,5280863,Unspecified,21903432.0,3417.0,,,Inhibition of human IDH1 expressed in IPTG-induced Escherichia coli BL21 cells assessed as reduction of NADP+ to NADPH after 5 mins by spectrophotometry,Other,26508549.0,
1622,1259241,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1623,1259241,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
1624,1259242,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1625,1259242,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
1626,1259243,1,1,,144208363,5280863,Active,124375976.0,367.0,24.2376,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1627,1259243,1,1,,144213678,5280863,Active,124375976.0,367.0,16.4265,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
1628,1259244,1,1,,144208363,5280863,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1629,1259244,1,1,,144213678,5280863,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
1630,1259247,1,1,,144208363,5280863,Active,124375976.0,367.0,31.706999999999997,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1631,1259247,1,1,,144213678,5280863,Active,124375976.0,367.0,14.6402,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
1632,1259248,1,1,,144208363,5280863,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1633,1259248,1,1,,144213678,5280863,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
1634,1259252,1,1,,174007227,5280863,Active,169655958.0,,16.6261,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (RDES),Confirmatory,,
1635,1259253,1,1,,174007227,5280863,Active,169655958.0,,18.6548,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC71),Confirmatory,,
1636,1259255,1,1,,174007227,5280863,Active,169655958.0,,11.7704,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (EW8),Confirmatory,,
1637,1259256,1,1,,174007227,5280863,Inconclusive,169655958.0,,23.485,Potency,qHTS Screen of the MIPE 4.0 Collection Against Ewings Sarcoma (TC32),Confirmatory,,
1638,1259309,1,1,,124811880,5280863,Inactive,,,,,A screen for compounds that are lethal to S. aureus RN4220 with the processive glycosyltransferase UgtP deleted,Other,,
1639,1259310,1,1,,333473459,5280863,Inactive,,,,,AlphaScreen-based biochemical high throughput primary assay to identify activators of the E3 ligase (FBW7).,Screening,,
1640,1259311,1,1,,124811880,5280863,Inactive,,,,,A screen for compounds that are lethal to S. aureus RN4220,Other,,
1641,1259313,1,1,,46501187,5280863,Active,,,,,uHTS identification of small molecule modulators of NR3A,Screening,,
1642,1259318,1,1,,49674535,5280863,Inactive,,,,,uHTS identification of small molecule modulators of Rev-erb Alpha.,Screening,,
1643,1259354,1,1,,348466727,5280863,Inactive,534286618.0,,,,Small-molecule inhibitors of ST2 (IL1RL1),Screening,,
1644,1259364,1,1,,144208363,5280863,Active,1013403374.0,9734.0,21.6017,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1645,1259364,1,1,,144213678,5280863,Active,1013403374.0,9734.0,16.4265,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
1646,1259365,1,1,,144208363,5280863,Inconclusive,,,27.195,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1647,1259365,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
1648,1259366,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1649,1259366,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1650,1259367,1,1,,144208363,5280863,Active,,,48.3603,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1651,1259367,1,1,,144213678,5280863,Inconclusive,,,29.2109,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
1652,1259368,1,1,,144208363,5280863,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1653,1259368,1,1,,144213678,5280863,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1654,1259369,1,1,,144208363,5280863,Active,109731339.0,2737.0,21.6017,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1655,1259369,1,1,,144213678,5280863,Active,109731339.0,2737.0,26.0343,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
1656,1259377,1,1,,144208363,5280863,Active,54288833.0,2100.0,9.6491,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1657,1259377,1,1,,144213678,5280863,Inconclusive,54288833.0,2100.0,13.0481,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1658,1259378,1,1,,144208363,5280863,Inconclusive,54288833.0,2100.0,24.2376,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1659,1259378,1,1,,144213678,5280863,Inconclusive,54288833.0,2100.0,18.4309,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
1660,1259379,1,1,,144208363,5280863,Inconclusive,,,60.882,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1661,1259379,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1662,1259380,1,1,,144208363,5280863,Inconclusive,,,68.3107,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1663,1259380,1,1,,144213678,5280863,Inconclusive,,,36.7744,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1664,1259381,1,1,,144208363,5280863,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1665,1259381,1,1,,144213678,5280863,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
1666,1259382,1,1,,144208363,5280863,Inconclusive,,,68.3107,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1667,1259382,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
1668,1259383,1,1,,144208363,5280863,Active,348019627.0,2099.0,27.195,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1669,1259383,1,1,,144213678,5280863,Active,348019627.0,2099.0,13.0481,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
1670,1259384,1,1,,144208363,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1671,1259384,1,1,,144213678,5280863,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
1672,1259385,1,1,,144208363,5280863,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1673,1259385,1,1,,144213678,5280863,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
1674,1259386,1,1,,144208363,5280863,Inconclusive,,,54.2611,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1675,1259386,1,1,,144213678,5280863,Inconclusive,,,41.2616,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
1676,1259387,1,1,,144208363,5280863,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1677,1259387,1,1,,144213678,5280863,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
1678,1259388,1,1,,144208363,5280863,Active,1013403374.0,9734.0,20.0058,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1679,1259388,1,1,,144213678,5280863,Active,1013403374.0,9734.0,14.6402,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
1680,1259389,1,1,,124748994,5280863,Inactive,,,,,HIV1_TAR : FRET assay measuring displacement of FAM and TAMRA-labeled Tat peptide from HIV-1 TAR RNA.,Screening,,
1681,1259390,1,1,,144208363,5280863,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1682,1259390,1,1,,144213678,5280863,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1683,1259391,1,1,,144208363,5280863,Active,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1684,1259391,1,1,,144213678,5280863,Active,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
1685,1259392,1,1,,144208363,5280863,Inconclusive,109731339.0,2737.0,21.6017,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1686,1259392,1,1,,144213678,5280863,Inconclusive,109731339.0,2737.0,19.9012,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
1687,1259393,1,1,,144208363,5280863,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1688,1259393,1,1,,144213678,5280863,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
1689,1259394,1,1,,144208363,5280863,Active,54288833.0,2100.0,11.468,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1690,1259394,1,1,,144213678,5280863,Active,54288833.0,2100.0,14.089,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1691,1259395,1,1,,144208363,5280863,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1692,1259395,1,1,,144213678,5280863,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
1693,1259396,1,1,,144208363,5280863,Active,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1694,1259396,1,1,,144213678,5280863,Active,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
1695,1259401,1,1,,144208363,5280863,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1696,1259401,1,1,,144213678,5280863,Inconclusive,325495545.0,2101.0,9.78466,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1697,1259402,1,1,,144208363,5280863,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1698,1259402,1,1,,144213678,5280863,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
1699,1259403,1,1,,144208363,5280863,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1700,1259403,1,1,,144213678,5280863,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1701,1259404,1,1,,144208363,5280863,Inconclusive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1702,1259404,1,1,,144213678,5280863,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
1703,1259407,1,1,,363897991,5280863,Inactive,,,,,CCRIS mutagenicity studies,Other,,
1704,1259408,1,1,,363895677,5280863,Active,,,,,GENE-TOX mutagenicity studies,Other,,
1705,1259416,1,2,,340086735,5280863,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
1706,1259416,1,2,,375172155,5280863,Inactive,56786138.0,3458.0,,,Toxoplasma gondii inhibition HTS in the presence of IFN-y,Screening,,
1707,1259421,1,1,,340086735,5280863,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
1708,1259421,1,1,,375172155,5280863,Inactive,56786138.0,3458.0,,,Toxoplasma gondii HTS in the absence of IFN-y,Screening,,
1709,1259423,1,2,,354765709,5280863,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
1710,1259423,1,2,,354913975,5280863,Inactive,,,,,Primary cell-based high-throughput screening assay for identification of small molecule agonists of Aedes aegypti NPYLR7 [Small Molecule Inhibitors of Mosquito Biting Behavior],Screening,,
